P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
1.919e-16 | -36.19 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 19 | 16828 | 49 |
DAB1,SGCZ,LRP1B,HS6ST3,DSCAM,TMEM132D,ANKS1B,GPC6,NXPH1,LUZP2,CNTNAP5,KCND2,LHFPL3,FGF14,OPCML,DLGAP1,CSMD3,PCDH15,DCC |
3.781e-16 | -35.51 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 27 | 16828 | 49 |
PID1,LHFPL3,CNTNAP5,LUZP2,GPC6,TNR,ANKS1B,TMEM132D,SGCZ,DAB1,CHST11,PCDH15,ADARB2,DLGAP1,CADM2,RORA,SLC8A1,OPCML,KCND2,XYLT1,NXPH1,DSCAM,HS6ST3,LRP1B,DCC,CSMD3,FGF14 |
3.781e-16 | -35.51 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 27 | 16828 | 49 |
SGCZ,DAB1,TMEM132D,TNR,GPC6,LUZP2,ANKS1B,LHFPL3,PID1,CNTNAP5,OPCML,SLC8A1,CADM2,RORA,DLGAP1,ADARB2,CHST11,PCDH15,LRP1B,HS6ST3,DSCAM,NXPH1,XYLT1,KCND2,FGF14,CSMD3,DCC |
5.634e-16 | -35.11 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 21 | 16828 | 49 |
DAB1,SGCZ,LRP1B,HS6ST3,DSCAM,TMEM132D,ANKS1B,GPC6,LUZP2,KCND2,CNTNAP5,LHFPL3,PID1,OPCML,KAZN,CADM2,ADARB2,CSMD3,DPP6,PCDH15,DCC |
7.413e-16 | -34.84 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 35 | 16828 | 49 |
TMEM132D,DAB1,PDZRN4,SGCZ,CNTNAP5,GRIK1,PID1,LHFPL3,ANKS1B,LUZP2,TNR,GPC6,RORA,CADM2,LRRC7,SLC8A1,OPCML,PCDH15,ADARB2,DLGAP1,DPP6,DSCAM,HS6ST3,SCD5,LRP1B,KCND2,NXPH1,KAZN,ZBTB20,LRRC4C,FGF14,DCC,ABHD2,CSMD3,DLG2 |
1.389e-15 | -34.21 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 30 | 16828 | 49 |
EPN2,TMEM132D,SGCZ,DAB1,PID1,LHFPL3,CNTNAP5,LUZP2,GPC6,ANKS1B,CADM2,SLC8A1,OPCML,LRRC7,CHST11,PCDH15,DPP6,ZSWIM6,ADARB2,DSCAM,HS6ST3,LRP1B,KCND2,XYLT1,NXPH1,KAZN,NLGN4Y,FGF14,DCC,CSMD3 |
1.389e-15 | -34.21 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 30 | 16828 | 49 |
SGCZ,DAB1,EPN2,TMEM132D,LUZP2,GPC6,ANKS1B,PID1,LHFPL3,CNTNAP5,SLC8A1,OPCML,LRRC7,CADM2,ZSWIM6,DPP6,ADARB2,CHST11,PCDH15,LRP1B,DSCAM,HS6ST3,NXPH1,KCND2,XYLT1,NLGN4Y,FGF14,KAZN,CSMD3,DCC |
1.833e-15 | -33.93 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 32 | 16828 | 49 |
CNTNAP5,PID1,GRIK1,LHFPL3,ANKS1B,LUZP2,GPC6,TNR,TMEM132D,DAB1,SGCZ,PCDH15,ADARB2,DLGAP1,DPP6,RORA,CADM2,LRRC7,SLC8A1,OPCML,KCND2,NXPH1,DSCAM,HS6ST3,SCD5,LRP1B,DCC,ABHD2,CSMD3,KAZN,ZBTB20,FGF14 |
3.529e-15 | -33.28 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 30 | 16828 | 49 |
KCND2,XYLT1,NXPH1,SCD5,DSCAM,HS6ST3,LRP1B,DCC,CSMD3,KAZN,FGF14,PID1,LHFPL3,CNTNAP5,LUZP2,GPC6,ANKS1B,EPN2,TMEM132D,SGCZ,DAB1,CHST11,PCDH15,DPP6,ZSWIM6,ADARB2,DLGAP1,CADM2,OPCML,LRRC7 |
3.529e-15 | -33.28 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 30 | 16828 | 49 |
CSMD3,DCC,FGF14,KAZN,NXPH1,XYLT1,KCND2,LRP1B,HS6ST3,DSCAM,SCD5,DLGAP1,ADARB2,DPP6,ZSWIM6,PCDH15,CHST11,LRRC7,OPCML,CADM2,ANKS1B,GPC6,LUZP2,CNTNAP5,LHFPL3,PID1,DAB1,SGCZ,TMEM132D,EPN2 |
3.952e-15 | -33.16 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 15 | 16828 | 49 |
KCND2,NXPH1,GPC6,ANKS1B,TMEM132D,DSCAM,LRP1B,SGCZ,DAB1,DCC,PCDH15,CSMD3,DLGAP1,OPCML,FGF14 |
4.472e-15 | -33.04 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 30 | 16828 | 49 |
CADM2,OPCML,LRRC7,CHST11,PCDH15,ZSWIM6,DPP6,DLGAP1,ADARB2,TMEM132D,EPN2,SGCZ,DAB1,LHFPL3,PID1,CNTNAP5,GPC6,LUZP2,ANKS1B,KAZN,FGF14,DCC,CSMD3,SCD5,HS6ST3,DSCAM,LRP1B,XYLT1,KCND2,NXPH1 |
3.796e-14 | -30.90 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 46 | 16828 | 49 |
DPP6,ADARB2,DLGAP1,CHST11,PCDH15,SLC8A1,OPCML,LRRC7,NTM,RORA,LUZP2,TNR,PID1,LHFPL3,CNTNAP5,SGCZ,EPN2,TMEM132D,ABHD2,NLGN4Y,ZBTB20,RBFOX1,XYLT1,LRP1B,DSCAM,ZSWIM6,CADM2,GPC6,ANKS1B,GRIK1,DAB1,CSMD3,DLG2,NTNG1,DCC,FGF14,LRRC4C,KAZN,NXPH1,SNTG1,KCND2,KCNMB2,NRXN1,SCD5,HS6ST3,KCNIP4 |
9.093e-14 | -30.03 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 35 | 16828 | 49 |
TMEM132D,EPN2,SGCZ,PDZRN4,DAB1,LHFPL3,PID1,PCDHGC3,CNTNAP5,GPC6,LUZP2,ANKS1B,CADM2,RORA,OPCML,SLC8A1,LRRC7,CHST11,PCDH15,DPP6,ZSWIM6,DLGAP1,ADARB2,SCD5,HS6ST3,DSCAM,LRP1B,XYLT1,KCND2,NXPH1,KAZN,FGF14,LRRC4C,DCC,CSMD3 |
9.926e-13 | -27.64 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 21 | 16828 | 49 |
LRP1B,SGCZ,DSCAM,TMEM132D,LUZP2,GPC6,KCND2,CNTNAP5,SNTG1,LHFPL3,LRRC7,SLC8A1,FGF14,OPCML,KAZN,CSMD3,ADARB2,DLG2,DLGAP1,DPP6,PCDH15 |
1.437e-12 | -27.27 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 30 | 16828 | 49 |
CADM2,OPCML,SLC8A1,LRRC7,PCDH15,LRRTM4,DPP6,ZSWIM6,DLGAP1,ADARB2,TMEM132D,SGCZ,PDZRN4,LHFPL3,PID1,PCDHGC3,CNTNAP5,GPC6,LUZP2,ANKS1B,KAZN,FGF14,DCC,CSMD3,SCD5,HS6ST3,DSCAM,LRP1B,KCND2,NXPH1 |
1.889e-12 | -27.00 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 18 | 16828 | 49 |
DAB1,SGCZ,LRP1B,DSCAM,TMEM132D,NRXN1,GPC6,LUZP2,NXPH1,KCND2,OPCML,FGF14,SLC8A1,NTNG1,CSMD3,DPP6,PCDH15,DCC |
2.038e-12 | -26.92 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 41 | 16828 | 49 |
NXPH1,RBFOX1,SNTG1,XYLT1,KCND2,LRP1B,SCD5,HS6ST3,DSCAM,NTNG1,CSMD3,ABHD2,DCC,FGF14,LRRC4C,KAZN,TNR,GPC6,LUZP2,ANKS1B,LHFPL3,PID1,PCDHGC3,CNTNAP5,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2,LRRTM4,DPP6,ZSWIM6,DLGAP1,ADARB2,CHST11,PCDH15,OPCML,SLC8A1,LRRC7,CADM2,RORA |
4.167e-12 | -26.20 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 30 | 16828 | 49 |
SLC8A1,OPCML,LRRC7,CADM2,DPP6,ZSWIM6,LRRTM4,ADARB2,DLGAP1,PCDH15,PDZRN4,SGCZ,TMEM132D,LUZP2,GPC6,ANKS1B,PID1,LHFPL3,CNTNAP5,PCDHGC3,FGF14,KAZN,CSMD3,DCC,LRP1B,SCD5,DSCAM,HS6ST3,NXPH1,KCND2 |
7.147e-12 | -25.66 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 35 | 16828 | 49 |
CSMD3,DCC,FGF14,LRRC4C,KAZN,NXPH1,XYLT1,KCND2,LRP1B,SCD5,HS6ST3,DSCAM,ZSWIM6,DPP6,DLGAP1,ADARB2,CHST11,PCDH15,OPCML,SLC8A1,LRRC7,CADM2,RORA,GPC6,LUZP2,ANKS1B,LHFPL3,PID1,PCDHGC3,CNTNAP5,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2 |
2.150e-11 | -24.56 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 32 | 16828 | 49 |
DPP6,DLGAP1,ADARB2,CHST11,PCDH15,OPCML,SLC8A1,CADM2,GPC6,TNR,LUZP2,ANKS1B,LHFPL3,CNTNAP5,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2,DLG2,CSMD3,DCC,LRRC4C,KAZN,NXPH1,SNTG1,RBFOX1,XYLT1,KCND2,LRP1B,HS6ST3,DSCAM |
2.150e-11 | -24.56 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 32 | 16828 | 49 |
DLG2,CSMD3,DCC,LRRC4C,KAZN,NXPH1,SNTG1,RBFOX1,XYLT1,KCND2,LRP1B,HS6ST3,DSCAM,DPP6,DLGAP1,ADARB2,CHST11,PCDH15,OPCML,SLC8A1,CADM2,GPC6,TNR,LUZP2,ANKS1B,LHFPL3,CNTNAP5,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2 |
2.188e-11 | -24.55 | humerus | COSMIC cancer mutations | humerus | 546 | 15 | 16828 | 49 |
PCDH15,DCC,DLGAP1,CSMD3,FGF14,OPCML,KCND2,ANKS1B,GPC6,NXPH1,DSCAM,TMEM132D,DAB1,SGCZ,LRP1B |
2.238e-11 | -24.52 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 16 | 16828 | 49 |
OPCML,FGF14,CSMD3,NTNG1,DPP6,PCDH15,DCC,DAB1,LRP1B,SGCZ,DSCAM,NRXN1,TMEM132D,LUZP2,GPC6,KCND2 |
2.289e-11 | -24.50 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 16 | 16828 | 49 |
KCND2,GPC6,LUZP2,DSCAM,TMEM132D,NRXN1,DAB1,SGCZ,LRP1B,PCDH15,DCC,NTNG1,CSMD3,DPP6,FGF14,OPCML |
1.029e-10 | -23.00 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 10 | 16828 | 49 |
PCDH15,CNTNAP5,LHFPL3,CSMD3,LUZP2,DSCAM,HS6ST3,TMEM132D,LRP1B,FGF14 |
2.337e-10 | -22.18 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 32 | 16828 | 49 |
LRRTM4,DPP6,ZSWIM6,DLGAP1,ADARB2,PCDH15,OPCML,SLC8A1,LRRC7,CADM2,RORA,NTM,TNR,GPC6,LUZP2,ANKS1B,LHFPL3,PID1,CNTNAP5,SGCZ,DAB1,TMEM132D,CSMD3,DCC,FGF14,ZBTB20,NXPH1,KCND2,LRP1B,NRXN1,HS6ST3,DSCAM |
2.337e-10 | -22.18 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 32 | 16828 | 49 |
NXPH1,KCND2,LRP1B,DSCAM,HS6ST3,NRXN1,CSMD3,DCC,ZBTB20,FGF14,ANKS1B,LUZP2,GPC6,TNR,CNTNAP5,PID1,LHFPL3,DAB1,SGCZ,TMEM132D,ADARB2,DLGAP1,ZSWIM6,DPP6,LRRTM4,PCDH15,LRRC7,SLC8A1,OPCML,NTM,RORA,CADM2 |
3.654e-10 | -21.73 | cell adhesion | biological process | GO:0007155 | 942 | 16 | 18204 | 45 |
DAB1,OPCML,TNR,NLGN4Y,NTM,CNTNAP5,NTNG1,LRRC7,NRXN1,CADM2,PCDH15,DSCAM,DCC,LRRC4C,PCDHGC3,DLG2 |
4.181e-10 | -21.60 | cell-cell adhesion | biological process | GO:0098609 | 546 | 13 | 18204 | 45 |
PCDH15,CADM2,LRRC4C,DSCAM,DCC,PCDHGC3,DLG2,DAB1,TNR,LRRC7,NTNG1,NLGN4Y,NRXN1 |
6.000e-10 | -21.23 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 46 | 16828 | 49 |
ZSWIM6,CADM2,GPC6,ANKS1B,GRIK1,DAB1,DLG2,CSMD3,DCC,FGF14,LRRC4C,KAZN,NXPH1,SNTG1,KCND2,KCNMB2,NRXN1,KCNIP4,HS6ST3,LRRTM4,DPP6,DLGAP1,ADARB2,CHST11,PCDH15,OPCML,SLC8A1,LRRC7,RORA,NTM,TNR,LUZP2,LHFPL3,PID1,CNTNAP5,SGCZ,PDZRN4,TMEM132D,EPN2,ABHD2,NLGN4Y,ZBTB20,RBFOX1,XYLT1,LRP1B,DSCAM |
9.988e-10 | -20.72 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 17 | 16828 | 49 |
SGCZ,LRP1B,DAB1,HS6ST3,DSCAM,GPC6,LUZP2,ANKS1B,CNTNAP5,FGF14,OPCML,SLC8A1,CADM2,RORA,CSMD3,ADARB2,PCDH15 |
1.049e-09 | -20.68 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 42 | 16828 | 49 |
EPN2,TMEM132D,SGCZ,DAB1,GRIK1,PID1,LHFPL3,CNTNAP5,LUZP2,TNR,GPC6,ANKS1B,CADM2,RORA,SLC8A1,OPCML,LRRC7,CHST11,PCDH15,DPP6,ZSWIM6,LRRTM4,ADARB2,DLGAP1,SCD5,DSCAM,KCNIP4,HS6ST3,LRP1B,KCNMB2,SNTG1,KCND2,XYLT1,NXPH1,KAZN,NLGN4Y,FGF14,LRRC4C,DCC,ABHD2,CSMD3,DLG2 |
1.952e-09 | -20.05 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 18 | 16828 | 49 |
CSMD3,ADARB2,PCDH15,DCC,OPCML,CADM2,ANKS1B,LUZP2,GPC6,KCND2,CNTNAP5,PID1,LHFPL3,LRP1B,PDZRN4,SGCZ,DSCAM,TMEM132D |
1.952e-09 | -20.05 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 18 | 16828 | 49 |
OPCML,CADM2,CSMD3,ADARB2,DCC,PCDH15,SGCZ,LRP1B,PDZRN4,TMEM132D,DSCAM,GPC6,LUZP2,ANKS1B,LHFPL3,PID1,CNTNAP5,KCND2 |
4.816e-09 | -19.15 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 22 | 16828 | 49 |
PCDH15,LRRTM4,DPP6,DLGAP1,RORA,LRRC7,CNTNAP5,GPC6,TMEM132D,PDZRN4,DAB1,DCC,DLG2,CSMD3,LRRC4C,ZBTB20,SNTG1,XYLT1,KCND2,NRXN1,DSCAM,LRP1B |
4.910e-09 | -19.13 | larynx | COSMIC cancer mutations | larynx | 1948 | 22 | 16828 | 49 |
SNTG1,XYLT1,CNTNAP5,KCND2,GPC6,TMEM132D,NRXN1,DSCAM,PDZRN4,LRP1B,DAB1,DCC,PCDH15,LRRTM4,DPP6,DLG2,DLGAP1,CSMD3,RORA,LRRC4C,ZBTB20,LRRC7 |
5.612e-09 | -19.00 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 19 | 16828 | 49 |
DCC,PCDH15,ZSWIM6,CSMD3,CADM2,OPCML,LHFPL3,CNTNAP5,NXPH1,LUZP2,GPC6,ANKS1B,TMEM132D,DSCAM,HS6ST3,LRP1B,PDZRN4,SGCZ,DAB1 |
9.562e-09 | -18.47 | synapse | cellular component | GO:0045202 | 1473 | 18 | 19108 | 49 |
LRRC4C,GPC6,ANKS1B,NLGN4Y,NRXN1,DLGAP1,LRRC7,DCC,NTNG1,PCDH15,KCND2,TNR,DSCAM,GRIK1,SLC8A1,DLG2,LRRTM4,CADM2 |
1.422e-08 | -18.07 | postsynaptic specialization | cellular component | GO:0099572 | 345 | 10 | 19108 | 49 |
NLGN4Y,DLG2,SLC8A1,GRIK1,LRRC4C,ANKS1B,KCND2,LRRC7,DCC,DLGAP1 |
2.241e-08 | -17.61 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 19 | 16828 | 49 |
TMEM132D,DSCAM,HS6ST3,PDZRN4,LRP1B,SGCZ,DAB1,LHFPL3,CNTNAP5,LUZP2,NXPH1,GPC6,ANKS1B,CADM2,OPCML,DCC,PCDH15,ZSWIM6,CSMD3 |
2.320e-08 | -17.58 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 17 | 16828 | 49 |
CADM2,RORA,SLC8A1,OPCML,FGF14,PCDH15,ADARB2,CSMD3,DSCAM,HS6ST3,LRP1B,SGCZ,DAB1,CNTNAP5,LUZP2,GPC6,ANKS1B |
5.732e-08 | -16.67 | synaptic membrane | cellular component | GO:0097060 | 400 | 10 | 19108 | 49 |
LRRC4C,GRIK1,NLGN4Y,DLG2,NRXN1,LRRTM4,DCC,LRRC7,KCND2,NTNG1 |
9.120e-08 | -16.21 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 11 | 16828 | 49 |
OPCML,DCC,PCDH15,ZSWIM6,CSMD3,DSCAM,SGCZ,LRP1B,CNTNAP5,GPC6,NXPH1 |
9.748e-08 | -16.14 | postsynaptic density | cellular component | GO:0014069 | 317 | 9 | 19108 | 49 |
DLGAP1,DCC,LRRC7,GRIK1,SLC8A1,ANKS1B,LRRC4C,DLG2,NLGN4Y |
1.481e-07 | -15.73 | asymmetric synapse | cellular component | GO:0032279 | 333 | 9 | 19108 | 49 |
SLC8A1,GRIK1,ANKS1B,LRRC4C,NLGN4Y,DLG2,DLGAP1,DCC,LRRC7 |
2.184e-07 | -15.34 | potassium channel complex | cellular component | GO:0034705 | 101 | 6 | 19108 | 49 |
KCNIP4,KCND2,KCNMB2,GRIK1,DLG2,DPP6 |
2.851e-07 | -15.07 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 49 | 16828 | 49 |
DSCAM,KCNIP4,HS6ST3,NRXN1,SCD5,KCNMB2,LRP1B,KCND2,XYLT1,SNTG1,RBFOX1,NXPH1,KAZN,LRRC4C,ZBTB20,NLGN4Y,FGF14,DCC,ABHD2,CSMD3,NTNG1,DLG2,EPN2,TMEM132D,DAB1,PDZRN4,SGCZ,CNTNAP5,PCDHGC3,GRIK1,PID1,LHFPL3,ANKS1B,LUZP2,GPC6,TNR,NTM,RORA,CADM2,LRRC7,SLC8A1,OPCML,PCDH15,CHST11,ADARB2,DLGAP1,DPP6,ZSWIM6,LRRTM4 |
3.213e-07 | -14.95 | neuron to neuron synapse | cellular component | GO:0098984 | 365 | 9 | 19108 | 49 |
ANKS1B,LRRC4C,SLC8A1,GRIK1,NLGN4Y,DLG2,DLGAP1,DCC,LRRC7 |
3.340e-07 | -14.91 | bone | COSMIC cancer mutations | bone | 8157 | 41 | 16828 | 49 |
OPCML,SLC8A1,LRRC7,CADM2,RORA,LRRTM4,DPP6,DLGAP1,ADARB2,CHST11,PCDH15,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2,GPC6,TNR,LUZP2,ANKS1B,LHFPL3,PCDHGC3,CNTNAP5,FGF14,ZBTB20,LRRC4C,DLG2,NTNG1,CSMD3,ABHD2,DCC,LRP1B,KCNMB2,SCD5,NRXN1,KCNIP4,HS6ST3,DSCAM,NXPH1,SNTG1,KCND2 |
4.257e-07 | -14.67 | Interactions of neurexins and neuroligins at synapses | REACTOME pathways | R-HSA-6794361 | 58 | 5 | 10285 | 28 |
NLGN4Y,DLGAP1,LRRTM4,NRXN1,DLG2 |
4.628e-07 | -14.59 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 16 | 16828 | 49 |
ZBTB20,LRRC4C,OPCML,SLC8A1,NTM,NTNG1,DLG2,CSMD3,DCC,PDZRN4,LRP1B,EPN2,TNR,LUZP2,XYLT1,KCND2 |
5.155e-07 | -14.48 | postsynaptic membrane | cellular component | GO:0045211 | 280 | 8 | 19108 | 49 |
LRRTM4,KCND2,LRRC7,DCC,GRIK1,LRRC4C,DLG2,NLGN4Y |
5.309e-07 | -14.45 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 29 | 16828 | 49 |
DLGAP1,LRRTM4,DPP6,CHST11,LRRC7,OPCML,NTM,CADM2,ANKS1B,TNR,GPC6,PCDHGC3,CNTNAP5,GRIK1,PID1,PDZRN4,TMEM132D,DLG2,CSMD3,DCC,LRRC4C,ZBTB20,NXPH1,KCND2,RBFOX1,SNTG1,LRP1B,HS6ST3,DSCAM |
5.320e-07 | -14.45 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 8 | 16828 | 49 |
DSCAM,KAZN,TMEM132D,SGCZ,PDZRN4,CNTNAP5,PCDH15,ANKS1B |
5.320e-07 | -14.45 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 8 | 16828 | 49 |
DSCAM,TMEM132D,KAZN,PDZRN4,SGCZ,PCDH15,CNTNAP5,ANKS1B |
5.478e-07 | -14.42 | postsynapse | cellular component | GO:0098794 | 646 | 11 | 19108 | 49 |
DLG2,NLGN4Y,ANKS1B,LRRC4C,SLC8A1,GRIK1,DCC,LRRC7,KCND2,DLGAP1,LRRTM4 |
5.854e-07 | -14.35 | arm | COSMIC cancer mutations | arm | 1331 | 16 | 16828 | 49 |
PDZRN4,LRP1B,EPN2,TNR,LUZP2,XYLT1,KCND2,OPCML,SLC8A1,LRRC4C,ZBTB20,NTM,NTNG1,DLG2,CSMD3,DCC |
6.436e-07 | -14.26 | plasma membrane | cellular component | GO:0005886 | 5538 | 31 | 19108 | 49 |
DPP6,ABHD2,GRIK1,PCDHGC3,SLC8A1,CADM2,KAZN,OPCML,KCNMB2,LRRTM4,NLGN4Y,LRP1B,GPC6,ANKS1B,KCND2,LHFPL3,EPN2,DCC,KCNIP4,DLG2,DSCAM,SNTG1,CSMD3,LRRC4C,NTNG1,PCDH15,LRRC7,SGCZ,NTM,NRXN1,DLGAP1 |
7.716e-07 | -14.07 | postsynaptic specialization membrane | cellular component | GO:0099634 | 125 | 6 | 19108 | 49 |
NLGN4Y,DLG2,KCND2,DCC,GRIK1,LRRC4C |
9.618e-07 | -13.85 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 29 | 16828 | 49 |
LRP1B,KCNMB2,DSCAM,HS6ST3,SNTG1,XYLT1,NLGN4Y,FGF14,LRRC4C,KAZN,CSMD3,NTNG1,DLG2,DCC,EPN2,TMEM132D,LUZP2,TNR,ANKS1B,GRIK1,CNTNAP5,SLC8A1,LRRC7,CADM2,DPP6,ADARB2,DLGAP1,CHST11,PCDH15 |
9.618e-07 | -13.85 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 29 | 16828 | 49 |
PCDH15,CHST11,ADARB2,DLGAP1,DPP6,CADM2,LRRC7,SLC8A1,CNTNAP5,GRIK1,ANKS1B,LUZP2,TNR,EPN2,TMEM132D,DCC,CSMD3,NTNG1,DLG2,KAZN,LRRC4C,NLGN4Y,FGF14,XYLT1,SNTG1,DSCAM,HS6ST3,KCNMB2,LRP1B |
9.787e-07 | -13.84 | cell junction | cellular component | GO:0030054 | 2224 | 19 | 19108 | 49 |
DLG2,TNR,DSCAM,GRIK1,SLC8A1,CADM2,KAZN,LRRTM4,NLGN4Y,LRRC4C,GPC6,ANKS1B,LRRC7,DCC,PCDH15,NTNG1,KCND2,NRXN1,DLGAP1 |
1.167e-06 | -13.66 | cell periphery | cellular component | GO:0071944 | 6020 | 32 | 19108 | 49 |
SNTG1,LRRC4C,CSMD3,LRRC7,PCDH15,NTNG1,NTM,NRXN1,DLGAP1,SGCZ,DLG2,TNR,DSCAM,LRP1B,NLGN4Y,GPC6,ANKS1B,EPN2,DCC,LHFPL3,KCND2,KCNIP4,DPP6,ABHD2,GRIK1,PCDHGC3,SLC8A1,CADM2,KCNMB2,OPCML,KAZN,LRRTM4 |
1.266e-06 | -13.58 | Protein-protein interactions at synapses | REACTOME pathways | R-HSA-6794362 | 72 | 5 | 10285 | 28 |
DLG2,NRXN1,LRRTM4,DLGAP1,NLGN4Y |
1.393e-06 | -13.48 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 35 | 16828 | 49 |
PCDHGC3,CNTNAP5,PID1,ANKS1B,GPC6,TNR,LUZP2,TMEM132D,DAB1,SGCZ,PDZRN4,PCDH15,CHST11,DLGAP1,ADARB2,LRRTM4,DPP6,RORA,CADM2,LRRC7,OPCML,SLC8A1,SNTG1,RBFOX1,KCNIP4,DSCAM,NRXN1,KCNMB2,LRP1B,DCC,DLG2,CSMD3,KAZN,LRRC4C,ZBTB20 |
1.693e-06 | -13.29 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 25 | 16828 | 49 |
CSMD3,DCC,LRRC4C,FGF14,KCND2,KCNMB2,LRP1B,DSCAM,HS6ST3,KCNIP4,NRXN1,ADARB2,DLGAP1,DPP6,PCDH15,CADM2,ANKS1B,LUZP2,TNR,CNTNAP5,PCDHGC3,GRIK1,PDZRN4,SGCZ,TMEM132D |
1.742e-06 | -13.26 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 22 | 16828 | 49 |
CADM2,SLC8A1,LRRC4C,PCDH15,DPP6,ZSWIM6,DLGAP1,NTNG1,DLG2,CSMD3,DSCAM,SGCZ,PDZRN4,LRP1B,DAB1,SNTG1,RBFOX1,PID1,PCDHGC3,GPC6,TNR,LUZP2 |
2.782e-06 | -12.79 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 8 | 10285 | 28 |
GRIK1,KCND2,DLGAP1,NLGN4Y,DLG2,NRXN1,LRRTM4,KCNMB2 |
3.102e-06 | -12.68 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 48 | 16828 | 49 |
LUZP2,GPC6,TNR,ANKS1B,PID1,GRIK1,LHFPL3,CNTNAP5,PCDHGC3,PDZRN4,SGCZ,DAB1,EPN2,TMEM132D,ZSWIM6,DPP6,LRRTM4,ADARB2,DLGAP1,CHST11,PCDH15,SLC8A1,OPCML,LRRC7,CADM2,NTM,RORA,NXPH1,SNTG1,RBFOX1,KCND2,XYLT1,LRP1B,KCNMB2,NRXN1,SCD5,DSCAM,HS6ST3,KCNIP4,CSMD3,DLG2,DCC,ABHD2,NLGN4Y,FGF14,ZBTB20,LRRC4C,KAZN |
3.234e-06 | -12.64 | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | 683 | 11 | 16828 | 49 |
KCNIP4,NRXN1,EPN2,DAB1,LRP1B,SNTG1,GPC6,ZBTB20,DCC,CHST11,CSMD3 |
3.234e-06 | -12.64 | primary_central_nervous_system_lymphoma | COSMIC cancer mutations | primary_central_nervous_system_lymphoma | 683 | 11 | 16828 | 49 |
GPC6,CSMD3,DCC,CHST11,SNTG1,LRP1B,ZBTB20,DAB1,EPN2,NRXN1,KCNIP4 |
3.275e-06 | -12.63 | cell-cell adhesion via plasma-membrane adhesion molecules | biological process | GO:0098742 | 261 | 7 | 18204 | 45 |
DSCAM,LRRC4C,NTNG1,DAB1,CADM2,PCDH15,PCDHGC3 |
3.355e-06 | -12.61 | voltage-gated potassium channel complex | cellular component | GO:0008076 | 90 | 5 | 19108 | 49 |
KCNIP4,DPP6,KCNMB2,DLG2,KCND2 |
3.696e-06 | -12.51 | DLG4 (discs large MAGUK scaffold protein 4) | protein interactions | 1742 | 163 | 6 | 19454 | 50 |
DLGAP1,KCND2,LRRC7,GRIK1,DLG2,DSCAM |
3.969e-06 | -12.44 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 37 | 16828 | 49 |
XYLT1,KCND2,NXPH1,SCD5,HS6ST3,DSCAM,LRP1B,KCNMB2,ABHD2,DCC,CSMD3,KAZN,FGF14,NLGN4Y,LHFPL3,PID1,CNTNAP5,GPC6,TNR,LUZP2,ANKS1B,TMEM132D,EPN2,SGCZ,DAB1,CHST11,PCDH15,LRRTM4,ZSWIM6,DPP6,DLGAP1,ADARB2,CADM2,RORA,OPCML,SLC8A1,LRRC7 |
4.804e-06 | -12.25 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 49 | 16828 | 49 |
KAZN,LRRC4C,FGF14,DCC,DLG2,NTNG1,CSMD3,KCNIP4,HS6ST3,SCD5,NRXN1,KCNMB2,KCND2,SNTG1,NXPH1,CADM2,ZSWIM6,DAB1,GRIK1,ANKS1B,GPC6,ZBTB20,NLGN4Y,ABHD2,DSCAM,LRP1B,XYLT1,RBFOX1,RORA,NTM,LRRC7,OPCML,SLC8A1,PCDH15,CHST11,DLGAP1,ADARB2,LRRTM4,DPP6,TMEM132D,EPN2,SGCZ,PDZRN4,PCDHGC3,CNTNAP5,LHFPL3,PID1,TNR,LUZP2 |
4.977e-06 | -12.21 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 36 | 16828 | 49 |
PID1,GRIK1,LHFPL3,CNTNAP5,PCDHGC3,TNR,GPC6,ANKS1B,TMEM132D,PDZRN4,SGCZ,DAB1,PCDH15,DPP6,LRRTM4,DLGAP1,NTM,RORA,SLC8A1,LRRC7,SNTG1,RBFOX1,KCND2,XYLT1,NRXN1,SCD5,DSCAM,HS6ST3,KCNIP4,LRP1B,DCC,CSMD3,DLG2,KAZN,LRRC4C,ZBTB20 |
5.921e-06 | -12.04 | postsynaptic density membrane | cellular component | GO:0098839 | 101 | 5 | 19108 | 49 |
NLGN4Y,DLG2,DCC,GRIK1,LRRC4C |
6.472e-06 | -11.95 | membrane | cellular component | GO:0016020 | 9220 | 39 | 19108 | 49 |
LRRC7,SCD5,NTNG1,PCDH15,DLGAP1,NTM,NRXN1,SGCZ,SNTG1,LRRC4C,CSMD3,TMEM132D,CHST11,DLG2,TNR,DSCAM,DCC,HS6ST3,CNTNAP5,EPN2,KCND2,LHFPL3,KCNIP4,LRP1B,NLGN4Y,ANKS1B,GPC6,XYLT1,OPCML,KCNMB2,KAZN,CADM2,LRRTM4,DPP6,CSMD1,PCDHGC3,SLC8A1,GRIK1,ABHD2 |
6.705e-06 | -11.91 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 38 | 16828 | 49 |
FGF14,NLGN4Y,KAZN,CSMD3,ABHD2,DCC,KCNMB2,LRP1B,HS6ST3,DSCAM,SCD5,NXPH1,XYLT1,KCND2,SNTG1,LRRC7,OPCML,SLC8A1,RORA,CADM2,DLGAP1,ADARB2,LRRTM4,DPP6,ZSWIM6,PCDH15,CHST11,DAB1,SGCZ,TMEM132D,EPN2,ANKS1B,TNR,GPC6,LUZP2,CNTNAP5,LHFPL3,PID1 |
7.729e-06 | -11.77 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 3 | 18204 | 45 |
TNR,NRXN1,NLGN4Y |
9.223e-06 | -11.59 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 34 | 16828 | 49 |
GRIK1,LHFPL3,CNTNAP5,TNR,ANKS1B,EPN2,TMEM132D,PDZRN4,SGCZ,DAB1,CHST11,PCDH15,ZSWIM6,DPP6,LRRTM4,NTM,RORA,SLC8A1,LRRC7,SNTG1,RBFOX1,KCND2,XYLT1,SCD5,DSCAM,HS6ST3,KCNIP4,LRP1B,DCC,CSMD3,KAZN,NLGN4Y,ZBTB20,LRRC4C |
1.129e-05 | -11.39 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 8 | 18204 | 45 |
CSMD3,LRRC7,LRRC4C,NTNG1,DCC,DSCAM,DAB1,TNR |
1.241e-05 | -11.30 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 44 | 16828 | 49 |
NXPH1,SNTG1,KCND2,KCNMB2,NRXN1,HS6ST3,KCNIP4,CSMD3,NTNG1,DLG2,DCC,FGF14,LRRC4C,KAZN,GPC6,ANKS1B,GRIK1,DAB1,ZSWIM6,CADM2,XYLT1,LRP1B,DSCAM,ABHD2,NLGN4Y,LUZP2,TNR,PID1,LHFPL3,CNTNAP5,PCDHGC3,PDZRN4,SGCZ,TMEM132D,DPP6,LRRTM4,ADARB2,DLGAP1,PCDH15,SLC8A1,OPCML,LRRC7,NTM,RORA |
1.241e-05 | -11.30 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 44 | 16828 | 49 |
DAB1,SGCZ,PDZRN4,TMEM132D,ANKS1B,TNR,GPC6,LUZP2,PCDHGC3,CNTNAP5,LHFPL3,GRIK1,PID1,LRRC7,OPCML,SLC8A1,RORA,NTM,CADM2,DLGAP1,ADARB2,LRRTM4,DPP6,ZSWIM6,PCDH15,KCNMB2,LRP1B,HS6ST3,KCNIP4,DSCAM,NRXN1,NXPH1,XYLT1,KCND2,SNTG1,LRRC4C,FGF14,NLGN4Y,KAZN,NTNG1,DLG2,CSMD3,ABHD2,DCC |
1.349e-05 | -11.21 | cation channel complex | cellular component | GO:0034703 | 205 | 6 | 19108 | 49 |
KCNIP4,GRIK1,DPP6,KCNMB2,DLG2,KCND2 |
1.607e-05 | -11.04 | synapse organization | biological process | GO:0050808 | 333 | 7 | 18204 | 45 |
NRXN1,PCDHGC3,LRRC4C,NTNG1,DSCAM,NLGN4Y,TNR |
1.962e-05 | -10.84 | ion channel regulator activity | molecular function | GO:0099106 | 140 | 5 | 18094 | 43 |
FGF14,KCNMB2,DPP6,NRXN1,KCNIP4 |
2.068e-05 | -10.79 | skin-hand-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-hand-carcinoma-squamous_cell_carcinoma | 407 | 8 | 16828 | 49 |
LRRC4C,TMEM132D,CADM2,DSCAM,CSMD3,DCC,KCND2,PCDH15 |
2.229e-05 | -10.71 | regulation of axonogenesis | biological process | GO:0050770 | 138 | 5 | 18204 | 45 |
TNR,DAB1,LRRC4C,DSCAM,DCC |
2.302e-05 | -10.68 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 45 | 16828 | 49 |
TMEM132D,DAB1,PDZRN4,SGCZ,CNTNAP5,PCDHGC3,GRIK1,PID1,LHFPL3,ANKS1B,LUZP2,GPC6,TNR,NTM,RORA,CADM2,LRRC7,SLC8A1,OPCML,PCDH15,CHST11,ADARB2,DLGAP1,ZSWIM6,DPP6,LRRTM4,DSCAM,KCNIP4,HS6ST3,NRXN1,KCNMB2,LRP1B,KCND2,XYLT1,SNTG1,NXPH1,KAZN,LRRC4C,NLGN4Y,FGF14,DCC,ABHD2,CSMD3,NTNG1,DLG2 |
2.323e-05 | -10.67 | channel regulator activity | molecular function | GO:0016247 | 145 | 5 | 18094 | 43 |
NRXN1,KCNIP4,DPP6,KCNMB2,FGF14 |
2.401e-05 | -10.64 | transporter regulator activity | molecular function | GO:0141108 | 146 | 5 | 18094 | 43 |
FGF14,KCNMB2,KCNIP4,NRXN1,DPP6 |
2.476e-05 | -10.61 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 8 | 18204 | 45 |
GRIK1,NRXN1,TNR,DLGAP1,DCC,NLGN4Y,LRRC4C,NTNG1 |
2.512e-05 | -10.59 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 8 | 18204 | 45 |
LRRC4C,NTNG1,DCC,NLGN4Y,DLGAP1,TNR,GRIK1,NRXN1 |
2.624e-05 | -10.55 | femur | COSMIC cancer mutations | femur | 1197 | 13 | 16828 | 49 |
NTNG1,CSMD3,DPP6,LUZP2,CNTNAP5,PCDH15,LHFPL3,LRRC7,FGF14,LRP1B,HS6ST3,DSCAM,TMEM132D |
2.792e-05 | -10.49 | Ig_I-set | interpro domains | IPR013098 | 132 | 5 | 18521 | 50 |
DSCAM,LRRC4C,OPCML,DCC,NTM |
3.055e-05 | -10.40 | I-set | pfam domains | PF07679 | 132 | 5 | 17795 | 49 |
NTM,DCC,LRRC4C,OPCML,DSCAM |
3.684e-05 | -10.21 | mouth | COSMIC cancer mutations | mouth | 9004 | 40 | 16828 | 49 |
NRXN1,SCD5,DSCAM,KCNIP4,HS6ST3,LRP1B,SNTG1,RBFOX1,KCND2,XYLT1,KAZN,NLGN4Y,ZBTB20,LRRC4C,DCC,CSMD3,DLG2,EPN2,TMEM132D,PDZRN4,SGCZ,DAB1,PID1,GRIK1,LHFPL3,CNTNAP5,PCDHGC3,TNR,GPC6,ANKS1B,NTM,RORA,SLC8A1,LRRC7,CHST11,PCDH15,ZSWIM6,DPP6,LRRTM4,DLGAP1 |
3.914e-05 | -10.15 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 15 | 16828 | 49 |
CADM2,KAZN,ZBTB20,LRRC7,NLGN4Y,FGF14,PCDH15,DCC,CSMD3,NTNG1,TMEM132D,LRP1B,KCND2,GRIK1,RBFOX1 |
4.286e-05 | -10.06 | Ig_sub2 | interpro domains | IPR003598 | 239 | 6 | 18521 | 50 |
NTM,LRRC4C,DCC,OPCML,DSCAM,CADM2 |
4.606e-05 | -9.99 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 13 | 16828 | 49 |
DAB1,LRP1B,DSCAM,KCNIP4,HS6ST3,TMEM132D,LUZP2,GPC6,CNTNAP5,LRRC7,NTM,CSMD3,PCDH15 |
4.606e-05 | -9.99 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 13 | 16828 | 49 |
CNTNAP5,LUZP2,GPC6,DSCAM,HS6ST3,KCNIP4,TMEM132D,DAB1,LRP1B,PCDH15,CSMD3,NTM,LRRC7 |
5.020e-05 | -9.90 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 35 | 16828 | 49 |
PCDHGC3,CNTNAP5,GRIK1,PID1,ANKS1B,GPC6,TNR,TMEM132D,EPN2,DAB1,SGCZ,PDZRN4,PCDH15,DLGAP1,ADARB2,ZSWIM6,RORA,NTM,CADM2,LRRC7,SLC8A1,KCND2,RBFOX1,HS6ST3,DSCAM,NRXN1,LRP1B,DCC,DLG2,CSMD3,KAZN,ZBTB20,LRRC4C,FGF14,NLGN4Y |
5.020e-05 | -9.90 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 35 | 16828 | 49 |
FGF14,NLGN4Y,ZBTB20,LRRC4C,KAZN,DLG2,CSMD3,DCC,LRP1B,NRXN1,HS6ST3,DSCAM,RBFOX1,KCND2,SLC8A1,LRRC7,CADM2,RORA,NTM,ZSWIM6,DLGAP1,ADARB2,PCDH15,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2,TNR,GPC6,ANKS1B,PID1,GRIK1,PCDHGC3,CNTNAP5 |
5.142e-05 | -9.88 | multicellular organism development | biological process | GO:0007275 | 3957 | 22 | 18204 | 45 |
NRXN1,DAB1,OPCML,TNR,NTM,RBFOX1,CSMD1,ZSWIM6,RORA,SLC8A1,DCC,XYLT1,FGF14,DSCAM,CHST11,SGCZ,NTNG1,LRRC7,NLGN4Y,PCDHGC3,GRIK1,DLG2 |
5.335e-05 | -9.84 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 37 | 16828 | 49 |
DLG2,NTNG1,CSMD3,DCC,ZBTB20,LRRC4C,KAZN,XYLT1,SNTG1,RBFOX1,KCNMB2,LRP1B,KCNIP4,DSCAM,NRXN1,DLGAP1,ADARB2,LRRTM4,DPP6,PCDH15,CHST11,LRRC7,OPCML,SLC8A1,RORA,CADM2,ANKS1B,GPC6,TNR,LUZP2,PCDHGC3,CNTNAP5,PID1,DAB1,SGCZ,PDZRN4,TMEM132D |
5.549e-05 | -9.80 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 25 | 16828 | 49 |
KCND2,LRP1B,DSCAM,KCNIP4,NRXN1,CSMD3,NTNG1,DCC,ABHD2,LRRC4C,NLGN4Y,KAZN,GPC6,TNR,PCDHGC3,GRIK1,PDZRN4,TMEM132D,ADARB2,LRRTM4,PCDH15,CHST11,LRRC7,SLC8A1,OPCML |
6.028e-05 | -9.72 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 12 | 16828 | 49 |
SGCZ,LRP1B,SLC8A1,LRRC4C,TMEM132D,NTM,NTNG1,CSMD3,RBFOX1,SNTG1,DCC,PCDH15 |
6.534e-05 | -9.64 | anterograde trans-synaptic signaling | biological process | GO:0098916 | 415 | 7 | 18204 | 45 |
KCND2,GRIK1,NRXN1,DLG2,DLGAP1,TNR,NLGN4Y |
6.534e-05 | -9.64 | chemical synaptic transmission | biological process | GO:0007268 | 415 | 7 | 18204 | 45 |
TNR,DLGAP1,KCND2,GRIK1,NRXN1,DLG2,NLGN4Y |
7.798e-05 | -9.46 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 30 | 16828 | 49 |
DLG2,CSMD3,ABHD2,DCC,LRRC4C,RBFOX1,SNTG1,XYLT1,KCND2,LRP1B,HS6ST3,DSCAM,DPP6,DLGAP1,ADARB2,PCDH15,OPCML,SLC8A1,LRRC7,NTM,TNR,GPC6,LUZP2,ANKS1B,GRIK1,PCDHGC3,CNTNAP5,SGCZ,TMEM132D,EPN2 |
7.798e-05 | -9.46 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 30 | 16828 | 49 |
DCC,ABHD2,CSMD3,DLG2,LRRC4C,SNTG1,RBFOX1,KCND2,XYLT1,DSCAM,HS6ST3,LRP1B,PCDH15,DPP6,ADARB2,DLGAP1,NTM,SLC8A1,OPCML,LRRC7,GRIK1,CNTNAP5,PCDHGC3,LUZP2,GPC6,TNR,ANKS1B,EPN2,TMEM132D,SGCZ |
7.937e-05 | -9.44 | prostate | COSMIC cancer mutations | prostate | 13883 | 49 | 16828 | 49 |
SLC8A1,OPCML,LRRC7,NTM,RORA,DPP6,LRRTM4,ADARB2,DLGAP1,CHST11,PCDH15,PDZRN4,SGCZ,EPN2,TMEM132D,LUZP2,TNR,PID1,LHFPL3,CNTNAP5,PCDHGC3,NLGN4Y,ZBTB20,ABHD2,LRP1B,DSCAM,RBFOX1,XYLT1,CADM2,ZSWIM6,DAB1,GPC6,ANKS1B,GRIK1,FGF14,LRRC4C,KAZN,CSMD3,DLG2,NTNG1,DCC,KCNMB2,NRXN1,SCD5,KCNIP4,HS6ST3,NXPH1,SNTG1,KCND2 |
8.097e-05 | -9.42 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 7 | 19108 | 49 |
NLGN4Y,GPC6,LRRC4C,TNR,NTNG1,KCND2,DLGAP1 |
8.117e-05 | -9.42 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 19 | 16828 | 49 |
NLGN4Y,CADM2,DLGAP1,CSMD3,DCC,PCDH15,SGCZ,LRP1B,PDZRN4,DAB1,TMEM132D,NRXN1,EPN2,DSCAM,TNR,RBFOX1,SNTG1,XYLT1,CNTNAP5 |
8.283e-05 | -9.40 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 7 | 18204 | 45 |
NLGN4Y,DLG2,NRXN1,GRIK1,TNR,KCND2,DLGAP1 |
9.422e-05 | -9.27 | Schaffer collateral - CA1 synapse | cellular component | GO:0098685 | 93 | 4 | 19108 | 49 |
DCC,NTNG1,TNR,LRRC4C |
1.107e-04 | -9.11 | PID | prosite domains | PS01179 | 32 | 3 | 12186 | 36 |
ANKS1B,PID1,DAB1 |
1.122e-04 | -9.10 | system development | biological process | GO:0048731 | 3533 | 20 | 18204 | 45 |
NLGN4Y,NTM,NTNG1,TNR,DAB1,OPCML,SGCZ,NRXN1,CHST11,FGF14,DSCAM,XYLT1,DCC,SLC8A1,RORA,GRIK1,ZSWIM6,PCDHGC3,RBFOX1,CSMD1 |
1.226e-04 | -9.01 | synaptic signaling | biological process | GO:0099536 | 459 | 7 | 18204 | 45 |
GRIK1,NLGN4Y,DLG2,NRXN1,TNR,DLGAP1,KCND2 |
1.251e-04 | -8.99 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 43 | 16828 | 49 |
TMEM132D,EPN2,SGCZ,PDZRN4,DAB1,LHFPL3,PID1,CNTNAP5,TNR,GPC6,LUZP2,ANKS1B,CADM2,RORA,OPCML,SLC8A1,LRRC7,CHST11,PCDH15,ZSWIM6,DPP6,DLGAP1,ADARB2,SCD5,NRXN1,HS6ST3,DSCAM,LRP1B,KCNMB2,RBFOX1,SNTG1,XYLT1,KCND2,NXPH1,KAZN,FGF14,NLGN4Y,ZBTB20,ABHD2,DCC,DLG2,NTNG1,CSMD3 |
1.306e-04 | -8.94 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 8 | 19108 | 49 |
KCNIP4,SGCZ,GRIK1,DPP6,KCNMB2,SNTG1,DLG2,KCND2 |
1.317e-04 | -8.94 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 16 | 16828 | 49 |
DSCAM,TMEM132D,DAB1,LRP1B,KCND2,XYLT1,TNR,GPC6,RORA,LRRC7,SLC8A1,OPCML,PCDH15,DCC,CSMD3,DLGAP1 |
1.350e-04 | -8.91 | anatomical structure development | biological process | GO:0048856 | 5207 | 25 | 18204 | 45 |
PCDHGC3,GRIK1,DLG2,PCDH15,CHST11,SGCZ,NTNG1,LRRC7,NLGN4Y,RBFOX1,CSMD1,KAZN,ZSWIM6,RORA,SLC8A1,ABHD2,DCC,XYLT1,FGF14,DSCAM,NRXN1,TNR,OPCML,DAB1,NTM |
1.488e-04 | -8.81 | Phase 1 - inactivation of fast Na+ channels | REACTOME pathways | R-HSA-5576894 | 7 | 2 | 10285 | 28 |
KCNIP4,KCND2 |
1.495e-04 | -8.81 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 43 | 16828 | 49 |
KCNMB2,LRP1B,DSCAM,HS6ST3,NRXN1,SCD5,NXPH1,KCND2,XYLT1,SNTG1,RBFOX1,LRRC4C,ZBTB20,FGF14,KAZN,CSMD3,DLG2,NTNG1,DCC,ABHD2,DAB1,PDZRN4,SGCZ,TMEM132D,ANKS1B,LUZP2,TNR,CNTNAP5,PCDHGC3,GRIK1,LHFPL3,LRRC7,SLC8A1,OPCML,NTM,RORA,CADM2,ADARB2,DLGAP1,DPP6,LRRTM4,PCDH15,CHST11 |
1.497e-04 | -8.81 | nervous system development | biological process | GO:0007399 | 2185 | 15 | 18204 | 45 |
PCDHGC3,RBFOX1,ZSWIM6,RORA,GRIK1,FGF14,DSCAM,DCC,NRXN1,DAB1,OPCML,TNR,NTM,NTNG1,NLGN4Y |
1.525e-04 | -8.79 | skin-neck-malignant_melanoma | COSMIC cancer mutations | skin-neck-malignant_melanoma | 1223 | 12 | 16828 | 49 |
GPC6,TNR,LRP1B,DAB1,TMEM132D,DSCAM,CSMD3,NTNG1,DCC,PCDH15,SLC8A1,LRRC4C |
1.569e-04 | -8.76 | IGc2 | smart domains | SM00408 | 239 | 6 | 9717 | 34 |
DSCAM,LRRC4C,NTM,CADM2,OPCML,DCC |
1.622e-04 | -8.73 | neck | COSMIC cancer mutations | neck | 1231 | 12 | 16828 | 49 |
LRRC4C,SLC8A1,PCDH15,DCC,CSMD3,NTNG1,DSCAM,TMEM132D,DAB1,LRP1B,TNR,GPC6 |
1.770e-04 | -8.64 | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | COSMIC cancer mutations | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | 181 | 5 | 16828 | 49 |
PCDH15,DCC,LRRC4C,DLG2,PDZRN4 |
1.777e-04 | -8.64 | skin-upper_arm-malignant_melanoma | COSMIC cancer mutations | skin-upper_arm-malignant_melanoma | 553 | 8 | 16828 | 49 |
PCDHGC3,PCDH15,DCC,GRIK1,PID1,NTNG1,DAB1,LRP1B |
1.816e-04 | -8.61 | WNT_subtype | COSMIC cancer mutations | WNT_subtype | 182 | 5 | 16828 | 49 |
DLG2,LRRC4C,PDZRN4,PCDH15,DCC |
1.836e-04 | -8.60 | PTB/PI_dom | interpro domains | IPR006020 | 41 | 3 | 18521 | 50 |
ANKS1B,PID1,DAB1 |
1.874e-04 | -8.58 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 4 | 16828 | 49 |
CNTNAP5,PCDH15,LUZP2,LRP1B |
1.941e-04 | -8.55 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 19 | 16828 | 49 |
FGF14,CSMD3,ADARB2,DPP6,DCC,KCNMB2,DAB1,PDZRN4,LRP1B,DSCAM,TMEM132D,ANKS1B,TNR,LUZP2,NXPH1,PCDHGC3,CNTNAP5,KCND2,GRIK1 |
1.941e-04 | -8.55 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 19 | 16828 | 49 |
DSCAM,TMEM132D,KCNMB2,DAB1,PDZRN4,LRP1B,KCND2,CNTNAP5,PCDHGC3,GRIK1,ANKS1B,NXPH1,LUZP2,TNR,FGF14,DCC,CSMD3,ADARB2,DPP6 |
1.981e-04 | -8.53 | potassium channel activity | molecular function | GO:0005267 | 122 | 4 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,GRIK1 |
1.989e-04 | -8.52 | receptor clustering | biological process | GO:0043113 | 46 | 3 | 18204 | 45 |
LRRC7,NRXN1,DLG2 |
1.989e-04 | -8.52 | neuron recognition | biological process | GO:0008038 | 46 | 3 | 18204 | 45 |
DSCAM,NTM,OPCML |
2.001e-04 | -8.52 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 8 | 18204 | 45 |
DSCAM,DCC,LRRC4C,NTNG1,LRRC7,TNR,DAB1,CSMD3 |
2.007e-04 | -8.51 | potassium channel regulator activity | molecular function | GO:0015459 | 48 | 3 | 18094 | 43 |
KCNIP4,DPP6,KCNMB2 |
2.082e-04 | -8.48 | hand | COSMIC cancer mutations | hand | 566 | 8 | 16828 | 49 |
DSCAM,TMEM132D,CADM2,LRRC4C,KCND2,PCDH15,DCC,CSMD3 |
2.245e-04 | -8.40 | developmental process | biological process | GO:0032502 | 5716 | 26 | 18204 | 45 |
CHST11,SGCZ,NTNG1,LRRC7,NLGN4Y,PCDHGC3,GRIK1,PID1,DLG2,PCDH15,NRXN1,DAB1,TNR,OPCML,NTM,CSMD1,RBFOX1,KAZN,ZSWIM6,RORA,ABHD2,SLC8A1,XYLT1,DCC,DSCAM,FGF14 |
2.259e-04 | -8.40 | negative regulation of axonogenesis | biological process | GO:0050771 | 48 | 3 | 18204 | 45 |
TNR,DAB1,DCC |
2.330e-04 | -8.36 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 49 | 16828 | 49 |
NXPH1,SNTG1,KCND2,KCNMB2,NRXN1,SCD5,HS6ST3,KCNIP4,CSMD3,NTNG1,DLG2,DCC,FGF14,LRRC4C,KAZN,GPC6,ANKS1B,GRIK1,DAB1,ZSWIM6,CADM2,RBFOX1,XYLT1,LRP1B,DSCAM,ABHD2,NLGN4Y,ZBTB20,LUZP2,TNR,PID1,LHFPL3,CNTNAP5,PCDHGC3,PDZRN4,SGCZ,EPN2,TMEM132D,DPP6,LRRTM4,ADARB2,DLGAP1,CHST11,PCDH15,SLC8A1,OPCML,LRRC7,NTM,RORA |
2.333e-04 | -8.36 | neuronal cell body | cellular component | GO:0043025 | 489 | 7 | 19108 | 49 |
DLG2,KCND2,CADM2,DSCAM,SLC8A1,NRXN1,KCNIP4 |
2.355e-04 | -8.35 | face | COSMIC cancer mutations | face | 2139 | 16 | 16828 | 49 |
GPC6,TNR,XYLT1,KCND2,LRP1B,DAB1,TMEM132D,DSCAM,DLGAP1,CSMD3,DCC,PCDH15,OPCML,SLC8A1,LRRC7,RORA |
2.373e-04 | -8.35 | monoatomic ion channel complex | cellular component | GO:0034702 | 344 | 6 | 19108 | 49 |
DPP6,KCNMB2,DLG2,KCND2,KCNIP4,GRIK1 |
2.375e-04 | -8.35 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 8 | 18204 | 45 |
CSMD3,TNR,DAB1,DSCAM,DCC,NTNG1,LRRC7,LRRC4C |
2.388e-04 | -8.34 | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | 1485 | 13 | 16828 | 49 |
CSMD3,DLGAP1,DPP6,PCDH15,SLC8A1,LUZP2,GPC6,PID1,SNTG1,DAB1,PDZRN4,LRP1B,SGCZ |
2.443e-04 | -8.32 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 4 | 16828 | 49 |
FGF14,SLC8A1,NXPH1,LRP1B |
2.450e-04 | -8.31 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | 739 | 9 | 16828 | 49 |
LRRC4C,SLC8A1,DSCAM,CSMD3,ZSWIM6,TNR,KCND2,PCDH15,PCDHGC3 |
2.450e-04 | -8.31 | acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_T_cell_leukaemia | 739 | 9 | 16828 | 49 |
CSMD3,TNR,ZSWIM6,PCDHGC3,KCND2,PCDH15,LRRC4C,SLC8A1,DSCAM |
2.478e-04 | -8.30 | neuron differentiation | biological process | GO:0030182 | 1081 | 10 | 18204 | 45 |
DSCAM,DCC,NTM,NTNG1,DAB1,OPCML,TNR,RORA,NRXN1,ZSWIM6 |
2.515e-04 | -8.29 | upper_arm | COSMIC cancer mutations | upper_arm | 582 | 8 | 16828 | 49 |
NTNG1,PCDH15,PCDHGC3,DCC,PID1,GRIK1,DAB1,LRP1B |
2.531e-04 | -8.28 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 12 | 16828 | 49 |
ZBTB20,PCDH15,NTNG1,DLGAP1,CSMD3,DPP6,LRP1B,PCDHGC3,KCND2,RBFOX1,GRIK1,TNR |
2.547e-04 | -8.28 | cell-cell adhesion mediator activity | molecular function | GO:0098632 | 52 | 3 | 18094 | 43 |
DSCAM,LRRC4C,NTNG1 |
2.655e-04 | -8.23 | postsynaptic membrane assembly | biological process | GO:0097104 | 10 | 2 | 18204 | 45 |
NRXN1,NLGN4Y |
2.663e-04 | -8.23 | axonogenesis | biological process | GO:0007409 | 366 | 6 | 18204 | 45 |
NTNG1,DCC,NRXN1,DSCAM,DAB1,TNR |
2.705e-04 | -8.22 | neuromuscular process controlling balance | biological process | GO:0050885 | 51 | 3 | 18204 | 45 |
NRXN1,PCDH15,TNR |
2.730e-04 | -8.21 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 10 | 16828 | 49 |
PCDH15,SNTG1,RBFOX1,DCC,NTNG1,CSMD3,TMEM132D,LRRC4C,LRP1B,SLC8A1 |
3.017e-04 | -8.11 | multicellular organismal process | biological process | GO:0032501 | 6177 | 27 | 18204 | 45 |
KAZN,KCND2,RBFOX1,CSMD1,ZSWIM6,RORA,SLC8A1,DSCAM,FGF14,XYLT1,DCC,KCNMB2,NRXN1,DAB1,TNR,OPCML,NTM,LHFPL3,PCDHGC3,DLG2,GRIK1,PCDH15,CHST11,SGCZ,NTNG1,LRRC7,NLGN4Y |
3.030e-04 | -8.10 | cell junction organization | biological process | GO:0034330 | 532 | 7 | 18204 | 45 |
PCDHGC3,NRXN1,TNR,NLGN4Y,DSCAM,NTNG1,LRRC4C |
3.155e-04 | -8.06 | plasma membrane region | cellular component | GO:0098590 | 1278 | 11 | 19108 | 49 |
NRXN1,LRRTM4,LRRC7,DCC,NTNG1,KCND2,LRRC4C,GRIK1,SNTG1,NLGN4Y,DLG2 |
3.294e-04 | -8.02 | Glycosaminoglycan metabolism | REACTOME pathways | R-HSA-1630316 | 124 | 4 | 10285 | 28 |
GPC6,CHST11,HS6ST3,XYLT1 |
3.320e-04 | -8.01 | Laminin | gene3d domains | 2.10.25.10 | 226 | 5 | 14470 | 39 |
TNR,CNTNAP5,NTNG1,NRXN1,LRP1B |
3.448e-04 | -7.97 | Chondroitin sulfate/dermatan sulfate metabolism | REACTOME pathways | R-HSA-1793185 | 51 | 3 | 10285 | 28 |
XYLT1,CHST11,GPC6 |
3.471e-04 | -7.97 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 43 | 16828 | 49 |
TMEM132D,SGCZ,PDZRN4,DAB1,LHFPL3,GRIK1,PCDHGC3,CNTNAP5,TNR,LUZP2,ANKS1B,CADM2,RORA,NTM,OPCML,SLC8A1,LRRC7,CHST11,PCDH15,LRRTM4,DPP6,DLGAP1,ADARB2,SCD5,NRXN1,HS6ST3,DSCAM,LRP1B,KCNMB2,RBFOX1,SNTG1,XYLT1,KCND2,NXPH1,KAZN,FGF14,LRRC4C,ZBTB20,ABHD2,DCC,DLG2,NTNG1,CSMD3 |
3.510e-04 | -7.95 | PDZ | pfam domains | PF00595 | 122 | 4 | 17795 | 49 |
PDZRN4,DLG2,LRRC7,SNTG1 |
3.540e-04 | -7.95 | PTB | smart domains | SM00462 | 40 | 3 | 9717 | 34 |
DAB1,PID1,ANKS1B |
3.872e-04 | -7.86 | DSCAM interactions | REACTOME pathways | R-HSA-376172 | 11 | 2 | 10285 | 28 |
DSCAM,DCC |
3.954e-04 | -7.84 | EGF-like_dom | interpro domains | IPR000742 | 232 | 5 | 18521 | 50 |
NTNG1,TNR,NRXN1,CNTNAP5,LRP1B |
4.085e-04 | -7.80 | Heparan sulfate/heparin (HS-GAG) metabolism | REACTOME pathways | R-HSA-1638091 | 54 | 3 | 10285 | 28 |
GPC6,HS6ST3,XYLT1 |
4.108e-04 | -7.80 | EGF | smart domains | SM00181 | 184 | 5 | 9717 | 34 |
NRXN1,TNR,CNTNAP5,NTNG1,LRP1B |
4.165e-04 | -7.78 | protein localization to synapse | biological process | GO:0035418 | 59 | 3 | 18204 | 45 |
DLG2,NRXN1,LRRC7 |
4.203e-04 | -7.77 | SIRPB1 (signal regulatory protein beta 1) | protein interactions | 10326 | 12 | 2 | 19454 | 50 |
DAB1,RBFOX1 |
4.282e-04 | -7.76 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 49 | 16828 | 49 |
DSCAM,LRP1B,RBFOX1,XYLT1,NLGN4Y,ZBTB20,ABHD2,TMEM132D,EPN2,SGCZ,PDZRN4,LHFPL3,PID1,PCDHGC3,CNTNAP5,TNR,LUZP2,RORA,NTM,OPCML,SLC8A1,LRRC7,CHST11,PCDH15,LRRTM4,DPP6,DLGAP1,ADARB2,SCD5,NRXN1,HS6ST3,KCNIP4,KCNMB2,SNTG1,KCND2,NXPH1,KAZN,FGF14,LRRC4C,DCC,NTNG1,DLG2,CSMD3,DAB1,GRIK1,GPC6,ANKS1B,CADM2,ZSWIM6 |
4.300e-04 | -7.75 | generation of neurons | biological process | GO:0048699 | 1158 | 10 | 18204 | 45 |
ZSWIM6,RORA,NRXN1,NTNG1,NTM,DCC,DSCAM,OPCML,DAB1,TNR |
4.377e-04 | -7.73 | proteoglycan biosynthetic process | biological process | GO:0030166 | 60 | 3 | 18204 | 45 |
XYLT1,CHST11,HS6ST3 |
4.465e-04 | -7.71 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 21 | 16828 | 49 |
XYLT1,CNTNAP5,LHFPL3,SNTG1,ANKS1B,GPC6,TNR,HS6ST3,DSCAM,SGCZ,LRP1B,PCDH15,DLG2,DLGAP1,ADARB2,CSMD3,LRRTM4,LRRC4C,ZBTB20,LRRC7,SLC8A1 |
4.501e-04 | -7.71 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 21 | 16828 | 49 |
LRRC4C,ZBTB20,LRRC7,SLC8A1,PCDH15,CSMD3,ADARB2,DLG2,DLGAP1,LRRTM4,DSCAM,HS6ST3,LRP1B,SGCZ,CNTNAP5,XYLT1,LHFPL3,SNTG1,ANKS1B,TNR,GPC6 |
4.633e-04 | -7.68 | Sulfotransferase | interpro domains | IPR005331 | 12 | 2 | 18521 | 50 |
HS6ST3,CHST11 |
4.680e-04 | -7.67 | Cell adhesion molecules (CAMs) | KEGG pathways | hsa04514 | 143 | 4 | 7161 | 19 |
LRRC4C,NLGN4Y,NTNG1,NRXN1 |
4.680e-04 | -7.67 | Cell adhesion molecules (CAMs) | KEGG pathways | ko04514 | 143 | 4 | 7161 | 19 |
LRRC4C,NLGN4Y,NTNG1,NRXN1 |
4.764e-04 | -7.65 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | 485 | 7 | 16828 | 49 |
XYLT1,CNTNAP5,CSMD3,DAB1,LRRC4C,FGF14,LRP1B |
4.764e-04 | -7.65 | medullomyoblastoma | COSMIC cancer mutations | medullomyoblastoma | 485 | 7 | 16828 | 49 |
DAB1,LRRC4C,CSMD3,FGF14,LRP1B,XYLT1,CNTNAP5 |
4.817e-04 | -7.64 | Sulfotransfer_2 | pfam domains | PF03567 | 12 | 2 | 17795 | 49 |
HS6ST3,CHST11 |
4.895e-04 | -7.62 | trunk | COSMIC cancer mutations | trunk | 3554 | 21 | 16828 | 49 |
DCC,PCDH15,CSMD3,DLGAP1,CADM2,SLC8A1,NLGN4Y,LRRC4C,RBFOX1,SNTG1,CNTNAP5,XYLT1,TNR,NRXN1,EPN2,TMEM132D,DSCAM,PDZRN4,LRP1B,SGCZ,DAB1 |
4.948e-04 | -7.61 | neuromuscular process | biological process | GO:0050905 | 149 | 4 | 18204 | 45 |
TNR,PCDH15,CSMD1,NRXN1 |
4.959e-04 | -7.61 | LRRC4B (leucine rich repeat containing 4B) | protein interactions | 94030 | 13 | 2 | 19454 | 50 |
LRRC4C,SNTG1 |
5.060e-04 | -7.59 | cell body | cellular component | GO:0044297 | 556 | 7 | 19108 | 49 |
DLG2,SLC8A1,DSCAM,KCND2,CADM2,KCNIP4,NRXN1 |
5.299e-04 | -7.54 | potassium ion transmembrane transporter activity | molecular function | GO:0015079 | 158 | 4 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,GRIK1 |
5.387e-04 | -7.53 | cell adhesion mediator activity | molecular function | GO:0098631 | 67 | 3 | 18094 | 43 |
NTNG1,LRRC4C,DSCAM |
5.430e-04 | -7.52 | DLG2 (discs large MAGUK scaffold protein 2) | protein interactions | 1740 | 62 | 3 | 19454 | 50 |
DLGAP1,DSCAM,DLG2 |
5.512e-04 | -7.50 | Cardiac conduction | REACTOME pathways | R-HSA-5576891 | 142 | 4 | 10285 | 28 |
SLC8A1,FGF14,KCNIP4,KCND2 |
5.535e-04 | -7.50 | axon development | biological process | GO:0061564 | 420 | 6 | 18204 | 45 |
DCC,NRXN1,DSCAM,NTNG1,TNR,DAB1 |
5.603e-04 | -7.49 | learning | biological process | GO:0007612 | 154 | 4 | 18204 | 45 |
NLGN4Y,NRXN1,CSMD1,TNR |
5.644e-04 | -7.48 | LRP2 (LDL receptor related protein 2) | protein interactions | 4036 | 148 | 4 | 19454 | 50 |
ANKS1B,DAB1,LRP1B,DLG2 |
5.691e-04 | -7.47 | KCNA4 (potassium voltage-gated channel subfamily A member 4) | protein interactions | 3739 | 63 | 3 | 19454 | 50 |
DLGAP1,SNTG1,DLG2 |
5.776e-04 | -7.46 | KCNIP2 (potassium voltage-gated channel interacting protein 2) | protein interactions | 30819 | 14 | 2 | 19454 | 50 |
KCND2,KCNIP4 |
6.008e-04 | -7.42 | human chr11q25 | chromosome location | human chr11q25 | 19 | 2 | 26134 | 50 |
NTM,OPCML |
6.069e-04 | -7.41 | Ig_3 | pfam domains | PF13927 | 141 | 4 | 17795 | 49 |
OPCML,DSCAM,NTM,CADM2 |
6.239e-04 | -7.38 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 49 |
ZSWIM6,NTNG1,DLG2,PCDH15,LRRC4C,CADM2,TNR,SNTG1,RBFOX1,PCDHGC3,PDZRN4,DSCAM |
6.239e-04 | -7.38 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 49 |
DSCAM,CADM2,LRRC4C,PDZRN4,PCDHGC3,PCDH15,SNTG1,RBFOX1,NTNG1,DLG2,TNR,ZSWIM6 |
6.366e-04 | -7.36 | Neurexin-like | interpro domains | IPR003585 | 14 | 2 | 18521 | 50 |
CADM2,NRXN1 |
6.429e-04 | -7.35 | Ig_sub | interpro domains | IPR003599 | 394 | 6 | 18521 | 50 |
DSCAM,CADM2,NTM,OPCML,LRRC4C,DCC |
6.440e-04 | -7.35 | PDZ | interpro domains | IPR001478 | 146 | 4 | 18521 | 50 |
LRRC7,PDZRN4,SNTG1,DLG2 |
6.711e-04 | -7.31 | - | gene3d domains | 2.30.42.10 | 149 | 4 | 14470 | 39 |
DLG2,LRRC7,SNTG1,PDZRN4 |
6.811e-04 | -7.29 | skin-upper_leg-malignant_melanoma | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma | 850 | 9 | 16828 | 49 |
DSCAM,HS6ST3,DAB1,PDZRN4,SLC8A1,SGCZ,KCND2,DCC,RBFOX1 |
6.850e-04 | -7.29 | scalp | COSMIC cancer mutations | scalp | 2110 | 15 | 16828 | 49 |
TMEM132D,NRXN1,DSCAM,SGCZ,PDZRN4,XYLT1,TNR,RORA,NTM,SLC8A1,LRRC7,CHST11,DCC,ADARB2,CSMD3 |
6.938e-04 | -7.27 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 12 | 16828 | 49 |
NRXN1,TMEM132D,LRP1B,SNTG1,CNTNAP5,KCND2,ANKS1B,LRRC7,PCDH15,DPP6,CSMD3,ADARB2 |
6.950e-04 | -7.27 | PDZ_sf | interpro domains | IPR036034 | 149 | 4 | 18521 | 50 |
SNTG1,DLG2,PDZRN4,LRRC7 |
7.080e-04 | -7.25 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 4 | 16828 | 49 |
LRP1B,SLC8A1,NXPH1,FGF14 |
7.170e-04 | -7.24 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 41 | 16828 | 49 |
LRP1B,NRXN1,HS6ST3,DSCAM,SNTG1,RBFOX1,XYLT1,KCND2,NLGN4Y,ZBTB20,LRRC4C,DLG2,NTNG1,CSMD3,ABHD2,DCC,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2,GPC6,TNR,LUZP2,ANKS1B,LHFPL3,GRIK1,PCDHGC3,CNTNAP5,OPCML,SLC8A1,LRRC7,CADM2,RORA,NTM,LRRTM4,DPP6,DLGAP1,ADARB2,CHST11,PCDH15 |
7.170e-04 | -7.24 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 41 | 16828 | 49 |
DLG2,NTNG1,CSMD3,ABHD2,DCC,LRRC4C,ZBTB20,NLGN4Y,XYLT1,KCND2,SNTG1,RBFOX1,LRP1B,HS6ST3,DSCAM,NRXN1,DLGAP1,ADARB2,LRRTM4,DPP6,PCDH15,CHST11,LRRC7,OPCML,SLC8A1,RORA,NTM,CADM2,ANKS1B,GPC6,TNR,LUZP2,PCDHGC3,CNTNAP5,LHFPL3,GRIK1,DAB1,SGCZ,PDZRN4,TMEM132D,EPN2 |
7.259e-04 | -7.23 | homophilic cell adhesion via plasma membrane adhesion molecules | biological process | GO:0007156 | 165 | 4 | 18204 | 45 |
DSCAM,CADM2,PCDH15,PCDHGC3 |
7.319e-04 | -7.22 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 6 | 18204 | 45 |
DAB1,TNR,NTNG1,NRXN1,DSCAM,DCC |
7.492e-04 | -7.20 | behavior | biological process | GO:0007610 | 619 | 7 | 18204 | 45 |
NRXN1,KCND2,CSMD1,NLGN4Y,DSCAM,TNR,DAB1 |
7.686e-04 | -7.17 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 18 | 16828 | 49 |
TNR,KCND2,SNTG1,RBFOX1,GRIK1,LRP1B,TMEM132D,NTNG1,CSMD3,PCDH15,DCC,CHST11,ZBTB20,LRRC7,FGF14,NLGN4Y,KAZN,CADM2 |
8.000e-04 | -7.13 | PDZ | prosite domains | PS50106 | 143 | 4 | 12186 | 36 |
PDZRN4,DLG2,LRRC7,SNTG1 |
8.116e-04 | -7.12 | transmembrane transporter complex | cellular component | GO:1902495 | 434 | 6 | 19108 | 49 |
KCNIP4,GRIK1,KCNMB2,DPP6,KCND2,DLG2 |
8.150e-04 | -7.11 | cell-cell signaling | biological process | GO:0007267 | 822 | 8 | 18204 | 45 |
NLGN4Y,FGF14,TNR,DLGAP1,DLG2,NRXN1,GRIK1,KCND2 |
8.726e-04 | -7.04 | upper_leg | COSMIC cancer mutations | upper_leg | 880 | 9 | 16828 | 49 |
DSCAM,HS6ST3,PDZRN4,SLC8A1,SGCZ,DAB1,DCC,RBFOX1,KCND2 |
8.898e-04 | -7.02 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 33 | 16828 | 49 |
DAB1,SGCZ,PDZRN4,TMEM132D,EPN2,TNR,PCDHGC3,CNTNAP5,LHFPL3,LRRC7,OPCML,SLC8A1,RORA,CADM2,DLGAP1,ADARB2,PCDH15,KCNMB2,LRP1B,KCNIP4,DSCAM,SCD5,NRXN1,KCND2,SNTG1,LRRC4C,ZBTB20,FGF14,NTNG1,DLG2,CSMD3,ABHD2,DCC |
8.966e-04 | -7.02 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 13 | 16828 | 49 |
DCC,PCDH15,ZSWIM6,ADARB2,CSMD3,OPCML,LRRC7,CNTNAP5,NXPH1,GPC6,DSCAM,LRP1B,SGCZ |
9.087e-04 | -7.00 | regulation of synaptic transmission, glutamatergic | biological process | GO:0051966 | 77 | 3 | 18204 | 45 |
TNR,GRIK1,NRXN1 |
9.207e-04 | -6.99 | regulation of membrane potential | biological process | GO:0042391 | 463 | 6 | 18204 | 45 |
KCNMB2,SLC8A1,NRXN1,PID1,GRIK1,KCND2 |
9.601e-04 | -6.95 | dystrophin-associated glycoprotein complex | cellular component | GO:0016010 | 18 | 2 | 19108 | 49 |
SNTG1,SGCZ |
9.948e-04 | -6.91 | chondroitin sulfate biosynthetic process | biological process | GO:0030206 | 19 | 2 | 18204 | 45 |
XYLT1,CHST11 |
9.948e-04 | -6.91 | vocalization behavior | biological process | GO:0071625 | 19 | 2 | 18204 | 45 |
NRXN1,NLGN4Y |
1.037e-03 | -6.87 | Ig-like_dom | interpro domains | IPR007110 | 432 | 6 | 18521 | 50 |
DSCAM,CADM2,OPCML,DCC,LRRC4C,NTM |
1.053e-03 | -6.86 | 4.1m | smart domains | SM00294 | 14 | 2 | 9717 | 34 |
NRXN1,CADM2 |
1.055e-03 | -6.85 | LRP1 (LDL receptor related protein 1) | protein interactions | 4035 | 175 | 4 | 19454 | 50 |
PID1,ANKS1B,LRP1B,DAB1 |
1.077e-03 | -6.83 | LRRTM3 (leucine rich repeat transmembrane neuronal 3) | protein interactions | 347731 | 19 | 2 | 19454 | 50 |
GPC6,LRRTM4 |
1.077e-03 | -6.83 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 2 | 19454 | 50 |
DLG2,NRXN1 |
1.084e-03 | -6.83 | neuron development | biological process | GO:0048666 | 859 | 8 | 18204 | 45 |
DAB1,TNR,OPCML,NTM,NTNG1,DSCAM,DCC,NRXN1 |
1.109e-03 | -6.80 | transporter complex | cellular component | GO:1990351 | 461 | 6 | 19108 | 49 |
KCND2,KCNMB2,KCNIP4,DLG2,DPP6,GRIK1 |
1.142e-03 | -6.78 | PPP1CA (protein phosphatase 1 catalytic subunit alpha) | protein interactions | 100009298 | 80 | 3 | 19454 | 50 |
TMEM132D,DLG2,CSMD1 |
1.169e-03 | -6.75 | proteoglycan metabolic process | biological process | GO:0006029 | 84 | 3 | 18204 | 45 |
XYLT1,CHST11,HS6ST3 |
1.182e-03 | -6.74 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 6 | 18204 | 45 |
DAB1,TNR,NTNG1,DCC,NRXN1,DSCAM |
1.232e-03 | -6.70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | KEGG pathways | ko00532 | 20 | 2 | 7161 | 19 |
CHST11,XYLT1 |
1.232e-03 | -6.70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | KEGG pathways | hsa00532 | 20 | 2 | 7161 | 19 |
XYLT1,CHST11 |
1.246e-03 | -6.69 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 8 | 19108 | 49 |
CADM2,KCND2,KCNIP4,NRXN1,DLG2,ANKS1B,SLC8A1,DSCAM |
1.246e-03 | -6.69 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 6 | 18204 | 45 |
NTNG1,DSCAM,DCC,TNR,DAB1,NRXN1 |
1.252e-03 | -6.68 | protein localization to cell junction | biological process | GO:1902414 | 86 | 3 | 18204 | 45 |
LRRC7,NRXN1,DLG2 |
1.280e-03 | -6.66 | acral_lentiginous | COSMIC cancer mutations | acral_lentiginous | 745 | 8 | 16828 | 49 |
LRRC4C,LRP1B,CADM2,CSMD3,GPC6,LUZP2,GRIK1,DCC |
1.291e-03 | -6.65 | neurogenesis | biological process | GO:0022008 | 1334 | 10 | 18204 | 45 |
DAB1,OPCML,TNR,NTNG1,NTM,DCC,DSCAM,ZSWIM6,NRXN1,RORA |
1.312e-03 | -6.64 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 6 | 18204 | 45 |
DAB1,TNR,NTNG1,DSCAM,DCC,NRXN1 |
1.318e-03 | -6.63 | KCND2 (potassium voltage-gated channel subfamily D member 2) | protein interactions | 3751 | 21 | 2 | 19454 | 50 |
KCNIP4,DPP6 |
1.332e-03 | -6.62 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 14 | 16828 | 49 |
RORA,CADM2,LRRC7,SLC8A1,PCDH15,DCC,DLGAP1,CSMD3,TMEM132D,LRP1B,SNTG1,GPC6,TNR,LUZP2 |
1.332e-03 | -6.62 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 14 | 16828 | 49 |
CADM2,TMEM132D,RORA,LRP1B,SLC8A1,LRRC7,DCC,SNTG1,PCDH15,LUZP2,TNR,GPC6,CSMD3,DLGAP1 |
1.338e-03 | -6.62 | postsynapse assembly | biological process | GO:0099068 | 22 | 2 | 18204 | 45 |
NRXN1,NLGN4Y |
1.401e-03 | -6.57 | regulation of anatomical structure morphogenesis | biological process | GO:0022603 | 894 | 8 | 18204 | 45 |
DCC,DSCAM,LRRC4C,NTNG1,DAB1,EPN2,TNR,PID1 |
1.401e-03 | -6.57 | locomotory behavior | biological process | GO:0007626 | 197 | 4 | 18204 | 45 |
KCND2,TNR,DAB1,DSCAM |
1.477e-03 | -6.52 | IG_LIKE | prosite domains | PS50835 | 430 | 6 | 12186 | 36 |
OPCML,CADM2,DCC,NTM,DSCAM,LRRC4C |
1.480e-03 | -6.52 | PDZ | smart domains | SM00228 | 143 | 4 | 9717 | 34 |
SNTG1,DLG2,LRRC7,PDZRN4 |
1.503e-03 | -6.50 | NLGN3 (neuroligin 3) | protein interactions | 54413 | 88 | 3 | 19454 | 50 |
DLG2,NRXN1,NLGN4Y |
1.568e-03 | -6.46 | regulation of extent of cell growth | biological process | GO:0061387 | 93 | 3 | 18204 | 45 |
DCC,DSCAM,TNR |
1.575e-03 | -6.45 | glycoprotein complex | cellular component | GO:0090665 | 23 | 2 | 19108 | 49 |
SNTG1,SGCZ |
1.593e-03 | -6.44 | synaptic membrane adhesion | biological process | GO:0099560 | 24 | 2 | 18204 | 45 |
LRRC4C,NTNG1 |
1.593e-03 | -6.44 | chondroitin sulfate proteoglycan biosynthetic process | biological process | GO:0050650 | 24 | 2 | 18204 | 45 |
CHST11,XYLT1 |
1.603e-03 | -6.44 | lung-middle_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-middle_lobe-carcinoma-adenocarcinoma | 1368 | 11 | 16828 | 49 |
RBFOX1,GRIK1,XYLT1,PCDH15,TNR,CSMD3,SGCZ,PDZRN4,LRP1B,LRRC4C,LRRC7 |
1.623e-03 | -6.42 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 39 | 16828 | 49 |
PDZRN4,SGCZ,EPN2,TMEM132D,ANKS1B,LUZP2,GPC6,TNR,CNTNAP5,PCDHGC3,PID1,GRIK1,LRRC7,SLC8A1,OPCML,RORA,ADARB2,DLGAP1,ZSWIM6,DPP6,LRRTM4,PCDH15,CHST11,LRP1B,DSCAM,KCNIP4,NRXN1,SCD5,KCND2,XYLT1,RBFOX1,LRRC4C,NLGN4Y,KAZN,CSMD3,NTNG1,DLG2,DCC,ABHD2 |
1.723e-03 | -6.36 | KCNIP1 (potassium voltage-gated channel interacting protein 1) | protein interactions | 30820 | 24 | 2 | 19454 | 50 |
KCND2,KCNIP4 |
1.723e-03 | -6.36 | CNKSR2 (connector enhancer of kinase suppressor of Ras 2) | protein interactions | 22866 | 24 | 2 | 19454 | 50 |
DLG2,LRRC7 |
1.735e-03 | -6.36 | chondroitin sulfate biosynthesis | BIOCYC pathways | HUMAN_PWY-6569 | 16 | 2 | 902 | 4 |
CHST11,XYLT1 |
1.740e-03 | -6.35 | middle_lobe | COSMIC cancer mutations | middle_lobe | 1382 | 11 | 16828 | 49 |
LRP1B,PDZRN4,SGCZ,LRRC7,LRRC4C,TNR,CSMD3,GRIK1,RBFOX1,PCDH15,XYLT1 |
1.751e-03 | -6.35 | neuron projection | cellular component | GO:0043005 | 1331 | 10 | 19108 | 49 |
CADM2,LRRC7,DCC,PCDH15,KCND2,KCNIP4,DLG2,ANKS1B,DSCAM,SLC8A1 |
1.778e-03 | -6.33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | KEGG pathways | ko00534 | 24 | 2 | 7161 | 19 |
HS6ST3,XYLT1 |
1.778e-03 | -6.33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | KEGG pathways | hsa00534 | 24 | 2 | 7161 | 19 |
XYLT1,HS6ST3 |
1.829e-03 | -6.30 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 28 | 16828 | 49 |
DCC,ABHD2,CSMD3,DLG2,ZBTB20,LRRC4C,FGF14,KCND2,SNTG1,DSCAM,KCNIP4,SCD5,LRP1B,PCDH15,ADARB2,DLGAP1,RORA,CADM2,OPCML,CNTNAP5,PCDHGC3,LHFPL3,TNR,EPN2,TMEM132D,DAB1,PDZRN4,SGCZ |
1.833e-03 | -6.30 | hepatocellular_carcinoma | COSMIC cancer mutations | hepatocellular_carcinoma | 14800 | 49 | 16828 | 49 |
NRXN1,SCD5,KCNIP4,HS6ST3,KCNMB2,SNTG1,KCND2,NXPH1,KAZN,FGF14,LRRC4C,DCC,CSMD3,DLG2,NTNG1,DAB1,GRIK1,GPC6,ANKS1B,CADM2,ZSWIM6,DSCAM,LRP1B,RBFOX1,XYLT1,NLGN4Y,ZBTB20,ABHD2,EPN2,TMEM132D,PDZRN4,SGCZ,PID1,LHFPL3,CNTNAP5,PCDHGC3,LUZP2,TNR,NTM,RORA,SLC8A1,OPCML,LRRC7,CHST11,PCDH15,DPP6,LRRTM4,ADARB2,DLGAP1 |
1.833e-03 | -6.30 | liver-carcinoma-hepatocellular_carcinoma | COSMIC cancer mutations | liver-carcinoma-hepatocellular_carcinoma | 14800 | 49 | 16828 | 49 |
FGF14,LRRC4C,KAZN,DLG2,NTNG1,CSMD3,DCC,KCNMB2,SCD5,NRXN1,HS6ST3,KCNIP4,NXPH1,SNTG1,KCND2,CADM2,ZSWIM6,DAB1,GPC6,ANKS1B,GRIK1,NLGN4Y,ZBTB20,ABHD2,LRP1B,DSCAM,RBFOX1,XYLT1,OPCML,SLC8A1,LRRC7,RORA,NTM,LRRTM4,DPP6,DLGAP1,ADARB2,CHST11,PCDH15,SGCZ,PDZRN4,TMEM132D,EPN2,TNR,LUZP2,LHFPL3,PID1,PCDHGC3,CNTNAP5 |
1.833e-03 | -6.30 | Ig-like_dom_sf | interpro domains | IPR036179 | 483 | 6 | 18521 | 50 |
CADM2,DCC,OPCML,LRRC4C,NTM,DSCAM |
1.870e-03 | -6.28 | chondroitin sulfate metabolic process | biological process | GO:0030204 | 26 | 2 | 18204 | 45 |
CHST11,XYLT1 |
1.913e-03 | -6.26 | human chr4p15.31-p15.2 | chromosome location | human chr4p15.31-p15.2 | 1 | 1 | 26134 | 50 |
KCNIP4 |
1.913e-03 | -6.26 | human chr13q31.3-q32.1 | chromosome location | human chr13q31.3-q32.1 | 1 | 1 | 26134 | 50 |
GPC6 |
1.913e-03 | -6.26 | human chr2q22.1-q22.2 | chromosome location | human chr2q22.1-q22.2 | 1 | 1 | 26134 | 50 |
LRP1B |
1.930e-03 | -6.25 | Post-translational modification: synthesis of GPI-anchored proteins | REACTOME pathways | R-HSA-163125 | 92 | 3 | 10285 | 28 |
NTM,OPCML,NTNG1 |
1.970e-03 | -6.23 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 6 | 18094 | 43 |
NLGN4Y,NTNG1,EPN2,DSCAM,LRRC4C,NRXN1 |
2.023e-03 | -6.20 | DLGAP2 (DLG associated protein 2) | protein interactions | 9228 | 26 | 2 | 19454 | 50 |
DLG2,DLGAP1 |
2.118e-03 | -6.16 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 4 | 10285 | 28 |
FGF14,KCNIP4,SLC8A1,KCND2 |
2.162e-03 | -6.14 | upper_third | COSMIC cancer mutations | upper_third | 629 | 7 | 16828 | 49 |
KCND2,PCDH15,DPP6,CSMD3,TMEM132D,SGCZ,LRRC7 |
2.162e-03 | -6.14 | oesophagus-upper_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-upper_third-carcinoma-squamous_cell_carcinoma | 629 | 7 | 16828 | 49 |
CSMD3,DPP6,KCND2,PCDH15,LRRC7,SGCZ,TMEM132D |
2.174e-03 | -6.13 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 13 | 16828 | 49 |
LRP1B,SGCZ,TMEM132D,TNR,CNTNAP5,XYLT1,PCDHGC3,LRRC4C,CADM2,CSMD3,DPP6,PCDH15,DCC |
2.177e-03 | -6.13 | large_intestine-colon-carcinoma | COSMIC cancer mutations | large_intestine-colon-carcinoma | 2612 | 16 | 16828 | 49 |
DLGAP1,DLG2,CSMD3,PCDH15,DCC,LRRC4C,LRRC7,SLC8A1,RORA,GPC6,TNR,XYLT1,SNTG1,LRP1B,DSCAM,NRXN1 |
2.181e-03 | -6.13 | DLGAP3 (DLG associated protein 3) | protein interactions | 58512 | 27 | 2 | 19454 | 50 |
DLGAP1,DLG2 |
2.185e-03 | -6.13 | extremity | COSMIC cancer mutations | extremity | 1876 | 13 | 16828 | 49 |
TMEM132D,LRP1B,SGCZ,CNTNAP5,PCDHGC3,XYLT1,TNR,CADM2,LRRC4C,PCDH15,DCC,CSMD3,DPP6 |
2.192e-03 | -6.12 | IG | smart domains | SM00409 | 394 | 6 | 9717 | 34 |
DCC,OPCML,CADM2,NTM,LRRC4C,DSCAM |
2.206e-03 | -6.12 | chondroitin sulfate biosynthesis | BIOCYC pathways | META_PWY-6569 | 18 | 2 | 902 | 4 |
XYLT1,CHST11 |
2.231e-03 | -6.11 | A tetrasaccharide linker sequence is required for GAG synthesis | REACTOME pathways | R-HSA-1971475 | 26 | 2 | 10285 | 28 |
XYLT1,GPC6 |
2.240e-03 | -6.10 | axon guidance | biological process | GO:0007411 | 224 | 4 | 18204 | 45 |
DCC,DSCAM,NRXN1,TNR |
2.240e-03 | -6.10 | neuron projection guidance | biological process | GO:0097485 | 224 | 4 | 18204 | 45 |
TNR,NRXN1,DSCAM,DCC |
2.261e-03 | -6.09 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 7 | 16828 | 49 |
LRRC7,TNR,PDZRN4,XYLT1,NTM,TMEM132D,DCC |
2.275e-03 | -6.09 | cell development | biological process | GO:0048468 | 2236 | 13 | 18204 | 45 |
DCC,DSCAM,SLC8A1,ABHD2,RORA,NTNG1,NTM,OPCML,TNR,DAB1,NRXN1,SGCZ,CHST11 |
2.285e-03 | -6.08 | skin-upper_back-malignant_melanoma | COSMIC cancer mutations | skin-upper_back-malignant_melanoma | 319 | 5 | 16828 | 49 |
CSMD3,TMEM132D,DCC,CADM2,KCNIP4 |
2.325e-03 | -6.06 | postsynaptic membrane organization | biological process | GO:0001941 | 29 | 2 | 18204 | 45 |
NLGN4Y,NRXN1 |
2.325e-03 | -6.06 | heparan sulfate proteoglycan biosynthetic process | biological process | GO:0015012 | 29 | 2 | 18204 | 45 |
HS6ST3,XYLT1 |
2.472e-03 | -6.00 | cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration | biological process | GO:0021813 | 1 | 1 | 18204 | 45 |
DAB1 |
2.487e-03 | -6.00 | neuronal action potential | biological process | GO:0019228 | 30 | 2 | 18204 | 45 |
KCND2,KCNMB2 |
2.495e-03 | -5.99 | PID | pfam domains | PF00640 | 27 | 2 | 17795 | 49 |
ANKS1B,DAB1 |
2.502e-03 | -5.99 | neuronal cell body membrane | cellular component | GO:0032809 | 29 | 2 | 19108 | 49 |
KCND2,CADM2 |
2.556e-03 | -5.97 | EGF_3 | prosite domains | PS50026 | 196 | 4 | 12186 | 36 |
NRXN1,NTNG1,CNTNAP5,LRP1B |
2.570e-03 | -5.96 | Lrp1 (low density lipoprotein receptor-related protein 1) | protein interactions | 16971 | 1 | 1 | 19454 | 50 |
PID1 |
2.570e-03 | -5.96 | App (amyloid beta precursor protein) | protein interactions | 100689222 | 1 | 1 | 19454 | 50 |
LRP1B |
2.570e-03 | -5.96 | Kcnd2 (potassium voltage-gated channel subfamily D member 2) | protein interactions | 65180 | 1 | 1 | 19454 | 50 |
KCNIP4 |
2.570e-03 | -5.96 | Sytl1 (synaptotagmin-like 1) | protein interactions | 269589 | 1 | 1 | 19454 | 50 |
NRXN1 |
2.570e-03 | -5.96 | sina (seven in absentia) | protein interactions | 39884 | 1 | 1 | 19454 | 50 |
DCC |
2.577e-03 | -5.96 | upper_back | COSMIC cancer mutations | upper_back | 328 | 5 | 16828 | 49 |
CSMD3,CADM2,DCC,TMEM132D,KCNIP4 |
2.655e-03 | -5.93 | chondroitin sulfate proteoglycan metabolic process | biological process | GO:0050654 | 31 | 2 | 18204 | 45 |
CHST11,XYLT1 |
2.671e-03 | -5.93 | regulation of system process | biological process | GO:0044057 | 571 | 6 | 18204 | 45 |
NRXN1,KCND2,KCNMB2,DLGAP1,SLC8A1,TNR |
2.692e-03 | -5.92 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 29 | 16828 | 49 |
ZSWIM6,DPP6,PCDH15,SLC8A1,LRRC7,CADM2,GPC6,TNR,ANKS1B,GRIK1,PCDHGC3,CNTNAP5,PDZRN4,DAB1,TMEM132D,DLG2,CSMD3,DCC,FGF14,LRRC4C,ZBTB20,KAZN,NXPH1,SNTG1,KCND2,LRP1B,SCD5,NRXN1,DSCAM |
2.695e-03 | -5.92 | - | gene3d domains | 2.60.40.3430 | 1 | 1 | 14470 | 39 |
PCDH15 |
2.695e-03 | -5.92 | KCNMB2, ball/chain domain | gene3d domains | 4.10.81.20 | 1 | 1 | 14470 | 39 |
KCNMB2 |
2.700e-03 | -5.91 | KCNMB2_ball_chain_dom | interpro domains | IPR015382 | 1 | 1 | 18521 | 50 |
KCNMB2 |
2.700e-03 | -5.91 | Luzp2 | interpro domains | IPR026718 | 1 | 1 | 18521 | 50 |
LUZP2 |
2.700e-03 | -5.91 | EC_dom | interpro domains | IPR041149 | 1 | 1 | 18521 | 50 |
PCDH15 |
2.700e-03 | -5.91 | KCNMB2_ball/chain_dom_sf | interpro domains | IPR037096 | 1 | 1 | 18521 | 50 |
KCNMB2 |
2.700e-03 | -5.91 | DLG2_SH3 | interpro domains | IPR035759 | 1 | 1 | 18521 | 50 |
DLG2 |
2.700e-03 | -5.91 | EC_dom_sf | interpro domains | IPR030718 | 1 | 1 | 18521 | 50 |
PCDH15 |
2.700e-03 | -5.91 | Kazrin_SAM_rpt_2 | interpro domains | IPR037615 | 1 | 1 | 18521 | 50 |
KAZN |
2.700e-03 | -5.91 | ADAR3_DSRM_1 | interpro domains | IPR044460 | 1 | 1 | 18521 | 50 |
ADARB2 |
2.700e-03 | -5.91 | PID1_PTB | interpro domains | IPR039114 | 1 | 1 | 18521 | 50 |
PID1 |
2.700e-03 | -5.91 | K_chnl_volt-dep_Kv4 | interpro domains | IPR004055 | 1 | 1 | 18521 | 50 |
KCND2 |
2.700e-03 | -5.91 | Kazrin | interpro domains | IPR037614 | 1 | 1 | 18521 | 50 |
KAZN |
2.700e-03 | -5.91 | Kazrin_SAM_rpt_1 | interpro domains | IPR037613 | 1 | 1 | 18521 | 50 |
KAZN |
2.700e-03 | -5.91 | Kazrin_SAM_rpt_3 | interpro domains | IPR037616 | 1 | 1 | 18521 | 50 |
KAZN |
2.700e-03 | -5.91 | PID1 | interpro domains | IPR039112 | 1 | 1 | 18521 | 50 |
PID1 |
2.700e-03 | -5.91 | NaCa_exhngr1 | interpro domains | IPR002987 | 1 | 1 | 18521 | 50 |
SLC8A1 |
2.709e-03 | -5.91 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 48 | 16828 | 49 |
KCND2,SNTG1,NXPH1,HS6ST3,SCD5,NRXN1,KCNMB2,DCC,DLG2,NTNG1,CSMD3,KAZN,LRRC4C,FGF14,GRIK1,ANKS1B,GPC6,DAB1,ZSWIM6,CADM2,XYLT1,RBFOX1,DSCAM,LRP1B,ABHD2,ZBTB20,NLGN4Y,PCDHGC3,CNTNAP5,LHFPL3,PID1,TNR,LUZP2,TMEM132D,EPN2,SGCZ,PDZRN4,PCDH15,CHST11,DLGAP1,ADARB2,LRRTM4,DPP6,RORA,NTM,LRRC7,OPCML,SLC8A1 |
2.754e-03 | -5.89 | KcnmB2_inactiv | pfam domains | PF09303 | 1 | 1 | 17795 | 49 |
KCNMB2 |
2.754e-03 | -5.89 | ECD | pfam domains | PF18432 | 1 | 1 | 17795 | 49 |
PCDH15 |
2.809e-03 | -5.87 | caecum | COSMIC cancer mutations | caecum | 14248 | 48 | 16828 | 49 |
RBFOX1,XYLT1,LRP1B,DSCAM,ABHD2,NLGN4Y,ZBTB20,TNR,LUZP2,LHFPL3,PID1,PCDHGC3,CNTNAP5,SGCZ,PDZRN4,TMEM132D,EPN2,LRRTM4,DPP6,DLGAP1,ADARB2,CHST11,PCDH15,OPCML,SLC8A1,LRRC7,RORA,NTM,NXPH1,SNTG1,KCND2,KCNMB2,SCD5,NRXN1,HS6ST3,NTNG1,DLG2,CSMD3,DCC,FGF14,LRRC4C,KAZN,GPC6,ANKS1B,GRIK1,DAB1,ZSWIM6,CADM2 |
2.822e-03 | -5.87 | Immunoglobulins | gene3d domains | 2.60.40.10 | 721 | 7 | 14470 | 39 |
TNR,OPCML,CADM2,DCC,DSCAM,LRRC4C,NTM |
2.827e-03 | -5.87 | positive regulation of ATP metabolic process | biological process | GO:1903580 | 32 | 2 | 18204 | 45 |
ZBTB20,PID1 |
2.870e-03 | -5.85 | NACAEXCHNGR1 | prints domains | PR01260 | 1 | 1 | 5227 | 15 |
SLC8A1 |
2.870e-03 | -5.85 | KV42CHANNEL | prints domains | PR01517 | 1 | 1 | 5227 | 15 |
KCND2 |
3.042e-03 | -5.80 | cell body membrane | cellular component | GO:0044298 | 32 | 2 | 19108 | 49 |
CADM2,KCND2 |
3.060e-03 | -5.79 | Ig-like_fold | interpro domains | IPR013783 | 721 | 7 | 18521 | 50 |
DSCAM,TNR,OPCML,DCC,LRRC4C,NTM,CADM2 |
3.090e-03 | -5.78 | synapse assembly | biological process | GO:0007416 | 118 | 3 | 18204 | 45 |
NRXN1,DSCAM,NLGN4Y |
3.104e-03 | -5.78 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 46 | 16828 | 49 |
DAB1,GRIK1,ANKS1B,GPC6,CADM2,ZSWIM6,HS6ST3,KCNIP4,NRXN1,SCD5,KCNMB2,KCND2,SNTG1,KAZN,LRRC4C,DCC,CSMD3,NTNG1,DLG2,EPN2,TMEM132D,PDZRN4,SGCZ,CNTNAP5,PCDHGC3,PID1,LHFPL3,LUZP2,TNR,NTM,RORA,LRRC7,SLC8A1,PCDH15,CHST11,ADARB2,DLGAP1,DPP6,LRRTM4,DSCAM,LRP1B,XYLT1,RBFOX1,ZBTB20,NLGN4Y,ABHD2 |
3.165e-03 | -5.76 | HS-GAG biosynthesis | REACTOME pathways | R-HSA-2022928 | 31 | 2 | 10285 | 28 |
GPC6,HS6ST3 |
3.210e-03 | -5.74 | oesophagus | COSMIC cancer mutations | oesophagus | 14970 | 49 | 16828 | 49 |
OPCML,SLC8A1,LRRC7,CADM2,RORA,NTM,LRRTM4,DPP6,ZSWIM6,DLGAP1,ADARB2,CHST11,PCDH15,SGCZ,PDZRN4,DAB1,TMEM132D,EPN2,GPC6,TNR,LUZP2,ANKS1B,LHFPL3,PID1,GRIK1,PCDHGC3,CNTNAP5,FGF14,NLGN4Y,LRRC4C,ZBTB20,KAZN,DLG2,NTNG1,CSMD3,ABHD2,DCC,LRP1B,KCNMB2,SCD5,NRXN1,HS6ST3,KCNIP4,DSCAM,NXPH1,SNTG1,RBFOX1,XYLT1,KCND2 |
3.219e-03 | -5.74 | skin-leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-leg-malignant_melanoma-superficial_spreading | 210 | 4 | 16828 | 49 |
LRP1B,SGCZ,CSMD3,NTM |
3.240e-03 | -5.73 | regulation of nervous system process | biological process | GO:0031644 | 120 | 3 | 18204 | 45 |
DLGAP1,TNR,NRXN1 |
3.249e-03 | -5.73 | VLDLR (very low density lipoprotein receptor) | protein interactions | 7436 | 33 | 2 | 19454 | 50 |
LRRC4C,DAB1 |
3.249e-03 | -5.73 | NTM (neurotrimin) | protein interactions | 50863 | 33 | 2 | 19454 | 50 |
NTM,OPCML |
3.364e-03 | -5.69 | Fibrinogen_a/b/g_C_dom | interpro domains | IPR002181 | 32 | 2 | 18521 | 50 |
CNTNAP5,TNR |
3.364e-03 | -5.69 | Fibrinogen-like_C | interpro domains | IPR036056 | 32 | 2 | 18521 | 50 |
CNTNAP5,TNR |
3.383e-03 | -5.69 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 21 | 16828 | 49 |
KCND2,SNTG1,TNR,GPC6,DSCAM,EPN2,TMEM132D,DAB1,KCNMB2,PDZRN4,LRP1B,SGCZ,PCDH15,CHST11,CSMD3,ADARB2,DLGAP1,RORA,LRRC4C,SLC8A1,OPCML |
3.446e-03 | -5.67 | KALRN (kalirin RhoGEF kinase) | protein interactions | 8997 | 34 | 2 | 19454 | 50 |
DSCAM,GRIK1 |
3.553e-03 | -5.64 | action potential | biological process | GO:0001508 | 124 | 3 | 18204 | 45 |
KCNMB2,SLC8A1,KCND2 |
3.568e-03 | -5.64 | positive regulation of synaptic transmission, glutamatergic | biological process | GO:0051968 | 36 | 2 | 18204 | 45 |
TNR,NRXN1 |
3.620e-03 | -5.62 | heparan sulfate biosynthesis | BIOCYC pathways | META_PWY-6564 | 23 | 2 | 902 | 4 |
HS6ST3,XYLT1 |
3.718e-03 | -5.59 | alpha/beta hydrolase | gene3d domains | 3.40.50.1820 | 116 | 3 | 14470 | 39 |
DPP6,NLGN4Y,ABHD2 |
3.725e-03 | -5.59 | pancreas-carcinoma-adenocarcinoma | COSMIC cancer mutations | pancreas-carcinoma-adenocarcinoma | 517 | 6 | 16828 | 49 |
RBFOX1,DCC,XYLT1,HS6ST3,LRP1B,LRRC7 |
3.766e-03 | -5.58 | positive regulation of purine nucleotide metabolic process | biological process | GO:1900544 | 37 | 2 | 18204 | 45 |
PID1,ZBTB20 |
3.766e-03 | -5.58 | positive regulation of nucleotide metabolic process | biological process | GO:0045981 | 37 | 2 | 18204 | 45 |
ZBTB20,PID1 |
3.800e-03 | -5.57 | negative regulation of neuron projection development | biological process | GO:0010977 | 127 | 3 | 18204 | 45 |
DAB1,TNR,DCC |
3.813e-03 | -5.57 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 5 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,GRIK1,SLC8A1 |
3.823e-03 | -5.57 | human chr7q22.2-q22.3 | chromosome location | human chr7q22.2-q22.3 | 2 | 1 | 26134 | 50 |
LHFPL3 |
3.823e-03 | -5.57 | human chr8p23.2 | chromosome location | human chr8p23.2 | 2 | 1 | 26134 | 50 |
CSMD1 |
3.823e-03 | -5.57 | human chr1p32.2-p32.1 | chromosome location | human chr1p32.2-p32.1 | 2 | 1 | 26134 | 50 |
DAB1 |
3.857e-03 | -5.56 | SCN5A (sodium voltage-gated channel alpha subunit 5) | protein interactions | 6331 | 36 | 2 | 19454 | 50 |
FGF14,DLG2 |
3.973e-03 | -5.53 | AB_hydrolase | interpro domains | IPR029058 | 118 | 3 | 18521 | 50 |
NLGN4Y,DPP6,ABHD2 |
3.981e-03 | -5.53 | FIBRINOGEN_C_2 | prosite domains | PS51406 | 32 | 2 | 12186 | 36 |
TNR,CNTNAP5 |
4.071e-03 | -5.50 | MAGI2 (membrane associated guanylate kinase, WW and PDZ domain containing 2) | protein interactions | 9863 | 37 | 2 | 19454 | 50 |
DSCAM,DLGAP1 |
4.234e-03 | -5.46 | negative regulation of neurogenesis | biological process | GO:0050768 | 132 | 3 | 18204 | 45 |
DCC,DAB1,TNR |
4.280e-03 | -5.45 | heparan sulfate biosynthesis | BIOCYC pathways | HUMAN_PWY-6564 | 25 | 2 | 902 | 4 |
HS6ST3,XYLT1 |
4.310e-03 | -5.45 | membrane protein complex | cellular component | GO:0098796 | 1261 | 9 | 19108 | 49 |
SNTG1,DPP6,DLG2,GRIK1,KCNMB2,EPN2,KCND2,KCNIP4,SGCZ |
4.408e-03 | -5.42 | Laminin_G_2 | pfam domains | PF02210 | 36 | 2 | 17795 | 49 |
NRXN1,CNTNAP5 |
4.607e-03 | -5.38 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 27 | 16828 | 49 |
PDZRN4,SGCZ,DAB1,TMEM132D,LUZP2,GPC6,TNR,PCDHGC3,SLC8A1,OPCML,LRRC7,ADARB2,CHST11,PCDH15,LRP1B,NRXN1,DSCAM,KCNIP4,RBFOX1,SNTG1,XYLT1,NLGN4Y,ZBTB20,KAZN,CSMD3,DLG2,DCC |
4.631e-03 | -5.37 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 27 | 16828 | 49 |
CHST11,PCDH15,ADARB2,SLC8A1,OPCML,LRRC7,PCDHGC3,LUZP2,GPC6,TNR,TMEM132D,PDZRN4,SGCZ,DAB1,DCC,CSMD3,DLG2,KAZN,NLGN4Y,ZBTB20,SNTG1,RBFOX1,XYLT1,NRXN1,DSCAM,KCNIP4,LRP1B |
4.697e-03 | -5.36 | cell recognition | biological process | GO:0008037 | 137 | 3 | 18204 | 45 |
OPCML,DSCAM,NTM |
4.728e-03 | -5.35 | learning or memory | biological process | GO:0007611 | 276 | 4 | 18204 | 45 |
NRXN1,NLGN4Y,TNR,CSMD1 |
4.747e-03 | -5.35 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity | molecular function | GO:0050659 | 2 | 1 | 18094 | 43 |
CHST11 |
4.747e-03 | -5.35 | protein xylosyltransferase activity | molecular function | GO:0030158 | 2 | 1 | 18094 | 43 |
XYLT1 |
4.747e-03 | -5.35 | netrin receptor binding | molecular function | GO:1990890 | 2 | 1 | 18094 | 43 |
DSCAM |
4.747e-03 | -5.35 | hormone-sensitive lipase activity | molecular function | GO:0033878 | 2 | 1 | 18094 | 43 |
ABHD2 |
4.749e-03 | -5.35 | LAM_G_DOMAIN | prosite domains | PS50025 | 35 | 2 | 12186 | 36 |
NRXN1,CNTNAP5 |
4.793e-03 | -5.34 | negative regulation of nervous system development | biological process | GO:0051961 | 138 | 3 | 18204 | 45 |
TNR,DAB1,DCC |
4.938e-03 | -5.31 | neurotransmitter receptor transport postsynaptic membrane to endosome | biological process | GO:0098968 | 2 | 1 | 18204 | 45 |
LRRC7 |
4.938e-03 | -5.31 | retrograde axonal protein transport | biological process | GO:0099642 | 2 | 1 | 18204 | 45 |
DLG2 |
4.938e-03 | -5.31 | regulation of axon extension involved in regeneration | biological process | GO:0048690 | 2 | 1 | 18204 | 45 |
TNR |
4.938e-03 | -5.31 | hindbrain structural organization | biological process | GO:0021577 | 2 | 1 | 18204 | 45 |
DAB1 |
4.938e-03 | -5.31 | cerebellum structural organization | biological process | GO:0021589 | 2 | 1 | 18204 | 45 |
DAB1 |
4.938e-03 | -5.31 | negative regulation of sprouting of injured axon | biological process | GO:0048688 | 2 | 1 | 18204 | 45 |
TNR |
4.938e-03 | -5.31 | negative regulation of axon extension involved in regeneration | biological process | GO:0048692 | 2 | 1 | 18204 | 45 |
TNR |
4.938e-03 | -5.31 | axon extension involved in regeneration | biological process | GO:0048677 | 2 | 1 | 18204 | 45 |
TNR |
4.938e-03 | -5.31 | polysaccharide localization | biological process | GO:0033037 | 2 | 1 | 18204 | 45 |
CHST11 |
4.938e-03 | -5.31 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration | biological process | GO:0021812 | 2 | 1 | 18204 | 45 |
DAB1 |
4.938e-03 | -5.31 | sprouting of injured axon | biological process | GO:0048682 | 2 | 1 | 18204 | 45 |
TNR |
4.938e-03 | -5.31 | post-embryonic retina morphogenesis in camera-type eye | biological process | GO:0060060 | 2 | 1 | 18204 | 45 |
DSCAM |
4.977e-03 | -5.30 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 21 | 16828 | 49 |
RORA,LRRC7,LRRC4C,SLC8A1,PCDH15,DCC,ABHD2,ADARB2,CSMD3,NTNG1,DPP6,LRRTM4,DSCAM,PDZRN4,LRP1B,CNTNAP5,PCDHGC3,RBFOX1,SNTG1,LUZP2,TNR |
5.049e-03 | -5.29 | ARID5A (AT-rich interaction domain 5A) | protein interactions | 10865 | 135 | 3 | 19454 | 50 |
KAZN,DAB1,RBFOX1 |
5.122e-03 | -5.27 | Kv4.2-KChIP2 channel complex | cellular component | GO:0071193 | 2 | 1 | 19108 | 49 |
KCND2 |
5.134e-03 | -5.27 | AOAH (acyloxyacyl hydrolase) | protein interactions | 313 | 2 | 1 | 19454 | 50 |
DLG2 |
5.134e-03 | -5.27 | Cubn (cubilin) | protein interactions | 65969 | 2 | 1 | 19454 | 50 |
PID1 |
5.169e-03 | -5.27 | regulation of nervous system development | biological process | GO:0051960 | 456 | 5 | 18204 | 45 |
DSCAM,NRXN1,DCC,TNR,DAB1 |
5.220e-03 | -5.26 | GNPTAB (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) | protein interactions | 79158 | 42 | 2 | 19454 | 50 |
DSCAM,SGCZ |
5.247e-03 | -5.25 | calcium ion binding | molecular function | GO:0005509 | 683 | 6 | 18094 | 43 |
PCDH15,KCNIP4,LRP1B,PCDHGC3,SLC8A1,NRXN1 |
5.292e-03 | -5.24 | cerebellum morphogenesis | biological process | GO:0021587 | 44 | 2 | 18204 | 45 |
RORA,DAB1 |
5.292e-03 | -5.24 | receptor localization to synapse | biological process | GO:0097120 | 44 | 2 | 18204 | 45 |
LRRC7,DLG2 |
5.292e-03 | -5.24 | synaptic transmission, glutamatergic | biological process | GO:0035249 | 44 | 2 | 18204 | 45 |
TNR,GRIK1 |
5.302e-03 | -5.24 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 6 | 16828 | 49 |
DSCAM,CNTNAP5,LRP1B,ANKS1B,DLGAP1,CSMD3 |
5.392e-03 | -5.22 | Dab_PTB | interpro domains | IPR048561 | 2 | 1 | 18521 | 50 |
DAB1 |
5.392e-03 | -5.22 | Acyl-CoA_DS | interpro domains | IPR015876 | 2 | 1 | 18521 | 50 |
SCD5 |
5.392e-03 | -5.22 | XYLT | interpro domains | IPR043538 | 2 | 1 | 18521 | 50 |
XYLT1 |
5.392e-03 | -5.22 | DAB1/2_SBM | interpro domains | IPR048559 | 2 | 1 | 18521 | 50 |
DAB1 |
5.392e-03 | -5.22 | FADS-1_CS | interpro domains | IPR001522 | 2 | 1 | 18521 | 50 |
SCD5 |
5.392e-03 | -5.22 | XylT_C | interpro domains | IPR024448 | 2 | 1 | 18521 | 50 |
XYLT1 |
5.392e-03 | -5.22 | SAM_ANKS1_repeat1 | interpro domains | IPR041880 | 2 | 1 | 18521 | 50 |
ANKS1B |
5.392e-03 | -5.22 | LRP1-like_beta_prop | interpro domains | IPR032485 | 2 | 1 | 18521 | 50 |
LRP1B |
5.392e-03 | -5.22 | SAM_ANKS1_repeat2 | interpro domains | IPR041882 | 2 | 1 | 18521 | 50 |
ANKS1B |
5.392e-03 | -5.22 | Neogenin_C | interpro domains | IPR010560 | 2 | 1 | 18521 | 50 |
DCC |
5.394e-03 | -5.22 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 6 | 16828 | 49 |
CNTNAP5,DLGAP1,ANKS1B,CSMD3,DSCAM,LRP1B |
5.438e-03 | -5.21 | Activation of Na-permeable Kainate Receptors | REACTOME pathways | R-HSA-451307 | 2 | 1 | 10285 | 28 |
GRIK1 |
5.459e-03 | -5.21 | protein localization to membrane | biological process | GO:0072657 | 462 | 5 | 18204 | 45 |
DLG2,NRXN1,KCNIP4,DPP6,LRRC7 |
5.468e-03 | -5.21 | Cell-Cell communication | REACTOME pathways | R-HSA-1500931 | 133 | 3 | 10285 | 28 |
DCC,DSCAM,CADM2 |
5.476e-03 | -5.21 | Laminin_G | interpro domains | IPR001791 | 41 | 2 | 18521 | 50 |
CNTNAP5,NRXN1 |
5.500e-03 | -5.20 | Xylo_C | pfam domains | PF12529 | 2 | 1 | 17795 | 49 |
XYLT1 |
5.500e-03 | -5.20 | DUF5050 | pfam domains | PF16472 | 2 | 1 | 17795 | 49 |
LRP1B |
5.500e-03 | -5.20 | DAB2_SBM | pfam domains | PF21792 | 2 | 1 | 17795 | 49 |
DAB1 |
5.500e-03 | -5.20 | Neogenin_C | pfam domains | PF06583 | 2 | 1 | 17795 | 49 |
DCC |
5.732e-03 | -5.16 | BKCHANNELB | prints domains | PR01450 | 2 | 1 | 5227 | 15 |
KCNMB2 |
5.732e-03 | -5.16 | FACDDSATRASE | prints domains | PR00075 | 2 | 1 | 5227 | 15 |
SCD5 |
5.778e-03 | -5.15 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 8 | 16828 | 49 |
OPCML,SLC8A1,LRP1B,TMEM132D,DSCAM,TNR,CSMD3,LHFPL3 |
5.778e-03 | -5.15 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 8 | 16828 | 49 |
CSMD3,TNR,LHFPL3,SLC8A1,LRP1B,OPCML,DSCAM,TMEM132D |
5.900e-03 | -5.13 | FATTY_ACID_DESATUR_1 | prosite domains | PS00476 | 2 | 1 | 12186 | 36 |
SCD5 |
5.922e-03 | -5.13 | FAM168A (family with sequence similarity 168 member A) | protein interactions | 23201 | 143 | 3 | 19454 | 50 |
RBFOX1,EPN2,DAB1 |
6.018e-03 | -5.11 | hindbrain morphogenesis | biological process | GO:0021575 | 47 | 2 | 18204 | 45 |
RORA,DAB1 |
6.107e-03 | -5.10 | axon | cellular component | GO:0030424 | 650 | 6 | 19108 | 49 |
DCC,CADM2,LRRC7,DLG2,SLC8A1,DSCAM |
6.153e-03 | -5.09 | cell projection | cellular component | GO:0042995 | 2398 | 13 | 19108 | 49 |
KCNIP4,NRXN1,KCND2,PCDH15,DCC,LRRC7,ANKS1B,SNTG1,CADM2,SLC8A1,ABHD2,DSCAM,DLG2 |
6.224e-03 | -5.08 | fn3 | pfam domains | PF00041 | 136 | 3 | 17795 | 49 |
DSCAM,TNR,DCC |
6.233e-03 | -5.08 | skin-abdomen-malignant_melanoma | COSMIC cancer mutations | skin-abdomen-malignant_melanoma | 404 | 5 | 16828 | 49 |
DCC,RBFOX1,CSMD3,PDZRN4,LRP1B |
6.454e-03 | -5.04 | leg | COSMIC cancer mutations | leg | 969 | 8 | 16828 | 49 |
NTM,ZBTB20,LRP1B,SLC8A1,SGCZ,KCND2,DCC,CSMD3 |
6.500e-03 | -5.04 | CNTN1 (contactin 1) | protein interactions | 1272 | 47 | 2 | 19454 | 50 |
TNR,PCDHGC3 |
6.573e-03 | -5.02 | cell morphogenesis | biological process | GO:0000902 | 687 | 6 | 18204 | 45 |
DAB1,TNR,DSCAM,DCC,NTNG1,NRXN1 |
6.613e-03 | -5.02 | sulfur compound biosynthetic process | biological process | GO:0044272 | 155 | 3 | 18204 | 45 |
HS6ST3,CHST11,XYLT1 |
6.681e-03 | -5.01 | regulation of transmembrane transport | biological process | GO:0034762 | 485 | 5 | 18204 | 45 |
SLC8A1,FGF14,PID1,KCNIP4,DPP6 |
6.850e-03 | -4.98 | neuron projection development | biological process | GO:0031175 | 693 | 6 | 18204 | 45 |
TNR,DAB1,NRXN1,DSCAM,DCC,NTNG1 |
7.020e-03 | -4.96 | regulation of monoatomic cation transmembrane transport | biological process | GO:1904062 | 309 | 4 | 18204 | 45 |
SLC8A1,DPP6,KCNIP4,FGF14 |
7.040e-03 | -4.96 | sulfotransferase activity | molecular function | GO:0008146 | 53 | 2 | 18094 | 43 |
HS6ST3,CHST11 |
7.113e-03 | -4.95 | stearoyl-CoA 9-desaturase activity | molecular function | GO:0004768 | 3 | 1 | 18094 | 43 |
SCD5 |
7.113e-03 | -4.95 | heparan sulfate 6-O-sulfotransferase activity | molecular function | GO:0017095 | 3 | 1 | 18094 | 43 |
HS6ST3 |
7.113e-03 | -4.95 | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | molecular function | GO:1905030 | 3 | 1 | 18094 | 43 |
KCND2 |
7.398e-03 | -4.91 | neuroligin clustering involved in postsynaptic membrane assembly | biological process | GO:0097118 | 3 | 1 | 18204 | 45 |
NRXN1 |
7.398e-03 | -4.91 | regulation of sprouting of injured axon | biological process | GO:0048686 | 3 | 1 | 18204 | 45 |
TNR |
7.398e-03 | -4.91 | spinal cord ventral commissure morphogenesis | biological process | GO:0021965 | 3 | 1 | 18204 | 45 |
DCC |
7.398e-03 | -4.91 | negative regulation of ATP biosynthetic process | biological process | GO:2001170 | 3 | 1 | 18204 | 45 |
PID1 |
7.398e-03 | -4.91 | radial glia guided migration of Purkinje cell | biological process | GO:0021942 | 3 | 1 | 18204 | 45 |
DAB1 |
7.398e-03 | -4.91 | dorsal/ventral axon guidance | biological process | GO:0033563 | 3 | 1 | 18204 | 45 |
DCC |
7.398e-03 | -4.91 | lateral motor column neuron migration | biological process | GO:0097477 | 3 | 1 | 18204 | 45 |
DAB1 |
7.398e-03 | -4.91 | protein localization to early endosome | biological process | GO:1902946 | 3 | 1 | 18204 | 45 |
LRRC7 |
7.404e-03 | -4.91 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 4 | 16828 | 49 |
RBFOX1,CSMD3,LRP1B,TNR |
7.420e-03 | -4.90 | CUB | pfam domains | PF00431 | 47 | 2 | 17795 | 49 |
CSMD1,CSMD3 |
7.452e-03 | -4.90 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 5 | 18204 | 45 |
SLC8A1,TNR,DSCAM,KCNMB2,DCC |
7.600e-03 | -4.88 | biological process involved in intraspecies interaction between organisms | biological process | GO:0051703 | 53 | 2 | 18204 | 45 |
NRXN1,NLGN4Y |
7.600e-03 | -4.88 | social behavior | biological process | GO:0035176 | 53 | 2 | 18204 | 45 |
NLGN4Y,NRXN1 |
7.631e-03 | -4.88 | human chr8q23.3 | chromosome location | human chr8q23.3 | 4 | 1 | 26134 | 50 |
CSMD3 |
7.691e-03 | -4.87 | KLHL4 (kelch like family member 4) | protein interactions | 56062 | 3 | 1 | 19454 | 50 |
DSCAM |
7.691e-03 | -4.87 | QRFPR (pyroglutamylated RFamide peptide receptor) | protein interactions | 84109 | 3 | 1 | 19454 | 50 |
NTM |
7.691e-03 | -4.87 | TULP1 (TUB like protein 1) | protein interactions | 7287 | 3 | 1 | 19454 | 50 |
NRXN1 |
7.742e-03 | -4.86 | monoatomic cation channel activity | molecular function | GO:0005261 | 331 | 4 | 18094 | 43 |
KCND2,KCNMB2,GRIK1,KCNIP4 |
7.747e-03 | -4.86 | CUB_dom | interpro domains | IPR000859 | 49 | 2 | 18521 | 50 |
CSMD1,CSMD3 |
7.837e-03 | -4.85 | cognition | biological process | GO:0050890 | 319 | 4 | 18204 | 45 |
TNR,CSMD1,NRXN1,NLGN4Y |
7.851e-03 | -4.85 | potassium ion transmembrane transport | biological process | GO:0071805 | 165 | 3 | 18204 | 45 |
KCNMB2,KCNIP4,KCND2 |
7.980e-03 | -4.83 | Metabolism of carbohydrates | REACTOME pathways | R-HSA-71387 | 296 | 4 | 10285 | 28 |
CHST11,HS6ST3,XYLT1,GPC6 |
7.992e-03 | -4.83 | Spermadhesin, CUB domain | gene3d domains | 2.60.120.290 | 50 | 2 | 14470 | 39 |
CSMD1,CSMD3 |
8.078e-03 | -4.82 | Fox-1_C_dom | interpro domains | IPR025670 | 3 | 1 | 18521 | 50 |
RBFOX1 |
8.078e-03 | -4.82 | FOX1_RRM | interpro domains | IPR034237 | 3 | 1 | 18521 | 50 |
RBFOX1 |
8.078e-03 | -4.82 | ABHD4 | interpro domains | IPR012020 | 3 | 1 | 18521 | 50 |
ABHD2 |
8.078e-03 | -4.82 | Shal-type_N | interpro domains | IPR021645 | 3 | 1 | 18521 | 50 |
KCND2 |
8.078e-03 | -4.82 | RBFOX1-3 | interpro domains | IPR017325 | 3 | 1 | 18521 | 50 |
RBFOX1 |
8.078e-03 | -4.82 | RBFOX1-like | interpro domains | IPR047131 | 3 | 1 | 18521 | 50 |
RBFOX1 |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | Heparan_SO4-6-sulfoTrfase | interpro domains | IPR010635 | 3 | 1 | 18521 | 50 |
HS6ST3 |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | AB_hydrolase_4_CS | interpro domains | IPR000952 | 3 | 1 | 18521 | 50 |
ABHD2 |
8.078e-03 | -4.82 | Sarcoglycan_gamma/delta/zeta | interpro domains | IPR039972 | 3 | 1 | 18521 | 50 |
SGCZ |
8.078e-03 | -4.82 | K_chnl_volt-dep_Kv4_C | interpro domains | IPR024587 | 3 | 1 | 18521 | 50 |
KCND2 |
8.078e-03 | -4.82 | K_chnl_volt-dep_Kv4 | interpro domains | IPR003975 | 3 | 1 | 18521 | 50 |
KCND2 |
8.078e-03 | -4.82 | Na_Ca_Ex_C-exten | interpro domains | IPR032452 | 3 | 1 | 18521 | 50 |
SLC8A1 |
8.078e-03 | -4.82 | Na_Ca_Ex | interpro domains | IPR004836 | 3 | 1 | 18521 | 50 |
SLC8A1 |
8.165e-03 | -4.81 | establishment or maintenance of epithelial cell apical/basal polarity | biological process | GO:0045197 | 55 | 2 | 18204 | 45 |
DLG2,LRRC7 |
8.238e-03 | -4.80 | PID_2 | pfam domains | PF14719 | 3 | 1 | 17795 | 49 |
PID1 |
8.238e-03 | -4.80 | DUF3399 | pfam domains | PF11879 | 3 | 1 | 17795 | 49 |
KCND2 |
8.238e-03 | -4.80 | Na_Ca_ex_C | pfam domains | PF16494 | 3 | 1 | 17795 | 49 |
SLC8A1 |
8.238e-03 | -4.80 | MAGUK_N_PEST | pfam domains | PF10608 | 3 | 1 | 17795 | 49 |
DLG2 |
8.238e-03 | -4.80 | Shal-type | pfam domains | PF11601 | 3 | 1 | 17795 | 49 |
KCND2 |
8.238e-03 | -4.80 | Fox-1_C | pfam domains | PF12414 | 3 | 1 | 17795 | 49 |
RBFOX1 |
8.343e-03 | -4.79 | E6 (protein E6*;transforming protein E6) | protein interactions | 1489078 | 162 | 3 | 19454 | 50 |
PDZRN4,DLG2,SNTG1 |
8.482e-03 | -4.77 | skin-subungual-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-subungual-malignant_melanoma-acral_lentiginous | 144 | 3 | 16828 | 49 |
CSMD3,LRP1B,GPC6 |
8.507e-03 | -4.77 | NOS1 (nitric oxide synthase 1) | protein interactions | 4842 | 54 | 2 | 19454 | 50 |
HS6ST3,DLG2 |
8.507e-03 | -4.77 | LRRC4C (leucine rich repeat containing 4C) | protein interactions | 57689 | 54 | 2 | 19454 | 50 |
LRRC4C,NTNG1 |
8.529e-03 | -4.76 | LamG | smart domains | SM00282 | 40 | 2 | 9717 | 34 |
NRXN1,CNTNAP5 |
8.586e-03 | -4.76 | NACAEXCHNGR | prints domains | PR01259 | 3 | 1 | 5227 | 15 |
SLC8A1 |
8.586e-03 | -4.76 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 15 |
RORA |
8.586e-03 | -4.76 | SHALCHANNEL | prints domains | PR01497 | 3 | 1 | 5227 | 15 |
KCND2 |
8.690e-03 | -4.75 | Sperma_CUB_dom_sf | interpro domains | IPR035914 | 52 | 2 | 18521 | 50 |
CSMD3,CSMD1 |
8.690e-03 | -4.75 | Sushi | pfam domains | PF00084 | 51 | 2 | 17795 | 49 |
CSMD3,CSMD1 |
8.837e-03 | -4.73 | UPF0017 | prosite domains | PS01133 | 3 | 1 | 12186 | 36 |
ABHD2 |
8.934e-03 | -4.72 | regulation of cell size | biological process | GO:0008361 | 173 | 3 | 18204 | 45 |
DSCAM,DCC,TNR |
8.972e-03 | -4.71 | subungual | COSMIC cancer mutations | subungual | 147 | 3 | 16828 | 49 |
CSMD3,GPC6,LRP1B |
9.142e-03 | -4.69 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 42 | 16828 | 49 |
CSMD3,DLG2,NTNG1,DCC,ABHD2,FGF14,LRRC4C,ZBTB20,KAZN,NXPH1,SNTG1,RBFOX1,KCND2,XYLT1,LRP1B,NRXN1,SCD5,DSCAM,DPP6,ZSWIM6,LRRTM4,ADARB2,DLGAP1,CHST11,PCDH15,SLC8A1,OPCML,LRRC7,NTM,RORA,LUZP2,TNR,GPC6,ANKS1B,PID1,GRIK1,CNTNAP5,PDZRN4,SGCZ,DAB1,EPN2,TMEM132D |
9.146e-03 | -4.69 | CUB | prosite domains | PS01180 | 49 | 2 | 12186 | 36 |
CSMD1,CSMD3 |
9.147e-03 | -4.69 | presynaptic membrane | cellular component | GO:0042734 | 168 | 3 | 19108 | 49 |
NTNG1,GRIK1,NRXN1 |
9.206e-03 | -4.69 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 20 | 16828 | 49 |
LRRC7,LRRC4C,SLC8A1,RORA,NTNG1,ADARB2,CSMD3,LRRTM4,DPP6,PCDH15,DCC,PDZRN4,LRP1B,DSCAM,TNR,LUZP2,PCDHGC3,CNTNAP5,SNTG1,RBFOX1 |
9.227e-03 | -4.69 | cervix | COSMIC cancer mutations | cervix | 11793 | 42 | 16828 | 49 |
RBFOX1,SNTG1,XYLT1,KCND2,NXPH1,SCD5,NRXN1,DSCAM,LRP1B,ABHD2,DCC,NTNG1,DLG2,CSMD3,KAZN,FGF14,ZBTB20,LRRC4C,GRIK1,PID1,CNTNAP5,TNR,GPC6,LUZP2,ANKS1B,TMEM132D,EPN2,SGCZ,PDZRN4,DAB1,CHST11,PCDH15,LRRTM4,DPP6,ZSWIM6,DLGAP1,ADARB2,RORA,NTM,OPCML,SLC8A1,LRRC7 |
9.349e-03 | -4.67 | establishment or maintenance of bipolar cell polarity | biological process | GO:0061245 | 59 | 2 | 18204 | 45 |
DLG2,LRRC7 |
9.349e-03 | -4.67 | establishment or maintenance of apical/basal cell polarity | biological process | GO:0035088 | 59 | 2 | 18204 | 45 |
DLG2,LRRC7 |
9.362e-03 | -4.67 | potassium ion transport | biological process | GO:0006813 | 176 | 3 | 18204 | 45 |
KCNIP4,KCNMB2,KCND2 |
9.362e-03 | -4.67 | central nervous system neuron differentiation | biological process | GO:0021953 | 176 | 3 | 18204 | 45 |
ZSWIM6,DCC,RORA |
9.363e-03 | -4.67 | large_intestine-colon-adenoma | COSMIC cancer mutations | large_intestine-colon-adenoma | 627 | 6 | 16828 | 49 |
CADM2,CHST11,DCC,PCDH15,TNR,CSMD3 |
9.473e-03 | -4.66 | A-type (transient outward) potassium channel activity | molecular function | GO:0005250 | 4 | 1 | 18094 | 43 |
KCND2 |
9.473e-03 | -4.66 | chondroitin 4-sulfotransferase activity | molecular function | GO:0047756 | 4 | 1 | 18094 | 43 |
CHST11 |
9.473e-03 | -4.66 | acyl-CoA desaturase activity | molecular function | GO:0016215 | 4 | 1 | 18094 | 43 |
SCD5 |
9.530e-03 | -4.65 | human chr3p12.1 | chromosome location | human chr3p12.1 | 5 | 1 | 26134 | 50 |
CADM2 |
9.616e-03 | -4.64 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 48 | 16828 | 49 |
DAB1,GRIK1,GPC6,ANKS1B,CADM2,ZSWIM6,NRXN1,SCD5,KCNIP4,HS6ST3,KCNMB2,SNTG1,KCND2,NXPH1,KAZN,FGF14,LRRC4C,DCC,CSMD3,NTNG1,DLG2,EPN2,TMEM132D,PDZRN4,SGCZ,LHFPL3,CNTNAP5,PCDHGC3,LUZP2,TNR,NTM,RORA,SLC8A1,OPCML,LRRC7,CHST11,PCDH15,DPP6,LRRTM4,ADARB2,DLGAP1,DSCAM,LRP1B,RBFOX1,XYLT1,NLGN4Y,ZBTB20,ABHD2 |
9.656e-03 | -4.64 | transmission of nerve impulse | biological process | GO:0019226 | 60 | 2 | 18204 | 45 |
KCNMB2,KCND2 |
9.656e-03 | -4.64 | membrane assembly | biological process | GO:0071709 | 60 | 2 | 18204 | 45 |
NRXN1,NLGN4Y |
9.682e-03 | -4.64 | Sushi_SCR_CCP_dom | interpro domains | IPR000436 | 55 | 2 | 18521 | 50 |
CSMD3,CSMD1 |
9.709e-03 | -4.63 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 11 | 19454 | 50 |
GRIK1,DAB1,DPP6,CSMD1,NLGN4Y,LUZP2,ABHD2,ZSWIM6,LRRC7,CHST11,ZBTB20 |
9.852e-03 | -4.62 | striatal medium spiny neuron differentiation | biological process | GO:0021773 | 4 | 1 | 18204 | 45 |
ZSWIM6 |
9.852e-03 | -4.62 | spinal cord motor neuron migration | biological process | GO:0097476 | 4 | 1 | 18204 | 45 |
DAB1 |
9.852e-03 | -4.62 | negative regulation of nucleotide biosynthetic process | biological process | GO:0030809 | 4 | 1 | 18204 | 45 |
PID1 |
9.852e-03 | -4.62 | oviduct epithelium development | biological process | GO:0035846 | 4 | 1 | 18204 | 45 |
CSMD1 |
9.852e-03 | -4.62 | positive regulation of fat cell proliferation | biological process | GO:0070346 | 4 | 1 | 18204 | 45 |
PID1 |
9.852e-03 | -4.62 | negative regulation of purine nucleotide biosynthetic process | biological process | GO:1900372 | 4 | 1 | 18204 | 45 |
PID1 |
1.010e-02 | -4.60 | negative regulation of cell projection organization | biological process | GO:0031345 | 181 | 3 | 18204 | 45 |
TNR,DAB1,DCC |
1.022e-02 | -4.58 | tenascin complex | cellular component | GO:0090733 | 4 | 1 | 19108 | 49 |
TNR |
1.022e-02 | -4.58 | syntrophin complex | cellular component | GO:0016013 | 4 | 1 | 19108 | 49 |
SNTG1 |
1.022e-02 | -4.58 | symmetric, GABA-ergic, inhibitory synapse | cellular component | GO:0098983 | 4 | 1 | 19108 | 49 |
NLGN4Y |
1.024e-02 | -4.58 | SIGLEC1 (sialic acid binding Ig like lectin 1) | protein interactions | 6614 | 4 | 1 | 19454 | 50 |
TNR |
1.024e-02 | -4.58 | IGKV@ (immunoglobulin kappa variable cluster) | protein interactions | 3519 | 4 | 1 | 19454 | 50 |
LRP1B |
1.024e-02 | -4.58 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 50 |
RORA |
1.026e-02 | -4.58 | Axon guidance | KEGG pathways | ko04360 | 174 | 3 | 7161 | 19 |
DCC,NTNG1,LRRC4C |
1.026e-02 | -4.58 | Axon guidance | KEGG pathways | hsa04360 | 174 | 3 | 7161 | 19 |
LRRC4C,DCC,NTNG1 |
1.028e-02 | -4.58 | telencephalon cell migration | biological process | GO:0022029 | 62 | 2 | 18204 | 45 |
TNR,DAB1 |
1.028e-02 | -4.58 | regulation of postsynaptic membrane neurotransmitter receptor levels | biological process | GO:0099072 | 62 | 2 | 18204 | 45 |
LRRC7,DLG2 |
1.037e-02 | -4.57 | Sushi/SCR/CCP_sf | interpro domains | IPR035976 | 57 | 2 | 18521 | 50 |
CSMD1,CSMD3 |
1.045e-02 | -4.56 | regulation of monoatomic ion transmembrane transport | biological process | GO:0034765 | 347 | 4 | 18204 | 45 |
SLC8A1,KCNIP4,DPP6,FGF14 |
1.050e-02 | -4.56 | central nervous system development | biological process | GO:0007417 | 995 | 7 | 18204 | 45 |
TNR,DAB1,DSCAM,DCC,ZSWIM6,RORA,GRIK1 |
1.076e-02 | -4.53 | DLG1-like | interpro domains | IPR016313 | 4 | 1 | 18521 | 50 |
DLG2 |
1.076e-02 | -4.53 | ANKS1/Caskin | interpro domains | IPR033635 | 4 | 1 | 18521 | 50 |
ANKS1B |
1.076e-02 | -4.53 | DLG1_PEST_dom | interpro domains | IPR019590 | 4 | 1 | 18521 | 50 |
DLG2 |
1.076e-02 | -4.53 | Sarcoglycan | interpro domains | IPR006875 | 4 | 1 | 18521 | 50 |
SGCZ |
1.076e-02 | -4.53 | DLG1-4_PDZ_assoc | interpro domains | IPR019583 | 4 | 1 | 18521 | 50 |
DLG2 |
1.076e-02 | -4.53 | ZSWIM4-8_C | interpro domains | IPR048370 | 4 | 1 | 18521 | 50 |
ZSWIM6 |
1.076e-02 | -4.53 | K_chnl_Ca-activ_BK_bsu | interpro domains | IPR003930 | 4 | 1 | 18521 | 50 |
KCNMB2 |
1.076e-02 | -4.53 | Nxph | interpro domains | IPR010450 | 4 | 1 | 18521 | 50 |
NXPH1 |
1.077e-02 | -4.53 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 3 | 19454 | 50 |
LRRC7,ANKS1B,DLG2 |
1.097e-02 | -4.51 | Sarcoglycan_1 | pfam domains | PF04790 | 4 | 1 | 17795 | 49 |
SGCZ |
1.097e-02 | -4.51 | PDZ_assoc | pfam domains | PF10600 | 4 | 1 | 17795 | 49 |
DLG2 |
1.097e-02 | -4.51 | ZSWIM4-8_C | pfam domains | PF21055 | 4 | 1 | 17795 | 49 |
ZSWIM6 |
1.097e-02 | -4.51 | CaKB | pfam domains | PF03185 | 4 | 1 | 17795 | 49 |
KCNMB2 |
1.104e-02 | -4.51 | cell differentiation | biological process | GO:0030154 | 3645 | 16 | 18204 | 45 |
CHST11,NRXN1,SGCZ,OPCML,TNR,DAB1,NTM,NTNG1,KAZN,PID1,RORA,ZSWIM6,ABHD2,SLC8A1,DSCAM,DCC |
1.108e-02 | -4.50 | localization within membrane | biological process | GO:0051668 | 549 | 5 | 18204 | 45 |
NRXN1,DLG2,LRRC7,KCNIP4,DPP6 |
1.111e-02 | -4.50 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 12 | 19108 | 49 |
KCND2,PCDH15,DCC,LRRC7,KCNIP4,SNTG1,ANKS1B,CADM2,DLG2,SLC8A1,ABHD2,DSCAM |
1.112e-02 | -4.50 | cellular developmental process | biological process | GO:0048869 | 3648 | 16 | 18204 | 45 |
ABHD2,SLC8A1,DSCAM,DCC,KAZN,ZSWIM6,RORA,PID1,TNR,DAB1,OPCML,NTM,NTNG1,CHST11,SGCZ,NRXN1 |
1.126e-02 | -4.49 | glycosaminoglycan biosynthetic process | biological process | GO:0006024 | 65 | 2 | 18204 | 45 |
CHST11,XYLT1 |
1.126e-02 | -4.49 | forebrain cell migration | biological process | GO:0021885 | 65 | 2 | 18204 | 45 |
TNR,DAB1 |
1.126e-02 | -4.49 | membrane biogenesis | biological process | GO:0044091 | 65 | 2 | 18204 | 45 |
NRXN1,NLGN4Y |
1.138e-02 | -4.48 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 49 | 16828 | 49 |
DCC,ABHD2,CSMD3,DLG2,NTNG1,KAZN,NLGN4Y,FGF14,LRRC4C,ZBTB20,SNTG1,RBFOX1,KCND2,XYLT1,NXPH1,NRXN1,SCD5,DSCAM,HS6ST3,KCNIP4,LRP1B,KCNMB2,CHST11,PCDH15,ZSWIM6,DPP6,LRRTM4,ADARB2,DLGAP1,CADM2,NTM,RORA,SLC8A1,OPCML,LRRC7,PID1,GRIK1,LHFPL3,CNTNAP5,PCDHGC3,LUZP2,TNR,GPC6,ANKS1B,EPN2,TMEM132D,PDZRN4,SGCZ,DAB1 |
1.138e-02 | -4.48 | Ig_V-set | interpro domains | IPR013106 | 173 | 3 | 18521 | 50 |
LRRC4C,CADM2,DSCAM |
1.142e-02 | -4.47 | SUSHI | prosite domains | PS50923 | 55 | 2 | 12186 | 36 |
CSMD1,CSMD3 |
1.144e-02 | -4.47 | NLGN2 (neuroligin 2) | protein interactions | 57555 | 63 | 2 | 19454 | 50 |
DLG2,NRXN1 |
1.164e-02 | -4.45 | CUB | smart domains | SM00042 | 47 | 2 | 9717 | 34 |
CSMD1,CSMD3 |
1.174e-02 | -4.44 | Leu-rich_rpt_typical-subtyp | interpro domains | IPR003591 | 175 | 3 | 18521 | 50 |
LRRC4C,LRRC7,LRRTM4 |
1.178e-02 | -4.44 | DAZAP2 (DAZ associated protein 2) | protein interactions | 9802 | 184 | 3 | 19454 | 50 |
DAB1,EPN2,RBFOX1 |
1.183e-02 | -4.44 | acetylesterase activity | molecular function | GO:0008126 | 5 | 1 | 18094 | 43 |
ABHD2 |
1.183e-02 | -4.44 | N-acetylgalactosamine 4-O-sulfotransferase activity | molecular function | GO:0001537 | 5 | 1 | 18094 | 43 |
CHST11 |
1.183e-02 | -4.44 | kainate selective glutamate receptor activity | molecular function | GO:0015277 | 5 | 1 | 18094 | 43 |
GRIK1 |
1.183e-02 | -4.44 | neuroligin family protein binding | molecular function | GO:0097109 | 5 | 1 | 18094 | 43 |
NRXN1 |
1.199e-02 | -4.42 | LRR_8 | pfam domains | PF13855 | 173 | 3 | 17795 | 49 |
LRRTM4,LRRC7,LRRC4C |
1.215e-02 | -4.41 | ARHGAP26 (Rho GTPase activating protein 26) | protein interactions | 23092 | 65 | 2 | 19454 | 50 |
NRXN1,ANKS1B |
1.230e-02 | -4.40 | conditioned place preference | biological process | GO:1990708 | 5 | 1 | 18204 | 45 |
CSMD1 |
1.230e-02 | -4.40 | positive regulation of the force of heart contraction | biological process | GO:0098735 | 5 | 1 | 18204 | 45 |
SLC8A1 |
1.230e-02 | -4.40 | medium-chain fatty acid catabolic process | biological process | GO:0051793 | 5 | 1 | 18204 | 45 |
ABHD2 |
1.230e-02 | -4.40 | regulation of postsynaptic neurotransmitter receptor activity | biological process | GO:0098962 | 5 | 1 | 18204 | 45 |
DLGAP1 |
1.230e-02 | -4.40 | gephyrin clustering involved in postsynaptic density assembly | biological process | GO:0097116 | 5 | 1 | 18204 | 45 |
NRXN1 |
1.236e-02 | -4.39 | transferase activity, transferring sulphur-containing groups | molecular function | GO:0016782 | 71 | 2 | 18094 | 43 |
HS6ST3,CHST11 |
1.247e-02 | -4.38 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 5 | 18094 | 43 |
KCNIP4,SLC8A1,GRIK1,KCNMB2,KCND2 |
1.262e-02 | -4.37 | aminoglycan biosynthetic process | biological process | GO:0006023 | 69 | 2 | 18204 | 45 |
CHST11,XYLT1 |
1.269e-02 | -4.37 | protein localization to plasma membrane | biological process | GO:0072659 | 197 | 3 | 18204 | 45 |
KCNIP4,LRRC7,DPP6 |
1.276e-02 | -4.36 | kainate selective glutamate receptor complex | cellular component | GO:0032983 | 5 | 1 | 19108 | 49 |
GRIK1 |
1.276e-02 | -4.36 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_myeloid_leukaemia | 312 | 4 | 16828 | 49 |
CSMD3,LRP1B,DSCAM,DCC |
1.276e-02 | -4.36 | chronic_myeloid_leukaemia | COSMIC cancer mutations | chronic_myeloid_leukaemia | 312 | 4 | 16828 | 49 |
LRP1B,CSMD3,DCC,DSCAM |
1.279e-02 | -4.36 | MLANA (melan-A) | protein interactions | 2315 | 5 | 1 | 19454 | 50 |
EPN2 |
1.279e-02 | -4.36 | TAAR1 (trace amine associated receptor 1) | protein interactions | 134864 | 5 | 1 | 19454 | 50 |
GRIK1 |
1.279e-02 | -4.36 | SYT13 (synaptotagmin 13) | protein interactions | 57586 | 5 | 1 | 19454 | 50 |
NRXN1 |
1.279e-02 | -4.36 | DLX4 (distal-less homeobox 4) | protein interactions | 1748 | 5 | 1 | 19454 | 50 |
GPC6 |
1.279e-02 | -4.36 | DPP10 (dipeptidyl peptidase like 10) | protein interactions | 57628 | 5 | 1 | 19454 | 50 |
KCND2 |
1.279e-02 | -4.36 | TRH (thyrotropin releasing hormone) | protein interactions | 7200 | 5 | 1 | 19454 | 50 |
KCNIP4 |
1.279e-02 | -4.36 | ASTN1 (astrotactin 1) | protein interactions | 460 | 5 | 1 | 19454 | 50 |
DSCAM |
1.287e-02 | -4.35 | soft_tissue-striated_muscle-rhabdoid_tumour | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdoid_tumour | 168 | 3 | 16828 | 49 |
NTNG1,SLC8A1,ABHD2 |
1.287e-02 | -4.35 | rhabdoid_tumour | COSMIC cancer mutations | rhabdoid_tumour | 168 | 3 | 16828 | 49 |
SLC8A1,NTNG1,ABHD2 |
1.304e-02 | -4.34 | SAM_1 | pfam domains | PF00536 | 63 | 2 | 17795 | 49 |
ANKS1B,KAZN |
1.318e-02 | -4.33 | main axon | cellular component | GO:0044304 | 68 | 2 | 19108 | 49 |
LRRC7,DLG2 |
1.320e-02 | -4.33 | Glycosaminoglycan biosynthesis, linkage tetrasaccharide | KEGG pathways | hsa_M00057 | 5 | 1 | 7161 | 19 |
XYLT1 |
1.320e-02 | -4.33 | Glycosaminoglycan biosynthesis, linkage tetrasaccharide | KEGG pathways | M00057 | 5 | 1 | 7161 | 19 |
XYLT1 |
1.332e-02 | -4.32 | human chr7q36.2 | chromosome location | human chr7q36.2 | 7 | 1 | 26134 | 50 |
DPP6 |
1.342e-02 | -4.31 | salivary_gland-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma-adenoid_cystic_carcinoma | 488 | 5 | 16828 | 49 |
NTNG1,CNTNAP5,PCDHGC3,RORA,CADM2 |
1.343e-02 | -4.31 | TMEM132 | interpro domains | IPR026307 | 5 | 1 | 18521 | 50 |
TMEM132D |
1.343e-02 | -4.31 | Syntrophin | interpro domains | IPR015482 | 5 | 1 | 18521 | 50 |
SNTG1 |
1.343e-02 | -4.31 | Nlgn | interpro domains | IPR000460 | 5 | 1 | 18521 | 50 |
NLGN4Y |
1.343e-02 | -4.31 | TMEM132_C | interpro domains | IPR031436 | 5 | 1 | 18521 | 50 |
TMEM132D |
1.343e-02 | -4.31 | SAPAP | interpro domains | IPR005026 | 5 | 1 | 18521 | 50 |
DLGAP1 |
1.343e-02 | -4.31 | EGF_Tenascin | interpro domains | IPR041161 | 5 | 1 | 18521 | 50 |
TNR |
1.343e-02 | -4.31 | TMEM132_N | interpro domains | IPR031435 | 5 | 1 | 18521 | 50 |
TMEM132D |
1.343e-02 | -4.31 | TMEM132_M | interpro domains | IPR031437 | 5 | 1 | 18521 | 50 |
TMEM132D |
1.354e-02 | -4.30 | Reelin signalling pathway | REACTOME pathways | R-HSA-8866376 | 5 | 1 | 10285 | 28 |
DAB1 |
1.369e-02 | -4.29 | regulation of ATP metabolic process | biological process | GO:1903578 | 72 | 2 | 18204 | 45 |
PID1,ZBTB20 |
1.369e-02 | -4.29 | EGF_Tenascin | pfam domains | PF18720 | 5 | 1 | 17795 | 49 |
TNR |
1.369e-02 | -4.29 | TMEM132D_C | pfam domains | PF15706 | 5 | 1 | 17795 | 49 |
TMEM132D |
1.369e-02 | -4.29 | GKAP | pfam domains | PF03359 | 5 | 1 | 17795 | 49 |
DLGAP1 |
1.369e-02 | -4.29 | TMEM132D_N | pfam domains | PF15705 | 5 | 1 | 17795 | 49 |
TMEM132D |
1.369e-02 | -4.29 | TMEM132 | pfam domains | PF16070 | 5 | 1 | 17795 | 49 |
TMEM132D |
1.383e-02 | -4.28 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 4 | 18204 | 45 |
TNR,DAB1,DCC,DSCAM |
1.392e-02 | -4.27 | MAGUK_N_PEST | smart domains | SM01277 | 4 | 1 | 9717 | 34 |
DLG2 |
1.399e-02 | -4.27 | GPC4 (glypican 4) | protein interactions | 2239 | 70 | 2 | 19454 | 50 |
GPC6,LRRTM4 |
1.418e-02 | -4.26 | chondroitin sulfotransferase activity | molecular function | GO:0034481 | 6 | 1 | 18094 | 43 |
CHST11 |
1.418e-02 | -4.26 | short-chain carboxylesterase activity | molecular function | GO:0034338 | 6 | 1 | 18094 | 43 |
ABHD2 |
1.418e-02 | -4.26 | double-stranded RNA adenosine deaminase activity | molecular function | GO:0003726 | 6 | 1 | 18094 | 43 |
ADARB2 |
1.424e-02 | -4.25 | EGF | pfam domains | PF00008 | 66 | 2 | 17795 | 49 |
NRXN1,LRP1B |
1.427e-02 | -4.25 | NEUROLIGIN | prints domains | PR01090 | 5 | 1 | 5227 | 15 |
NLGN4Y |
1.446e-02 | -4.24 | EGF_1 | prosite domains | PS00022 | 174 | 3 | 12186 | 36 |
NTNG1,TNR,LRP1B |
1.465e-02 | -4.22 | CCP | smart domains | SM00032 | 53 | 2 | 9717 | 34 |
CSMD3,CSMD1 |
1.474e-02 | -4.22 | post-embryonic animal morphogenesis | biological process | GO:0009886 | 6 | 1 | 18204 | 45 |
DSCAM |
1.474e-02 | -4.22 | neuroblast migration | biological process | GO:0097402 | 6 | 1 | 18204 | 45 |
TNR |
1.474e-02 | -4.22 | medium-chain fatty acid biosynthetic process | biological process | GO:0051792 | 6 | 1 | 18204 | 45 |
ABHD2 |
1.474e-02 | -4.22 | imitative learning | biological process | GO:0098596 | 6 | 1 | 18204 | 45 |
NRXN1 |
1.474e-02 | -4.22 | postsynaptic density protein 95 clustering | biological process | GO:0097119 | 6 | 1 | 18204 | 45 |
NRXN1 |
1.474e-02 | -4.22 | vocal learning | biological process | GO:0042297 | 6 | 1 | 18204 | 45 |
NRXN1 |
1.474e-02 | -4.22 | oviduct development | biological process | GO:0060066 | 6 | 1 | 18204 | 45 |
CSMD1 |
1.474e-02 | -4.22 | radial glia-guided pyramidal neuron migration | biological process | GO:0140650 | 6 | 1 | 18204 | 45 |
DAB1 |
1.476e-02 | -4.22 | GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A) | protein interactions | 2903 | 72 | 2 | 19454 | 50 |
DLG2,DLGAP1 |
1.493e-02 | -4.20 | presynapse | cellular component | GO:0098793 | 569 | 5 | 19108 | 49 |
GRIK1,SLC8A1,NRXN1,NTNG1,NLGN4Y |
1.493e-02 | -4.20 | skin-foot-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-foot-malignant_melanoma-acral_lentiginous | 64 | 2 | 16828 | 49 |
DCC,CSMD3 |
1.493e-02 | -4.20 | meninges-meningioma | COSMIC cancer mutations | meninges-meningioma | 327 | 4 | 16828 | 49 |
CSMD3,OPCML,KAZN,TMEM132D |
1.494e-02 | -4.20 | FN3 | smart domains | SM00060 | 149 | 3 | 9717 | 34 |
DSCAM,TNR,DCC |
1.500e-02 | -4.20 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 8 | 16828 | 49 |
CNTNAP5,PCDHGC3,CSMD3,NTNG1,CADM2,RORA,LRP1B,LRRC7 |
1.515e-02 | -4.19 | DAB2IP (DAB2 interacting protein) | protein interactions | 153090 | 73 | 2 | 19454 | 50 |
DAB1,ANKS1B |
1.516e-02 | -4.19 | regulation of axon extension | biological process | GO:0030516 | 76 | 2 | 18204 | 45 |
DSCAM,TNR |
1.517e-02 | -4.19 | breast-carcinoma-ductal_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductal_carcinoma | 14824 | 48 | 16828 | 49 |
NXPH1,KCND2,SNTG1,KCNMB2,HS6ST3,KCNIP4,SCD5,NRXN1,NTNG1,DLG2,CSMD3,DCC,LRRC4C,FGF14,KAZN,ANKS1B,GPC6,GRIK1,DAB1,ZSWIM6,CADM2,XYLT1,RBFOX1,LRP1B,DSCAM,ABHD2,ZBTB20,TNR,LUZP2,PCDHGC3,CNTNAP5,LHFPL3,PID1,SGCZ,PDZRN4,TMEM132D,EPN2,DLGAP1,ADARB2,LRRTM4,DPP6,PCDH15,CHST11,LRRC7,OPCML,SLC8A1,RORA,NTM |
1.520e-02 | -4.19 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 10 | 16828 | 49 |
CSMD3,ADARB2,CHST11,SGCZ,SLC8A1,LRRC7,TMEM132D,NRXN1,RORA,DSCAM |
1.529e-02 | -4.18 | sarcoglycan complex | cellular component | GO:0016012 | 6 | 1 | 19108 | 49 |
SGCZ |
1.529e-02 | -4.18 | nuclear stress granule | cellular component | GO:0097165 | 6 | 1 | 19108 | 49 |
RBFOX1 |
1.532e-02 | -4.18 | SYTL3 (synaptotagmin like 3) | protein interactions | 94120 | 6 | 1 | 19454 | 50 |
NRXN1 |
1.532e-02 | -4.18 | PCDHGB3 (protocadherin gamma subfamily B, 3) | protein interactions | 56102 | 6 | 1 | 19454 | 50 |
PCDHGC3 |
1.532e-02 | -4.18 | DEFB116 (defensin beta 116) | protein interactions | 245930 | 6 | 1 | 19454 | 50 |
HS6ST3 |
1.532e-02 | -4.18 | RNASE2 (ribonuclease A family member 2) | protein interactions | 6036 | 6 | 1 | 19454 | 50 |
DLG2 |
1.532e-02 | -4.18 | CDH17 (cadherin 17) | protein interactions | 1015 | 6 | 1 | 19454 | 50 |
PCDHGC3 |
1.532e-02 | -4.18 | KCNN1 (potassium calcium-activated channel subfamily N member 1) | protein interactions | 3780 | 6 | 1 | 19454 | 50 |
DSCAM |
1.535e-02 | -4.18 | Immunoglobulin | interpro domains | IPR013151 | 70 | 2 | 18521 | 50 |
NTM,OPCML |
1.554e-02 | -4.16 | MANF (mesencephalic astrocyte derived neurotrophic factor) | protein interactions | 7873 | 74 | 2 | 19454 | 50 |
DAB1,NTNG1 |
1.588e-02 | -4.14 | regulation of metal ion transport | biological process | GO:0010959 | 393 | 4 | 18204 | 45 |
FGF14,KCNIP4,DPP6,SLC8A1 |
1.592e-02 | -4.14 | ig | pfam domains | PF00047 | 70 | 2 | 17795 | 49 |
OPCML,NTM |
1.607e-02 | -4.13 | Dipeptidylpeptidase IV, N-terminal domain | gene3d domains | 2.140.10.30 | 6 | 1 | 14470 | 39 |
DPP6 |
1.609e-02 | -4.13 | A_deamin | interpro domains | IPR002466 | 6 | 1 | 18521 | 50 |
ADARB2 |
1.609e-02 | -4.13 | Syndecan/Neurexin_dom | interpro domains | IPR027789 | 6 | 1 | 18521 | 50 |
NRXN1 |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC6 |
1.609e-02 | -4.13 | Peptidase_S9B_N | interpro domains | IPR002469 | 6 | 1 | 18521 | 50 |
DPP6 |
1.609e-02 | -4.13 | Glyco_trans_14 | interpro domains | IPR003406 | 6 | 1 | 18521 | 50 |
XYLT1 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC6 |
1.622e-02 | -4.12 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 8 | 16828 | 49 |
RORA,CADM2,LRRC7,LRP1B,CNTNAP5,PCDHGC3,CSMD3,NTNG1 |
1.627e-02 | -4.12 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 5 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,SLC8A1,GRIK1 |
1.641e-02 | -4.11 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 49 |
GPC6 |
1.641e-02 | -4.11 | ENTH | pfam domains | PF01417 | 6 | 1 | 17795 | 49 |
EPN2 |
1.641e-02 | -4.11 | Branch | pfam domains | PF02485 | 6 | 1 | 17795 | 49 |
XYLT1 |
1.641e-02 | -4.11 | Syndecan | pfam domains | PF01034 | 6 | 1 | 17795 | 49 |
NRXN1 |
1.641e-02 | -4.11 | A_deamin | pfam domains | PF02137 | 6 | 1 | 17795 | 49 |
ADARB2 |
1.641e-02 | -4.11 | DPPIV_N | pfam domains | PF00930 | 6 | 1 | 17795 | 49 |
DPP6 |
1.647e-02 | -4.11 | meninges | COSMIC cancer mutations | meninges | 514 | 5 | 16828 | 49 |
CNTNAP5,KAZN,TMEM132D,CSMD3,OPCML |
1.647e-02 | -4.11 | meningioma | COSMIC cancer mutations | meningioma | 514 | 5 | 16828 | 49 |
TMEM132D,KAZN,CNTNAP5,OPCML,CSMD3 |
1.666e-02 | -4.09 | central_nervous_system-brainstem-glioma | COSMIC cancer mutations | central_nervous_system-brainstem-glioma | 338 | 4 | 16828 | 49 |
LRP1B,SGCZ,CSMD3,ADARB2 |
1.668e-02 | -4.09 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 10 | 16828 | 49 |
CSMD3,ADARB2,NTNG1,DPP6,DCC,GRIK1,LRRC7,PDZRN4,FGF14,RORA |
1.668e-02 | -4.09 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 10 | 16828 | 49 |
DPP6,CSMD3,ADARB2,NTNG1,GRIK1,DCC,PDZRN4,FGF14,LRRC7,RORA |
1.676e-02 | -4.09 | Htt (huntingtin) | protein interactions | 15194 | 77 | 2 | 19454 | 50 |
NTM,OPCML |
1.676e-02 | -4.09 | LITAF (lipopolysaccharide induced TNF factor) | protein interactions | 9516 | 77 | 2 | 19454 | 50 |
KCNIP4,EPN2 |
1.676e-02 | -4.09 | SP3 (Sp3 transcription factor) | protein interactions | 6670 | 77 | 2 | 19454 | 50 |
SGCZ,NXPH1 |
1.680e-02 | -4.09 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 14 | 16828 | 49 |
DSCAM,PDZRN4,LRP1B,CNTNAP5,LUZP2,TNR,RORA,DCC,PCDH15,DPP6,LRRTM4,ADARB2,CSMD3,NTNG1 |
1.680e-02 | -4.09 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 14 | 16828 | 49 |
LRRTM4,DPP6,NTNG1,ADARB2,CSMD3,DCC,PCDH15,RORA,TNR,LUZP2,CNTNAP5,PDZRN4,LRP1B,DSCAM |
1.692e-02 | -4.08 | Complement Module, domain 1 | gene3d domains | 2.10.70.10 | 74 | 2 | 14470 | 39 |
CSMD3,CSMD1 |
1.709e-02 | -4.07 | human chr11p14.3 | chromosome location | human chr11p14.3 | 9 | 1 | 26134 | 50 |
LUZP2 |
1.709e-02 | -4.07 | human chr7q31.31 | chromosome location | human chr7q31.31 | 9 | 1 | 26134 | 50 |
KCND2 |
1.709e-02 | -4.07 | GABA-ergic synapse | cellular component | GO:0098982 | 78 | 2 | 19108 | 49 |
KCND2,NLGN4Y |
1.717e-02 | -4.06 | CLASRP (CLK4 associating serine/arginine rich protein) | protein interactions | 11129 | 78 | 2 | 19454 | 50 |
DAB1,ZBTB20 |
1.718e-02 | -4.06 | mammary gland branching involved in pregnancy | biological process | GO:0060745 | 7 | 1 | 18204 | 45 |
CSMD1 |
1.718e-02 | -4.06 | relaxation of smooth muscle | biological process | GO:0044557 | 7 | 1 | 18204 | 45 |
SLC8A1 |
1.718e-02 | -4.06 | adenosine to inosine editing | biological process | GO:0006382 | 7 | 1 | 18204 | 45 |
ADARB2 |
1.718e-02 | -4.06 | anterior/posterior axon guidance | biological process | GO:0033564 | 7 | 1 | 18204 | 45 |
DCC |
1.718e-02 | -4.06 | observational learning | biological process | GO:0098597 | 7 | 1 | 18204 | 45 |
NRXN1 |
1.718e-02 | -4.06 | positive regulation of axon extension involved in axon guidance | biological process | GO:0048842 | 7 | 1 | 18204 | 45 |
DSCAM |
1.718e-02 | -4.06 | positive regulation of transmission of nerve impulse | biological process | GO:0051971 | 7 | 1 | 18204 | 45 |
TNR |
1.722e-02 | -4.06 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 17 | 16828 | 49 |
DLGAP1,NTNG1,CSMD3,LRRTM4,PCDH15,DCC,ZBTB20,LRRC7,KAZN,TNR,XYLT1,CNTNAP5,SNTG1,LRP1B,PDZRN4,DSCAM,TMEM132D |
1.743e-02 | -4.05 | FN3_dom | interpro domains | IPR003961 | 203 | 3 | 18521 | 50 |
DSCAM,TNR,DCC |
1.743e-02 | -4.05 | FN3_sf | interpro domains | IPR036116 | 203 | 3 | 18521 | 50 |
TNR,DSCAM,DCC |
1.760e-02 | -4.04 | A_DEAMIN_EDITASE | prosite domains | PS50141 | 6 | 1 | 12186 | 36 |
ADARB2 |
1.760e-02 | -4.04 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 36 |
GPC6 |
1.761e-02 | -4.04 | DLG1 (discs large MAGUK scaffold protein 1) | protein interactions | 1739 | 214 | 3 | 19454 | 50 |
DLGAP1,DLG2,DSCAM |
1.761e-02 | -4.04 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 3 | 19454 | 50 |
DSCAM,DCC,DAB1 |
1.782e-02 | -4.03 | dystroglycan complex | cellular component | GO:0016011 | 7 | 1 | 19108 | 49 |
SGCZ |
1.786e-02 | -4.03 | GRIK3 (glutamate ionotropic receptor kainate type subunit 3) | protein interactions | 2899 | 7 | 1 | 19454 | 50 |
GRIK1 |
1.786e-02 | -4.03 | Eps15l1 (epidermal growth factor receptor pathway substrate 15-like 1) | protein interactions | 13859 | 7 | 1 | 19454 | 50 |
EPN2 |
1.786e-02 | -4.03 | ARRDC2 (arrestin domain containing 2) | protein interactions | 27106 | 7 | 1 | 19454 | 50 |
EPN2 |
1.786e-02 | -4.03 | ZBTB45 (zinc finger and BTB domain containing 45) | protein interactions | 84878 | 7 | 1 | 19454 | 50 |
ZBTB20 |
1.786e-02 | -4.03 | HGD (homogentisate 1,2-dioxygenase) | protein interactions | 3081 | 7 | 1 | 19454 | 50 |
PCDHGC3 |
1.786e-02 | -4.03 | WBP1L (WW domain binding protein 1 like) | protein interactions | 54838 | 7 | 1 | 19454 | 50 |
EPN2 |
1.786e-02 | -4.03 | regulation of developmental process | biological process | GO:0050793 | 2540 | 12 | 18204 | 45 |
NTNG1,EPN2,TNR,DAB1,NRXN1,CSMD3,LRRC4C,DCC,DSCAM,SLC8A1,PID1,RORA |
1.827e-02 | -4.00 | nervous system process | biological process | GO:0050877 | 1376 | 8 | 18204 | 45 |
CSMD1,KCND2,NRXN1,PCDH15,TNR,KCNMB2,LHFPL3,NLGN4Y |
1.865e-02 | -3.98 | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing | 72 | 2 | 16828 | 49 |
TMEM132D,LRP1B |
1.865e-02 | -3.98 | cortisol_producing | COSMIC cancer mutations | cortisol_producing | 72 | 2 | 16828 | 49 |
LRP1B,TMEM132D |
1.873e-02 | -3.98 | mucopolysaccharide metabolic process | biological process | GO:1903510 | 85 | 2 | 18204 | 45 |
XYLT1,CHST11 |
1.875e-02 | -3.98 | LHFPL | interpro domains | IPR019372 | 7 | 1 | 18521 | 50 |
LHFPL3 |
1.875e-02 | -3.98 | FA_desaturase_dom | interpro domains | IPR005804 | 7 | 1 | 18521 | 50 |
SCD5 |
1.875e-02 | -3.98 | Carb_sulfotrans_8-10 | interpro domains | IPR018011 | 7 | 1 | 18521 | 50 |
CHST11 |
1.878e-02 | -3.98 | FN3 | prosite domains | PS50853 | 192 | 3 | 12186 | 36 |
DSCAM,DCC,TNR |
1.886e-02 | -3.97 | tRNA-specific adenosine deaminase activity | molecular function | GO:0008251 | 8 | 1 | 18094 | 43 |
ADARB2 |
1.897e-02 | -3.96 | human chrYq11.221 | chromosome location | human chrYq11.221 | 10 | 1 | 26134 | 50 |
NLGN4Y |
1.912e-02 | -3.96 | FA_desaturase | pfam domains | PF00487 | 7 | 1 | 17795 | 49 |
SCD5 |
1.912e-02 | -3.96 | L_HMGIC_fpl | pfam domains | PF10242 | 7 | 1 | 17795 | 49 |
LHFPL3 |
1.915e-02 | -3.96 | regulation of potassium ion transmembrane transport | biological process | GO:1901379 | 86 | 2 | 18204 | 45 |
KCNIP4,DPP6 |
1.956e-02 | -3.93 | LRR | prosite domains | PS51450 | 195 | 3 | 12186 | 36 |
LRRC4C,LRRTM4,LRRC7 |
1.957e-02 | -3.93 | associative learning | biological process | GO:0008306 | 87 | 2 | 18204 | 45 |
TNR,CSMD1 |
1.961e-02 | -3.93 | regulation of cell communication | biological process | GO:0010646 | 3541 | 15 | 18204 | 45 |
RORA,PID1,GRIK1,DCC,LRRC4C,SLC8A1,DLGAP1,NRXN1,CHST11,GPC6,NLGN4Y,NTNG1,TNR,EPN2,DAB1 |
1.961e-02 | -3.93 | equilibrioception | biological process | GO:0050957 | 8 | 1 | 18204 | 45 |
PCDH15 |
1.961e-02 | -3.93 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 1 | 18204 | 45 |
RORA |
1.961e-02 | -3.93 | negative regulation of dendrite development | biological process | GO:2000171 | 8 | 1 | 18204 | 45 |
DCC |
1.961e-02 | -3.93 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 1 | 18204 | 45 |
RORA |
1.961e-02 | -3.93 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 1 | 18204 | 45 |
RORA |
1.962e-02 | -3.93 | nipple | COSMIC cancer mutations | nipple | 197 | 3 | 16828 | 49 |
LRP1B,HS6ST3,DSCAM |
1.962e-02 | -3.93 | skin-nipple-malignant_melanoma | COSMIC cancer mutations | skin-nipple-malignant_melanoma | 197 | 3 | 16828 | 49 |
LRP1B,HS6ST3,DSCAM |
2.032e-02 | -3.90 | monoatomic ion channel activity | molecular function | GO:0005216 | 441 | 4 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,GRIK1 |
2.038e-02 | -3.89 | EIF4E3 (eukaryotic translation initiation factor 4E family member 3) | protein interactions | 317649 | 8 | 1 | 19454 | 50 |
DCC |
2.038e-02 | -3.89 | LHB (luteinizing hormone subunit beta) | protein interactions | 3972 | 8 | 1 | 19454 | 50 |
NTM |
2.038e-02 | -3.89 | GRIK4 (glutamate ionotropic receptor kainate type subunit 4) | protein interactions | 2900 | 8 | 1 | 19454 | 50 |
GRIK1 |
2.042e-02 | -3.89 | post-embryonic development | biological process | GO:0009791 | 89 | 2 | 18204 | 45 |
DSCAM,CHST11 |
2.057e-02 | -3.88 | SAM_DOMAIN | prosite domains | PS50105 | 75 | 2 | 12186 | 36 |
ANKS1B,KAZN |
2.063e-02 | -3.88 | RBFOX1 (RNA binding fox-1 homolog 1) | protein interactions | 54715 | 86 | 2 | 19454 | 50 |
RBFOX1,DAB1 |
2.063e-02 | -3.88 | ITIH2 (inter-alpha-trypsin inhibitor heavy chain 2) | protein interactions | 3698 | 86 | 2 | 19454 | 50 |
DPP6,LRRC4C |
2.073e-02 | -3.88 | stomach | COSMIC cancer mutations | stomach | 15550 | 49 | 16828 | 49 |
GRIK1,ANKS1B,GPC6,DAB1,ZSWIM6,CADM2,KCND2,SNTG1,NXPH1,KCNIP4,HS6ST3,SCD5,NRXN1,KCNMB2,DCC,DLG2,NTNG1,CSMD3,KAZN,LRRC4C,FGF14,PCDHGC3,CNTNAP5,LHFPL3,PID1,TNR,LUZP2,TMEM132D,EPN2,SGCZ,PDZRN4,PCDH15,CHST11,DLGAP1,ADARB2,LRRTM4,DPP6,RORA,NTM,LRRC7,OPCML,SLC8A1,XYLT1,RBFOX1,DSCAM,LRP1B,ABHD2,ZBTB20,NLGN4Y |
2.079e-02 | -3.87 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 6 | 16828 | 49 |
LRP1B,LRRC7,CSMD3,DCC,CNTNAP5,PCDH15 |
2.082e-02 | -3.87 | ADEAMc | smart domains | SM00552 | 6 | 1 | 9717 | 34 |
ADARB2 |
2.084e-02 | -3.87 | dendrite | cellular component | GO:0030425 | 620 | 5 | 19108 | 49 |
KCNIP4,ANKS1B,SLC8A1,DSCAM,KCND2 |
2.085e-02 | -3.87 | human chr11p12 | chromosome location | human chr11p12 | 11 | 1 | 26134 | 50 |
LRRC4C |
2.085e-02 | -3.87 | human chr8q11.21 | chromosome location | human chr8q11.21 | 11 | 1 | 26134 | 50 |
SNTG1 |
2.085e-02 | -3.87 | regulation of purine nucleotide metabolic process | biological process | GO:1900542 | 90 | 2 | 18204 | 45 |
ZBTB20,PID1 |
2.092e-02 | -3.87 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 45 |
KCNIP4,LRRC7,DPP6 |
2.110e-02 | -3.86 | dendritic tree | cellular component | GO:0097447 | 622 | 5 | 19108 | 49 |
KCNIP4,ANKS1B,SLC8A1,DSCAM,KCND2 |
2.119e-02 | -3.85 | guanylate kinase activity | molecular function | GO:0004385 | 9 | 1 | 18094 | 43 |
DLG2 |
2.123e-02 | -3.85 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 46 | 16828 | 49 |
ZBTB20,NLGN4Y,FGF14,KAZN,CSMD3,DLG2,NTNG1,DCC,ABHD2,KCNMB2,LRP1B,DSCAM,HS6ST3,NRXN1,SCD5,NXPH1,KCND2,XYLT1,RBFOX1,SNTG1,LRRC7,SLC8A1,OPCML,RORA,CADM2,ADARB2,DLGAP1,ZSWIM6,DPP6,LRRTM4,PCDH15,CHST11,DAB1,PDZRN4,SGCZ,EPN2,TMEM132D,ANKS1B,LUZP2,GPC6,TNR,CNTNAP5,PCDHGC3,GRIK1,PID1,LHFPL3 |
2.123e-02 | -3.85 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 46 | 16828 | 49 |
RBFOX1,XYLT1,DSCAM,LRP1B,ABHD2,NLGN4Y,ZBTB20,PID1,LHFPL3,CNTNAP5,PCDHGC3,LUZP2,TNR,EPN2,TMEM132D,PDZRN4,SGCZ,CHST11,PCDH15,DPP6,LRRTM4,ADARB2,DLGAP1,RORA,SLC8A1,OPCML,LRRC7,SNTG1,KCND2,NXPH1,NRXN1,SCD5,HS6ST3,KCNMB2,DCC,CSMD3,NTNG1,DLG2,KAZN,FGF14,GRIK1,GPC6,ANKS1B,DAB1,ZSWIM6,CADM2 |
2.126e-02 | -3.85 | skin-leg-malignant_melanoma | COSMIC cancer mutations | skin-leg-malignant_melanoma | 549 | 5 | 16828 | 49 |
DCC,KCND2,LRP1B,ZBTB20,CSMD3 |
2.129e-02 | -3.85 | regulation of nucleotide metabolic process | biological process | GO:0006140 | 91 | 2 | 18204 | 45 |
ZBTB20,PID1 |
2.136e-02 | -3.85 | Guanylate Kinase phosphate binding domain | gene3d domains | 3.30.63.10 | 8 | 1 | 14470 | 39 |
DLG2 |
2.140e-02 | -3.84 | NXPH/NXPE | interpro domains | IPR026845 | 8 | 1 | 18521 | 50 |
NXPH1 |
2.182e-02 | -3.82 | Neurexophilin | pfam domains | PF06312 | 8 | 1 | 17795 | 49 |
NXPH1 |
2.199e-02 | -3.82 | PLEKHA2 (pleckstrin homology domain containing A2) | protein interactions | 59339 | 89 | 2 | 19454 | 50 |
SNTG1,DLG2 |
2.203e-02 | -3.82 | positive regulation of synapse maturation | biological process | GO:0090129 | 9 | 1 | 18204 | 45 |
NRXN1 |
2.203e-02 | -3.82 | protein localization to presynapse | biological process | GO:1905383 | 9 | 1 | 18204 | 45 |
DLG2 |
2.203e-02 | -3.82 | netrin-activated signaling pathway | biological process | GO:0038007 | 9 | 1 | 18204 | 45 |
DSCAM |
2.203e-02 | -3.82 | presynaptic membrane assembly | biological process | GO:0097105 | 9 | 1 | 18204 | 45 |
NLGN4Y |
2.203e-02 | -3.82 | hindbrain radial glia guided cell migration | biological process | GO:0021932 | 9 | 1 | 18204 | 45 |
DAB1 |
2.203e-02 | -3.82 | anterograde axonal protein transport | biological process | GO:0099641 | 9 | 1 | 18204 | 45 |
DLG2 |
2.203e-02 | -3.82 | axo-dendritic protein transport | biological process | GO:0099640 | 9 | 1 | 18204 | 45 |
DLG2 |
2.283e-02 | -3.78 | LRR_TYP | smart domains | SM00369 | 175 | 3 | 9717 | 34 |
LRRTM4,LRRC4C,LRRC7 |
2.290e-02 | -3.78 | HYAL3 (hyaluronidase 3) | protein interactions | 8372 | 9 | 1 | 19454 | 50 |
DAB1 |
2.290e-02 | -3.78 | KLK4 (kallikrein related peptidase 4) | protein interactions | 9622 | 9 | 1 | 19454 | 50 |
KCNIP4 |
2.290e-02 | -3.78 | LSAMP (limbic system associated membrane protein) | protein interactions | 4045 | 9 | 1 | 19454 | 50 |
NTM |
2.290e-02 | -3.78 | CASS4 (Cas scaffold protein family member 4) | protein interactions | 57091 | 9 | 1 | 19454 | 50 |
ANKS1B |
2.290e-02 | -3.78 | NEGR1 (neuronal growth regulator 1) | protein interactions | 257194 | 9 | 1 | 19454 | 50 |
NTM |
2.290e-02 | -3.78 | LAMP5 (lysosomal associated membrane protein family member 5) | protein interactions | 24141 | 9 | 1 | 19454 | 50 |
ABHD2 |
2.290e-02 | -3.78 | CFAP91 (cilia and flagella associated protein 91) | protein interactions | 89876 | 9 | 1 | 19454 | 50 |
DSCAM |
2.302e-02 | -3.77 | system process | biological process | GO:0003008 | 2015 | 10 | 18204 | 45 |
PCDH15,SLC8A1,TNR,LHFPL3,NLGN4Y,KCNMB2,KCND2,CSMD1,SGCZ,NRXN1 |
2.339e-02 | -3.76 | IST1 (IST1 factor associated with ESCRT-III) | protein interactions | 9798 | 92 | 2 | 19454 | 50 |
DSCAM,NTNG1 |
2.352e-02 | -3.75 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | molecular function | GO:0016717 | 10 | 1 | 18094 | 43 |
SCD5 |
2.352e-02 | -3.75 | calcium:sodium antiporter activity | molecular function | GO:0005432 | 10 | 1 | 18094 | 43 |
SLC8A1 |
2.352e-02 | -3.75 | negative regulation of developmental growth | biological process | GO:0048640 | 96 | 2 | 18204 | 45 |
TNR,DCC |
2.380e-02 | -3.74 | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 377 | 4 | 16828 | 49 |
LRRC7,NRXN1,DSCAM,CNTNAP5 |
2.400e-02 | -3.73 | Spinal Cord Injury | WikiPathways | WP2431 | 119 | 2 | 5310 | 11 |
XYLT1,CHST11 |
2.400e-02 | -3.73 | NCX, central ion-binding region | gene3d domains | 1.20.1420.30 | 9 | 1 | 14470 | 39 |
SLC8A1 |
2.400e-02 | -3.73 | - | gene3d domains | 2.60.40.2030 | 9 | 1 | 14470 | 39 |
SLC8A1 |
2.404e-02 | -3.73 | Calx_beta | interpro domains | IPR003644 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | NCX_ion-bd_dom_sf | interpro domains | IPR044880 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | CalX-like_sf | interpro domains | IPR038081 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | NaCa_Exmemb | interpro domains | IPR004837 | 9 | 1 | 18521 | 50 |
SLC8A1 |
2.404e-02 | -3.73 | Znf_SWIM | interpro domains | IPR007527 | 9 | 1 | 18521 | 50 |
ZSWIM6 |
2.404e-02 | -3.73 | Peptidase_S9 | interpro domains | IPR001375 | 9 | 1 | 18521 | 50 |
DPP6 |
2.425e-02 | -3.72 | Ca2+ activated K+ channels | REACTOME pathways | R-HSA-1296052 | 9 | 1 | 10285 | 28 |
KCNMB2 |
2.445e-02 | -3.71 | neurotransmitter receptor transport, endosome to postsynaptic membrane | biological process | GO:0098887 | 10 | 1 | 18204 | 45 |
LRRC7 |
2.445e-02 | -3.71 | embryonic viscerocranium morphogenesis | biological process | GO:0048703 | 10 | 1 | 18204 | 45 |
CHST11 |
2.445e-02 | -3.71 | neurotransmitter receptor transport, endosome to plasma membrane | biological process | GO:0099639 | 10 | 1 | 18204 | 45 |
LRRC7 |
2.445e-02 | -3.71 | regulation of voltage-gated sodium channel activity | biological process | GO:1905150 | 10 | 1 | 18204 | 45 |
FGF14 |
2.445e-02 | -3.71 | regulation of fat cell proliferation | biological process | GO:0070344 | 10 | 1 | 18204 | 45 |
PID1 |
2.445e-02 | -3.71 | positive regulation of ATP biosynthetic process | biological process | GO:2001171 | 10 | 1 | 18204 | 45 |
PID1 |
2.445e-02 | -3.71 | learned vocalization behavior or vocal learning | biological process | GO:0098598 | 10 | 1 | 18204 | 45 |
NRXN1 |
2.445e-02 | -3.71 | postsynaptic density assembly | biological process | GO:0097107 | 10 | 1 | 18204 | 45 |
NRXN1 |
2.445e-02 | -3.71 | presynaptic membrane organization | biological process | GO:0097090 | 10 | 1 | 18204 | 45 |
NLGN4Y |
2.452e-02 | -3.71 | Na_Ca_ex | pfam domains | PF01699 | 9 | 1 | 17795 | 49 |
SLC8A1 |
2.452e-02 | -3.71 | Peptidase_S9 | pfam domains | PF00326 | 9 | 1 | 17795 | 49 |
DPP6 |
2.452e-02 | -3.71 | Calx-beta | pfam domains | PF03160 | 9 | 1 | 17795 | 49 |
SLC8A1 |
2.454e-02 | -3.71 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 11 | 16828 | 49 |
PID1,KCND2,GPC6,TNR,CSMD3,ANKS1B,CADM2,TMEM132D,DSCAM,ZBTB20,LRRC4C |
2.454e-02 | -3.71 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 11 | 16828 | 49 |
TMEM132D,DSCAM,TNR,GPC6,ANKS1B,PID1,KCND2,LRRC4C,ZBTB20,CADM2,CSMD3 |
2.459e-02 | -3.71 | human chr4q21.22 | chromosome location | human chr4q21.22 | 13 | 1 | 26134 | 50 |
SCD5 |
2.483e-02 | -3.70 | SCN4A (sodium voltage-gated channel alpha subunit 4) | protein interactions | 6329 | 95 | 2 | 19454 | 50 |
DLG2,CHST11 |
2.491e-02 | -3.69 | heart contraction | biological process | GO:0060047 | 99 | 2 | 18204 | 45 |
SGCZ,SLC8A1 |
2.491e-02 | -3.69 | spinal cord development | biological process | GO:0021510 | 99 | 2 | 18204 | 45 |
DCC,DAB1 |
2.505e-02 | -3.69 | ITSN1 (intersectin 1) | protein interactions | 6453 | 245 | 3 | 19454 | 50 |
DAB1,DLGAP1,EPN2 |
2.521e-02 | -3.68 | Platelet homeostasis | REACTOME pathways | R-HSA-418346 | 91 | 2 | 10285 | 28 |
KCNMB2,SLC8A1 |
2.534e-02 | -3.68 | Sulfite Oxidase Deficiency | SMPDB pathways | SMP0000532 | 7 | 1 | 1369 | 5 |
CHST11 |
2.534e-02 | -3.68 | Sulfate/Sulfite Metabolism | SMPDB pathways | SMP0000041 | 7 | 1 | 1369 | 5 |
CHST11 |
2.536e-02 | -3.67 | perineuronal net | cellular component | GO:0072534 | 10 | 1 | 19108 | 49 |
TNR |
2.537e-02 | -3.67 | regulation of dendrite development | biological process | GO:0050773 | 100 | 2 | 18204 | 45 |
DCC,CSMD3 |
2.541e-02 | -3.67 | ZNF563 (zinc finger protein 563) | protein interactions | 147837 | 10 | 1 | 19454 | 50 |
LRP1B |
2.541e-02 | -3.67 | CHRDL1 (chordin like 1) | protein interactions | 91851 | 10 | 1 | 19454 | 50 |
LRP1B |
2.541e-02 | -3.67 | FAIM2 (Fas apoptotic inhibitory molecule 2) | protein interactions | 23017 | 10 | 1 | 19454 | 50 |
EPN2 |
2.541e-02 | -3.67 | Eps15 (epidermal growth factor receptor pathway substrate 15) | protein interactions | 13858 | 10 | 1 | 19454 | 50 |
EPN2 |
2.541e-02 | -3.67 | PGA4 (pepsinogen A4) | protein interactions | 643847 | 10 | 1 | 19454 | 50 |
NTNG1 |
2.541e-02 | -3.67 | SCN8A (sodium voltage-gated channel alpha subunit 8) | protein interactions | 6334 | 10 | 1 | 19454 | 50 |
FGF14 |
2.541e-02 | -3.67 | IFNL3 (interferon lambda 3) | protein interactions | 282617 | 10 | 1 | 19454 | 50 |
DCC |
2.562e-02 | -3.66 | SAM | interpro domains | IPR001660 | 92 | 2 | 18521 | 50 |
KAZN,ANKS1B |
2.584e-02 | -3.66 | acetylcholine receptor binding | molecular function | GO:0033130 | 11 | 1 | 18094 | 43 |
NRXN1 |
2.584e-02 | -3.66 | xylosyltransferase activity | molecular function | GO:0042285 | 11 | 1 | 18094 | 43 |
XYLT1 |
2.584e-02 | -3.66 | UDP-xylosyltransferase activity | molecular function | GO:0035252 | 11 | 1 | 18094 | 43 |
XYLT1 |
2.585e-02 | -3.66 | regulation of potassium ion transport | biological process | GO:0043266 | 101 | 2 | 18204 | 45 |
KCNIP4,DPP6 |
2.589e-02 | -3.65 | fibula | COSMIC cancer mutations | fibula | 387 | 4 | 16828 | 49 |
DSCAM,CNTNAP5,NRXN1,LRRC7 |
2.628e-02 | -3.64 | ZF_SWIM | prosite domains | PS50966 | 9 | 1 | 12186 | 36 |
ZSWIM6 |
2.628e-02 | -3.64 | ENTH | prosite domains | PS50942 | 9 | 1 | 12186 | 36 |
EPN2 |
2.631e-02 | -3.64 | DMD (dystrophin) | protein interactions | 1756 | 98 | 2 | 19454 | 50 |
SGCZ,SNTG1 |
2.631e-02 | -3.64 | PSMF1 (proteasome inhibitor subunit 1) | protein interactions | 9491 | 98 | 2 | 19454 | 50 |
RBFOX1,NTNG1 |
2.634e-02 | -3.64 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 5 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,GRIK1,SLC8A1 |
2.639e-02 | -3.63 | glycoaminoglycan-protein linkage region biosynthesis | BIOCYC pathways | META_PWY-6557 | 6 | 1 | 902 | 4 |
XYLT1 |
2.639e-02 | -3.63 | oleate biosynthesis | BIOCYC pathways | HUMAN_PWY-5996 | 6 | 1 | 902 | 4 |
SCD5 |
2.639e-02 | -3.63 | glycoaminoglycan-protein linkage region biosynthesis | BIOCYC pathways | HUMAN_PWY-6557 | 6 | 1 | 902 | 4 |
XYLT1 |
2.646e-02 | -3.63 | human chr2p16.3 | chromosome location | human chr2p16.3 | 14 | 1 | 26134 | 50 |
NRXN1 |
2.646e-02 | -3.63 | human chr3q26.32 | chromosome location | human chr3q26.32 | 14 | 1 | 26134 | 50 |
KCNMB2 |
2.657e-02 | -3.63 | regulation of blood circulation | biological process | GO:1903522 | 261 | 3 | 18204 | 45 |
KCNMB2,KCND2,SLC8A1 |
2.668e-02 | -3.62 | ENTH | interpro domains | IPR013809 | 10 | 1 | 18521 | 50 |
EPN2 |
2.680e-02 | -3.62 | cerebellum development | biological process | GO:0021549 | 103 | 2 | 18204 | 45 |
RORA,DAB1 |
2.687e-02 | -3.62 | negative regulation of collateral sprouting | biological process | GO:0048671 | 11 | 1 | 18204 | 45 |
DCC |
2.687e-02 | -3.62 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | biological process | GO:0098696 | 11 | 1 | 18204 | 45 |
GPC6 |
2.687e-02 | -3.62 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 45 |
SLC8A1 |
2.687e-02 | -3.62 | GDP metabolic process | biological process | GO:0046710 | 11 | 1 | 18204 | 45 |
DLG2 |
2.688e-02 | -3.62 | breast-carcinoma | COSMIC cancer mutations | breast-carcinoma | 15030 | 48 | 16828 | 49 |
PCDHGC3,CNTNAP5,LHFPL3,PID1,TNR,LUZP2,TMEM132D,EPN2,SGCZ,PDZRN4,PCDH15,CHST11,DLGAP1,ADARB2,LRRTM4,DPP6,RORA,NTM,LRRC7,OPCML,SLC8A1,XYLT1,RBFOX1,DSCAM,LRP1B,ABHD2,ZBTB20,GRIK1,ANKS1B,GPC6,DAB1,ZSWIM6,CADM2,KCND2,SNTG1,NXPH1,HS6ST3,KCNIP4,SCD5,NRXN1,KCNMB2,DCC,NTNG1,DLG2,CSMD3,KAZN,LRRC4C,FGF14 |
2.690e-02 | -3.62 | Role of second messengers in netrin-1 signaling | REACTOME pathways | R-HSA-418890 | 10 | 1 | 10285 | 28 |
DCC |
2.690e-02 | -3.62 | Netrin mediated repulsion signals | REACTOME pathways | R-HSA-418886 | 10 | 1 | 10285 | 28 |
DCC |
2.693e-02 | -3.61 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 3 | 19454 | 50 |
TNR,DAB1,ANKS1B |
2.706e-02 | -3.61 | peritoneum-appendix-other-pseudomyxoma_peritonei | COSMIC cancer mutations | peritoneum-appendix-other-pseudomyxoma_peritonei | 585 | 5 | 16828 | 49 |
SNTG1,DLG2,DAB1,CSMD3,PDZRN4 |
2.706e-02 | -3.61 | pseudomyxoma_peritonei | COSMIC cancer mutations | pseudomyxoma_peritonei | 585 | 5 | 16828 | 49 |
PDZRN4,CSMD3,DAB1,DLG2,SNTG1 |
2.719e-02 | -3.60 | EGF-type_Asp/Asn_hydroxyl_site | interpro domains | IPR000152 | 95 | 2 | 18521 | 50 |
LRP1B,NRXN1 |
2.723e-02 | -3.60 | appendix | COSMIC cancer mutations | appendix | 586 | 5 | 16828 | 49 |
SNTG1,CSMD3,DLG2,DAB1,PDZRN4 |
2.731e-02 | -3.60 | PRIM1 (DNA primase subunit 1) | protein interactions | 5557 | 100 | 2 | 19454 | 50 |
NLGN4Y,NTNG1 |
2.737e-02 | -3.60 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-non_functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-non_functioning | 224 | 3 | 16828 | 49 |
TNR,LRP1B,DCC |
2.741e-02 | -3.60 | peritoneum | COSMIC cancer mutations | peritoneum | 587 | 5 | 16828 | 49 |
SNTG1,PDZRN4,DLG2,DAB1,CSMD3 |
2.765e-02 | -3.59 | regulation of monoatomic ion transport | biological process | GO:0043269 | 466 | 4 | 18204 | 45 |
SLC8A1,FGF14,KCNIP4,DPP6 |
2.766e-02 | -3.59 | Calx_beta | smart domains | SM00237 | 8 | 1 | 9717 | 34 |
SLC8A1 |
2.777e-02 | -3.58 | glycosaminoglycan metabolic process | biological process | GO:0030203 | 105 | 2 | 18204 | 45 |
XYLT1,CHST11 |
2.781e-02 | -3.58 | LDB1 (LIM domain binding 1) | protein interactions | 8861 | 101 | 2 | 19454 | 50 |
NXPH1,DSCAM |
2.786e-02 | -3.58 | symmetric synapse | cellular component | GO:0032280 | 11 | 1 | 19108 | 49 |
NLGN4Y |
2.786e-02 | -3.58 | perisynaptic extracellular matrix | cellular component | GO:0098966 | 11 | 1 | 19108 | 49 |
TNR |
2.792e-02 | -3.58 | CELF3 (CUGBP Elav-like family member 3) | protein interactions | 11189 | 11 | 1 | 19454 | 50 |
RBFOX1 |
2.792e-02 | -3.58 | IL17A (interleukin 17A) | protein interactions | 3605 | 11 | 1 | 19454 | 50 |
KCNIP4 |
2.792e-02 | -3.58 | SYTL1 (synaptotagmin like 1) | protein interactions | 84958 | 11 | 1 | 19454 | 50 |
NRXN1 |
2.792e-02 | -3.58 | DRAM1 (DNA damage regulated autophagy modulator 1) | protein interactions | 55332 | 11 | 1 | 19454 | 50 |
LRRC4C |
2.806e-02 | -3.57 | Galactose-binding domain-like | gene3d domains | 2.60.120.260 | 97 | 2 | 14470 | 39 |
NTNG1,CNTNAP5 |
2.812e-02 | -3.57 | IGv | smart domains | SM00406 | 75 | 2 | 9717 | 34 |
LRRC4C,DSCAM |
2.816e-02 | -3.57 | dipeptidyl-peptidase activity | molecular function | GO:0008239 | 12 | 1 | 18094 | 43 |
DPP6 |
2.826e-02 | -3.57 | regulation of postsynaptic membrane potential | biological process | GO:0060078 | 106 | 2 | 18204 | 45 |
KCND2,GRIK1 |
2.832e-02 | -3.56 | CTSV (cathepsin V) | protein interactions | 1515 | 102 | 2 | 19454 | 50 |
RBFOX1,DCC |
2.865e-02 | -3.55 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 46 | 16828 | 49 |
CADM2,DAB1,GRIK1,GPC6,ANKS1B,KAZN,FGF14,LRRC4C,DCC,DLG2,NTNG1,CSMD3,SCD5,NRXN1,HS6ST3,KCNIP4,KCNMB2,SNTG1,KCND2,NXPH1,RORA,NTM,OPCML,SLC8A1,LRRC7,CHST11,PCDH15,LRRTM4,DPP6,DLGAP1,ADARB2,TMEM132D,EPN2,SGCZ,PDZRN4,PCDHGC3,CNTNAP5,TNR,LUZP2,NLGN4Y,ZBTB20,ABHD2,DSCAM,LRP1B,RBFOX1,XYLT1 |
2.870e-02 | -3.55 | negative regulation of cell development | biological process | GO:0010721 | 269 | 3 | 18204 | 45 |
DAB1,TNR,DCC |
2.884e-02 | -3.55 | C1orf94 (chromosome 1 open reading frame 94) | protein interactions | 84970 | 103 | 2 | 19454 | 50 |
DAB1,RBFOX1 |
2.884e-02 | -3.55 | VENTX (VENT homeobox) | protein interactions | 27287 | 103 | 2 | 19454 | 50 |
DAB1,RBFOX1 |
2.927e-02 | -3.53 | negative regulation of vascular endothelial growth factor receptor signaling pathway | biological process | GO:0030948 | 12 | 1 | 18204 | 45 |
EPN2 |
2.927e-02 | -3.53 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 45 |
NRXN1 |
2.927e-02 | -3.53 | regulation of mitochondrial fusion | biological process | GO:0010635 | 12 | 1 | 18204 | 45 |
PID1 |
2.927e-02 | -3.53 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | biological process | GO:0015015 | 12 | 1 | 18204 | 45 |
HS6ST3 |
2.936e-02 | -3.53 | RHOXF2 (Rhox homeobox family member 2) | protein interactions | 84528 | 104 | 2 | 19454 | 50 |
DAB1,RBFOX1 |
2.956e-02 | -3.52 | Ligand-independent caspase activation via DCC | REACTOME pathways | R-HSA-418889 | 11 | 1 | 10285 | 28 |
DCC |
2.975e-02 | -3.51 | postsynapse organization | biological process | GO:0099173 | 109 | 2 | 18204 | 45 |
NLGN4Y,NRXN1 |
2.988e-02 | -3.51 | BTBD1 (BTB domain containing 1) | protein interactions | 53339 | 105 | 2 | 19454 | 50 |
LRRC4C,DSCAM |
3.002e-02 | -3.51 | Potassium Channels | REACTOME pathways | R-HSA-1296071 | 100 | 2 | 10285 | 28 |
KCNMB2,KCND2 |
3.018e-02 | -3.50 | human chr2p22.1 | chromosome location | human chr2p22.1 | 16 | 1 | 26134 | 50 |
SLC8A1 |
3.018e-02 | -3.50 | human chr5q12.1 | chromosome location | human chr5q12.1 | 16 | 1 | 26134 | 50 |
ZSWIM6 |
3.030e-02 | -3.50 | abdomen | COSMIC cancer mutations | abdomen | 603 | 5 | 16828 | 49 |
LRP1B,PDZRN4,CSMD3,DCC,RBFOX1 |
3.035e-02 | -3.49 | synapse-associated extracellular matrix | cellular component | GO:0099535 | 12 | 1 | 19108 | 49 |
TNR |
3.035e-02 | -3.49 | juxtaparanode region of axon | cellular component | GO:0044224 | 12 | 1 | 19108 | 49 |
DLG2 |
3.042e-02 | -3.49 | GRTP1 (growth hormone regulated TBC protein 1) | protein interactions | 79774 | 12 | 1 | 19454 | 50 |
PCDHGC3 |
3.042e-02 | -3.49 | CIART (circadian associated repressor of transcription) | protein interactions | 148523 | 12 | 1 | 19454 | 50 |
DAB1 |
3.042e-02 | -3.49 | PROK2 (prokineticin 2) | protein interactions | 60675 | 12 | 1 | 19454 | 50 |
LRP1B |
3.042e-02 | -3.49 | PDC (phosducin) | protein interactions | 5132 | 12 | 1 | 19454 | 50 |
DCC |
3.047e-02 | -3.49 | calcium-activated potassium channel activity | molecular function | GO:0015269 | 13 | 1 | 18094 | 43 |
KCNMB2 |
3.047e-02 | -3.49 | calcium:monoatomic cation antiporter activity | molecular function | GO:0015368 | 13 | 1 | 18094 | 43 |
SLC8A1 |
3.047e-02 | -3.49 | adenosine deaminase activity | molecular function | GO:0004000 | 13 | 1 | 18094 | 43 |
ADARB2 |
3.064e-02 | -3.49 | telencephalon development | biological process | GO:0021537 | 276 | 3 | 18204 | 45 |
DAB1,TNR,ZSWIM6 |
3.073e-02 | -3.48 | chondroitin sulfate biosynthesis (late stages) | BIOCYC pathways | META_PWY-6567 | 7 | 1 | 902 | 4 |
CHST11 |
3.081e-02 | -3.48 | channel activity | molecular function | GO:0015267 | 502 | 4 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,GRIK1 |
3.100e-02 | -3.47 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 4 | 18094 | 43 |
GRIK1,KCNIP4,KCND2,KCNMB2 |
3.107e-02 | -3.47 | ENTH | smart domains | SM00273 | 9 | 1 | 9717 | 34 |
EPN2 |
3.114e-02 | -3.47 | Leu-rich_rpt | interpro domains | IPR001611 | 254 | 3 | 18521 | 50 |
LRRC7,LRRC4C,LRRTM4 |
3.155e-02 | -3.46 | cellular process | biological process | GO:0009987 | 14996 | 42 | 18204 | 45 |
ZSWIM6,RORA,KAZN,KCND2,RBFOX1,LRRC4C,FGF14,DSCAM,DCC,KCNMB2,XYLT1,ABHD2,SLC8A1,CADM2,ANKS1B,SNTG1,NRXN1,LRP1B,ZBTB20,GPC6,NTM,CNTNAP5,TNR,EPN2,OPCML,DAB1,DPP6,SCD5,DLG2,PID1,ADARB2,GRIK1,PCDHGC3,HS6ST3,DLGAP1,PCDH15,KCNIP4,SGCZ,CHST11,NTNG1,LRRC7,NLGN4Y |
3.167e-02 | -3.45 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 45 |
RORA |
3.167e-02 | -3.45 | negative regulation of cytosolic calcium ion concentration | biological process | GO:0051481 | 13 | 1 | 18204 | 45 |
SLC8A1 |
3.167e-02 | -3.45 | cellular response to potassium ion | biological process | GO:0035865 | 13 | 1 | 18204 | 45 |
DLG2 |
3.167e-02 | -3.45 | motor neuron migration | biological process | GO:0097475 | 13 | 1 | 18204 | 45 |
DAB1 |
3.167e-02 | -3.45 | postsynaptic specialization assembly | biological process | GO:0098698 | 13 | 1 | 18204 | 45 |
NRXN1 |
3.167e-02 | -3.45 | calcium ion transport into cytosol | biological process | GO:0060402 | 13 | 1 | 18204 | 45 |
SLC8A1 |
3.167e-02 | -3.45 | locomotor rhythm | biological process | GO:0045475 | 13 | 1 | 18204 | 45 |
KCND2 |
3.167e-02 | -3.45 | detection of calcium ion | biological process | GO:0005513 | 13 | 1 | 18204 | 45 |
KCNMB2 |
3.167e-02 | -3.45 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 45 |
RORA |
3.178e-02 | -3.45 | glycoprotein biosynthetic process | biological process | GO:0009101 | 280 | 3 | 18204 | 45 |
XYLT1,CHST11,HS6ST3 |
3.179e-02 | -3.45 | dendrite development | biological process | GO:0016358 | 113 | 2 | 18204 | 45 |
DAB1,DSCAM |
3.179e-02 | -3.45 | metencephalon development | biological process | GO:0022037 | 113 | 2 | 18204 | 45 |
DAB1,RORA |
3.179e-02 | -3.45 | heart process | biological process | GO:0003015 | 113 | 2 | 18204 | 45 |
SGCZ,SLC8A1 |
3.199e-02 | -3.44 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 5 | 18094 | 43 |
KCNMB2,KCND2,KCNIP4,GRIK1,SLC8A1 |
3.200e-02 | -3.44 | PRR20A (proline rich 20A) | protein interactions | 122183 | 109 | 2 | 19454 | 50 |
DAB1,RBFOX1 |
3.220e-02 | -3.44 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 28 |
GPC6 |
3.220e-02 | -3.44 | Ionotropic activity of Kainate Receptors | REACTOME pathways | R-HSA-451306 | 12 | 1 | 10285 | 28 |
GRIK1 |
3.220e-02 | -3.44 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 28 |
GPC6 |
3.220e-02 | -3.44 | Activation of Ca-permeable Kainate Receptor | REACTOME pathways | R-HSA-451308 | 12 | 1 | 10285 | 28 |
GRIK1 |
3.229e-02 | -3.43 | non_functioning | COSMIC cancer mutations | non_functioning | 239 | 3 | 16828 | 49 |
LRP1B,TNR,DCC |
3.281e-02 | -3.42 | distal axon | cellular component | GO:0150034 | 273 | 3 | 19108 | 49 |
DCC,DSCAM,SLC8A1 |
3.283e-02 | -3.42 | fatty acid biosynthetic process | biological process | GO:0006633 | 115 | 2 | 18204 | 45 |
ABHD2,SCD5 |
3.291e-02 | -3.41 | KCNQ2 (potassium voltage-gated channel subfamily Q member 2) | protein interactions | 3785 | 13 | 1 | 19454 | 50 |
GRIK1 |
3.291e-02 | -3.41 | NCAN (neurocan) | protein interactions | 1463 | 13 | 1 | 19454 | 50 |
TNR |
3.291e-02 | -3.41 | LIPF (lipase F, gastric type) | protein interactions | 8513 | 13 | 1 | 19454 | 50 |
NTNG1 |
3.291e-02 | -3.41 | TBCC (tubulin folding cofactor C) | protein interactions | 6903 | 13 | 1 | 19454 | 50 |
NTM |
3.291e-02 | -3.41 | PCDH18 (protocadherin 18) | protein interactions | 54510 | 13 | 1 | 19454 | 50 |
DAB1 |
3.291e-02 | -3.41 | MYO16 (myosin XVI) | protein interactions | 23026 | 13 | 1 | 19454 | 50 |
NRXN1 |
3.291e-02 | -3.41 | RTL10 (retrotransposon Gag like 10) | protein interactions | 79680 | 13 | 1 | 19454 | 50 |
DSCAM |
3.291e-02 | -3.41 | SERTM1 (serine rich and transmembrane domain containing 1) | protein interactions | 400120 | 13 | 1 | 19454 | 50 |
LRRC4C |
3.291e-02 | -3.41 | RNASE4 (ribonuclease A family member 4) | protein interactions | 6038 | 13 | 1 | 19454 | 50 |
LRP1B |
3.291e-02 | -3.41 | CUBN (cubilin) | protein interactions | 8029 | 13 | 1 | 19454 | 50 |
PID1 |
3.291e-02 | -3.41 | CREB3L4 (cAMP responsive element binding protein 3 like 4) | protein interactions | 148327 | 13 | 1 | 19454 | 50 |
LRRC4C |
3.309e-02 | -3.41 | DLG3 (discs large MAGUK scaffold protein 3) | protein interactions | 1741 | 111 | 2 | 19454 | 50 |
DLG2,DLGAP1 |
3.310e-02 | -3.41 | bladder | COSMIC cancer mutations | bladder | 14112 | 46 | 16828 | 49 |
GPC6,ANKS1B,GRIK1,DAB1,CADM2,NXPH1,SNTG1,KCND2,KCNMB2,NRXN1,SCD5,KCNIP4,HS6ST3,CSMD3,DLG2,NTNG1,DCC,FGF14,LRRC4C,KAZN,LUZP2,TNR,CNTNAP5,PCDHGC3,PDZRN4,SGCZ,EPN2,TMEM132D,DPP6,LRRTM4,ADARB2,DLGAP1,CHST11,PCDH15,SLC8A1,OPCML,LRRC7,NTM,RORA,RBFOX1,XYLT1,LRP1B,DSCAM,ABHD2,NLGN4Y,ZBTB20 |
3.310e-02 | -3.41 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 46 | 16828 | 49 |
ABHD2,NLGN4Y,ZBTB20,RBFOX1,XYLT1,DSCAM,LRP1B,CHST11,PCDH15,DPP6,LRRTM4,ADARB2,DLGAP1,NTM,RORA,SLC8A1,OPCML,LRRC7,CNTNAP5,PCDHGC3,LUZP2,TNR,EPN2,TMEM132D,PDZRN4,SGCZ,DCC,CSMD3,NTNG1,DLG2,KAZN,FGF14,LRRC4C,SNTG1,KCND2,NXPH1,NRXN1,SCD5,HS6ST3,KCNIP4,KCNMB2,CADM2,GRIK1,GPC6,ANKS1B,DAB1 |
3.324e-02 | -3.40 | cell junction assembly | biological process | GO:0034329 | 285 | 3 | 18204 | 45 |
NLGN4Y,NRXN1,DSCAM |
3.331e-02 | -3.40 | bone-femur-chondrosarcoma | COSMIC cancer mutations | bone-femur-chondrosarcoma | 419 | 4 | 16828 | 49 |
NTNG1,LRRC7,DPP6,LRP1B |
3.335e-02 | -3.40 | aminoglycan metabolic process | biological process | GO:0006022 | 116 | 2 | 18204 | 45 |
CHST11,XYLT1 |
3.352e-02 | -3.40 | tibia | COSMIC cancer mutations | tibia | 836 | 6 | 16828 | 49 |
PCDH15,CNTNAP5,LUZP2,LRRTM4,LRP1B,LRRC7 |
3.389e-02 | -3.38 | human chr13q33.1 | chromosome location | human chr13q33.1 | 18 | 1 | 26134 | 50 |
FGF14 |
3.389e-02 | -3.38 | SAM | smart domains | SM00454 | 83 | 2 | 9717 | 34 |
ANKS1B,KAZN |
3.407e-02 | -3.38 | neurotransmitter receptor transport to postsynaptic membrane | biological process | GO:0098969 | 14 | 1 | 18204 | 45 |
LRRC7 |
3.407e-02 | -3.38 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 45 |
NRXN1 |
3.407e-02 | -3.38 | dendrite self-avoidance | biological process | GO:0070593 | 14 | 1 | 18204 | 45 |
DSCAM |
3.407e-02 | -3.38 | protein transport along microtubule | biological process | GO:0098840 | 14 | 1 | 18204 | 45 |
DLG2 |
3.407e-02 | -3.38 | smooth muscle cell migration | biological process | GO:0014909 | 14 | 1 | 18204 | 45 |
ABHD2 |
3.407e-02 | -3.38 | Golgi localization | biological process | GO:0051645 | 14 | 1 | 18204 | 45 |
DAB1 |
3.407e-02 | -3.38 | protein localization to endosome | biological process | GO:0036010 | 14 | 1 | 18204 | 45 |
LRRC7 |
3.407e-02 | -3.38 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 45 |
SLC8A1 |
3.407e-02 | -3.38 | positive regulation of nucleotide biosynthetic process | biological process | GO:0030810 | 14 | 1 | 18204 | 45 |
PID1 |
3.407e-02 | -3.38 | microtubule-based protein transport | biological process | GO:0099118 | 14 | 1 | 18204 | 45 |
DLG2 |
3.407e-02 | -3.38 | positive regulation of purine nucleotide biosynthetic process | biological process | GO:1900373 | 14 | 1 | 18204 | 45 |
PID1 |
3.407e-02 | -3.38 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 45 |
SLC8A1 |
3.443e-02 | -3.37 | muscle cell differentiation | biological process | GO:0042692 | 289 | 3 | 18204 | 45 |
SLC8A1,RORA,SGCZ |
3.454e-02 | -3.37 | Carboxylesterase_B_CS | interpro domains | IPR019819 | 13 | 1 | 18521 | 50 |
NLGN4Y |
3.484e-02 | -3.36 | Sodium/Calcium exchangers | REACTOME pathways | R-HSA-425561 | 13 | 1 | 10285 | 28 |
SLC8A1 |
3.500e-02 | -3.35 | Cadherin_CS | interpro domains | IPR020894 | 109 | 2 | 18521 | 50 |
PCDHGC3,PCDH15 |
3.505e-02 | -3.35 | ASX_HYDROXYL | prosite domains | PS00010 | 100 | 2 | 12186 | 36 |
LRP1B,NRXN1 |
3.507e-02 | -3.35 | chondroitin sulfate biosynthesis (late stages) | BIOCYC pathways | HUMAN_PWY-6567 | 8 | 1 | 902 | 4 |
CHST11 |
3.507e-02 | -3.35 | neurexin family protein binding | molecular function | GO:0042043 | 15 | 1 | 18094 | 43 |
NLGN4Y |
3.507e-02 | -3.35 | acylglycerol lipase activity | molecular function | GO:0047372 | 15 | 1 | 18094 | 43 |
ABHD2 |
3.507e-02 | -3.35 | heparan sulfate sulfotransferase activity | molecular function | GO:0034483 | 15 | 1 | 18094 | 43 |
HS6ST3 |
3.507e-02 | -3.35 | low-density lipoprotein particle receptor activity | molecular function | GO:0005041 | 15 | 1 | 18094 | 43 |
LRP1B |
3.522e-02 | -3.35 | Ldl_recept_b | pfam domains | PF00058 | 13 | 1 | 17795 | 49 |
LRP1B |
3.530e-02 | -3.34 | SULF2 (sulfatase 2) | protein interactions | 55959 | 115 | 2 | 19454 | 50 |
LRP1B,LRRC4C |
3.532e-02 | -3.34 | sperm plasma membrane | cellular component | GO:0097524 | 14 | 1 | 19108 | 49 |
ABHD2 |
3.540e-02 | -3.34 | RSPO1 (R-spondin 1) | protein interactions | 284654 | 14 | 1 | 19454 | 50 |
LRP1B |
3.540e-02 | -3.34 | GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2) | protein interactions | 2977 | 14 | 1 | 19454 | 50 |
DLG2 |
3.540e-02 | -3.34 | PLXNA4 (plexin A4) | protein interactions | 91584 | 14 | 1 | 19454 | 50 |
SGCZ |
3.540e-02 | -3.34 | UBI4 (ubiquitin) | protein interactions | 850620 | 14 | 1 | 19454 | 50 |
DCC |
3.540e-02 | -3.34 | SCRN3 (secernin 3) | protein interactions | 79634 | 14 | 1 | 19454 | 50 |
PID1 |
3.540e-02 | -3.34 | GRID2 (glutamate ionotropic receptor delta type subunit 2) | protein interactions | 2895 | 14 | 1 | 19454 | 50 |
DLG2 |
3.540e-02 | -3.34 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 50 |
ZBTB20 |
3.540e-02 | -3.34 | SYT5 (synaptotagmin 5) | protein interactions | 6861 | 14 | 1 | 19454 | 50 |
NRXN1 |
3.553e-02 | -3.34 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 48 | 16828 | 49 |
TMEM132D,EPN2,SGCZ,PDZRN4,DAB1,LHFPL3,GRIK1,PID1,PCDHGC3,CNTNAP5,TNR,GPC6,LUZP2,ANKS1B,CADM2,RORA,NTM,OPCML,SLC8A1,LRRC7,CHST11,PCDH15,LRRTM4,DPP6,DLGAP1,ADARB2,SCD5,NRXN1,KCNIP4,HS6ST3,DSCAM,LRP1B,KCNMB2,SNTG1,RBFOX1,XYLT1,KCND2,NXPH1,KAZN,FGF14,NLGN4Y,ZBTB20,LRRC4C,ABHD2,DCC,DLG2,NTNG1,CSMD3 |
3.574e-02 | -3.33 | human chr7p21.3 | chromosome location | human chr7p21.3 | 19 | 1 | 26134 | 50 |
NXPH1 |
3.574e-02 | -3.33 | human chr10p15.3 | chromosome location | human chr10p15.3 | 19 | 1 | 26134 | 50 |
ADARB2 |
3.601e-02 | -3.32 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 2 | 7161 | 19 |
GRIK1,DLGAP1 |
3.601e-02 | -3.32 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 2 | 7161 | 19 |
GRIK1,DLGAP1 |
3.646e-02 | -3.31 | negative regulation of axon regeneration | biological process | GO:0048681 | 15 | 1 | 18204 | 45 |
TNR |
3.646e-02 | -3.31 | endosome to plasma membrane protein transport | biological process | GO:0099638 | 15 | 1 | 18204 | 45 |
LRRC7 |
3.646e-02 | -3.31 | neurotransmitter receptor transport to plasma membrane | biological process | GO:0098877 | 15 | 1 | 18204 | 45 |
LRRC7 |
3.646e-02 | -3.31 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 45 |
RORA |
3.646e-02 | -3.31 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 45 |
NTNG1 |
3.646e-02 | -3.31 | medium-chain fatty acid metabolic process | biological process | GO:0051791 | 15 | 1 | 18204 | 45 |
ABHD2 |
3.646e-02 | -3.31 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 45 |
SLC8A1 |
3.646e-02 | -3.31 | establishment of protein localization to postsynaptic membrane | biological process | GO:1903540 | 15 | 1 | 18204 | 45 |
LRRC7 |
3.699e-02 | -3.30 | BHLHE40 (basic helix-loop-helix family member e40) | protein interactions | 8553 | 118 | 2 | 19454 | 50 |
DAB1,RBFOX1 |
3.715e-02 | -3.29 | Recoverin | interpro domains | IPR028846 | 14 | 1 | 18521 | 50 |
KCNIP4 |
3.715e-02 | -3.29 | CarbesteraseB | interpro domains | IPR002018 | 14 | 1 | 18521 | 50 |
NLGN4Y |
3.715e-02 | -3.29 | LDLR_classB_rpt | interpro domains | IPR000033 | 14 | 1 | 18521 | 50 |
LRP1B |
3.719e-02 | -3.29 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 48 | 16828 | 49 |
CSMD3,NTNG1,DLG2,DCC,FGF14,LRRC4C,KAZN,NXPH1,SNTG1,KCND2,KCNMB2,NRXN1,SCD5,HS6ST3,KCNIP4,CADM2,GPC6,ANKS1B,GRIK1,DAB1,ABHD2,NLGN4Y,ZBTB20,RBFOX1,XYLT1,LRP1B,DSCAM,DPP6,LRRTM4,ADARB2,DLGAP1,CHST11,PCDH15,SLC8A1,OPCML,LRRC7,NTM,RORA,LUZP2,TNR,PID1,LHFPL3,CNTNAP5,PCDHGC3,PDZRN4,SGCZ,EPN2,TMEM132D |
3.721e-02 | -3.29 | skin-vulva-malignant_melanoma | COSMIC cancer mutations | skin-vulva-malignant_melanoma | 13 | 1 | 16828 | 49 |
DCC |
3.737e-02 | -3.29 | glutamate-gated receptor activity | molecular function | GO:0004970 | 16 | 1 | 18094 | 43 |
GRIK1 |
3.737e-02 | -3.29 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 43 |
RORA |
3.747e-02 | -3.28 | Reduction of cytosolic Ca++ levels | REACTOME pathways | R-HSA-418359 | 14 | 1 | 10285 | 28 |
SLC8A1 |
3.747e-02 | -3.28 | DCC mediated attractive signaling | REACTOME pathways | R-HSA-418885 | 14 | 1 | 10285 | 28 |
DCC |
3.759e-02 | -3.28 | human chr10q21.1 | chromosome location | human chr10q21.1 | 20 | 1 | 26134 | 50 |
PCDH15 |
3.764e-02 | -3.28 | skin-sole-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-sole-malignant_melanoma-acral_lentiginous | 254 | 3 | 16828 | 49 |
LUZP2,GRIK1,DCC |
3.773e-02 | -3.28 | Cadherins | gene3d domains | 2.60.40.60 | 114 | 2 | 14470 | 39 |
PCDHGC3,PCDH15 |
3.775e-02 | -3.28 | LDLRB | prosite domains | PS51120 | 13 | 1 | 12186 | 36 |
LRP1B |
3.775e-02 | -3.28 | CARBOXYLESTERASE_B_2 | prosite domains | PS00941 | 13 | 1 | 12186 | 36 |
NLGN4Y |
3.788e-02 | -3.27 | DEFB123 (defensin beta 123) | protein interactions | 245936 | 15 | 1 | 19454 | 50 |
LRP1B |
3.788e-02 | -3.27 | MBNL3 (muscleblind like splicing regulator 3) | protein interactions | 55796 | 15 | 1 | 19454 | 50 |
DAB1 |
3.788e-02 | -3.27 | FZD1 (frizzled class receptor 1) | protein interactions | 8321 | 15 | 1 | 19454 | 50 |
DLG2 |
3.788e-02 | -3.27 | OLFM3 (olfactomedin 3) | protein interactions | 118427 | 15 | 1 | 19454 | 50 |
LRP1B |
3.788e-02 | -3.27 | COesterase | pfam domains | PF00135 | 14 | 1 | 17795 | 49 |
NLGN4Y |
3.798e-02 | -3.27 | Cadherin-like_dom | interpro domains | IPR002126 | 114 | 2 | 18521 | 50 |
PCDHGC3,PCDH15 |
3.811e-02 | -3.27 | Cadherin | pfam domains | PF00028 | 112 | 2 | 17795 | 49 |
PCDHGC3,PCDH15 |
3.814e-02 | -3.27 | ANKRD13A (ankyrin repeat domain 13A) | protein interactions | 88455 | 120 | 2 | 19454 | 50 |
KCNIP4,KCNMB2 |
3.833e-02 | -3.26 | Transcription Factor, Ets-1 | gene3d domains | 1.10.150.50 | 115 | 2 | 14470 | 39 |
KAZN,ANKS1B |
3.859e-02 | -3.25 | Reelin signaling pathway | Pathway Interaction DB | reelinpathway | 29 | 1 | 2226 | 3 |
DAB1 |
3.884e-02 | -3.25 | negative regulation of glucose import | biological process | GO:0046325 | 16 | 1 | 18204 | 45 |
PID1 |
3.884e-02 | -3.25 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 45 |
TNR |
3.884e-02 | -3.25 | regulation of axon extension involved in axon guidance | biological process | GO:0048841 | 16 | 1 | 18204 | 45 |
DSCAM |
3.884e-02 | -3.25 | regulation of ATP biosynthetic process | biological process | GO:2001169 | 16 | 1 | 18204 | 45 |
PID1 |
3.884e-02 | -3.25 | vascular associated smooth muscle contraction | biological process | GO:0014829 | 16 | 1 | 18204 | 45 |
SLC8A1 |
3.884e-02 | -3.25 | regulation of transmission of nerve impulse | biological process | GO:0051969 | 16 | 1 | 18204 | 45 |
TNR |
3.884e-02 | -3.25 | regulation of cell communication by electrical coupling | biological process | GO:0010649 | 16 | 1 | 18204 | 45 |
SLC8A1 |
3.884e-02 | -3.25 | negative regulation of neuron projection regeneration | biological process | GO:0070571 | 16 | 1 | 18204 | 45 |
TNR |
3.884e-02 | -3.25 | heparan sulfate proteoglycan metabolic process | biological process | GO:0030201 | 16 | 1 | 18204 | 45 |
HS6ST3 |
3.884e-02 | -3.25 | negative regulation of astrocyte differentiation | biological process | GO:0048712 | 16 | 1 | 18204 | 45 |
DAB1 |
3.920e-02 | -3.24 | Cadherin-like_sf | interpro domains | IPR015919 | 116 | 2 | 18521 | 50 |
PCDH15,PCDHGC3 |
3.943e-02 | -3.23 | human chr13q32.1 | chromosome location | human chr13q32.1 | 21 | 1 | 26134 | 50 |
HS6ST3 |
3.959e-02 | -3.23 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 5 |
RORA |
3.966e-02 | -3.23 | ligand-gated sodium channel activity | molecular function | GO:0015280 | 17 | 1 | 18094 | 43 |
GRIK1 |
3.985e-02 | -3.22 | animal organ development | biological process | GO:0048513 | 2846 | 12 | 18204 | 45 |
SLC8A1,PCDH15,XYLT1,DSCAM,CSMD1,KAZN,ZSWIM6,RORA,TNR,DAB1,CHST11,SGCZ |
3.990e-02 | -3.22 | embryonic skeletal system development | biological process | GO:0048706 | 128 | 2 | 18204 | 45 |
XYLT1,CHST11 |
4.021e-02 | -3.21 | gated channel activity | molecular function | GO:0022836 | 320 | 3 | 18094 | 43 |
KCND2,KCNMB2,GRIK1 |
4.027e-02 | -3.21 | asymmetric, glutamatergic, excitatory synapse | cellular component | GO:0098985 | 16 | 1 | 19108 | 49 |
NLGN4Y |
4.035e-02 | -3.21 | SYTL2 (synaptotagmin like 2) | protein interactions | 54843 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 50 |
ZBTB20 |
4.035e-02 | -3.21 | TMEM176A (transmembrane protein 176A) | protein interactions | 55365 | 16 | 1 | 19454 | 50 |
SCD5 |
4.035e-02 | -3.21 | KCNJ4 (potassium inwardly rectifying channel subfamily J member 4) | protein interactions | 3761 | 16 | 1 | 19454 | 50 |
DLG2 |
4.035e-02 | -3.21 | TWSG1 (twisted gastrulation BMP signaling modulator 1) | protein interactions | 57045 | 16 | 1 | 19454 | 50 |
LRRC4C |
4.035e-02 | -3.21 | APC2 (APC regulator of WNT signaling pathway 2) | protein interactions | 10297 | 16 | 1 | 19454 | 50 |
DSCAM |
4.035e-02 | -3.21 | SYT4 (synaptotagmin 4) | protein interactions | 6860 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | SYT9 (synaptotagmin 9) | protein interactions | 143425 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | FZD4 (frizzled class receptor 4) | protein interactions | 8322 | 16 | 1 | 19454 | 50 |
DLG2 |
4.049e-02 | -3.21 | CADHERIN | prints domains | PR00205 | 113 | 2 | 5227 | 15 |
PCDH15,PCDHGC3 |
4.066e-02 | -3.20 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 25 | 16828 | 49 |
GPC6,TNR,ANKS1B,PCDHGC3,CNTNAP5,TMEM132D,LRRTM4,ZSWIM6,DLGAP1,PCDH15,SLC8A1,CADM2,RORA,NTM,XYLT1,KCND2,LRP1B,SCD5,NRXN1,DSCAM,NTNG1,CSMD3,DCC,ZBTB20,LRRC4C |
4.066e-02 | -3.20 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 25 | 16828 | 49 |
XYLT1,KCND2,SCD5,NRXN1,DSCAM,LRP1B,DCC,NTNG1,CSMD3,ZBTB20,LRRC4C,PCDHGC3,CNTNAP5,GPC6,TNR,ANKS1B,TMEM132D,PCDH15,LRRTM4,ZSWIM6,DLGAP1,CADM2,RORA,NTM,SLC8A1 |
4.089e-02 | -3.20 | ligand-gated monoatomic cation channel activity | molecular function | GO:0099094 | 135 | 2 | 18094 | 43 |
KCNMB2,GRIK1 |
4.100e-02 | -3.19 | CADHERIN_1 | prosite domains | PS00232 | 109 | 2 | 12186 | 36 |
PCDHGC3,PCDH15 |
4.104e-02 | -3.19 | negative regulation of cell adhesion | biological process | GO:0007162 | 310 | 3 | 18204 | 45 |
DSCAM,DAB1,TNR |
4.106e-02 | -3.19 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 3 | 16828 | 49 |
XYLT1,GPC6,CSMD3 |
4.106e-02 | -3.19 | SCGB1D1 (secretoglobin family 1D member 1) | protein interactions | 10648 | 125 | 2 | 19454 | 50 |
LRP1B,KCNIP4 |
4.122e-02 | -3.19 | Lissencephaly gene (LIS1) in neuronal migration and development | Pathway Interaction DB | lis1pathway | 31 | 1 | 2226 | 3 |
DAB1 |
4.122e-02 | -3.19 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 45 |
RORA |
4.122e-02 | -3.19 | anatomical structure arrangement | biological process | GO:0048532 | 17 | 1 | 18204 | 45 |
DAB1 |
4.122e-02 | -3.19 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 45 |
SLC8A1 |
4.122e-02 | -3.19 | cellular response to leptin stimulus | biological process | GO:0044320 | 17 | 1 | 18204 | 45 |
PID1 |
4.122e-02 | -3.19 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 45 |
SLC8A1 |
4.122e-02 | -3.19 | cell migration in hindbrain | biological process | GO:0021535 | 17 | 1 | 18204 | 45 |
DAB1 |
4.122e-02 | -3.19 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 45 |
RORA |
4.127e-02 | -3.19 | human chr2q36.3 | chromosome location | human chr2q36.3 | 22 | 1 | 26134 | 50 |
PID1 |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
ZBTB20 |
4.137e-02 | -3.19 | sulfur compound metabolic process | biological process | GO:0006790 | 311 | 3 | 18204 | 45 |
XYLT1,HS6ST3,CHST11 |
4.159e-02 | -3.18 | regulation of signaling | biological process | GO:0023051 | 3534 | 14 | 18204 | 45 |
CHST11,GPC6,NRXN1,TNR,EPN2,DAB1,NTNG1,NLGN4Y,PID1,RORA,GRIK1,DLGAP1,LRRC4C,DCC |
4.167e-02 | -3.18 | SAM/pointed_sf | interpro domains | IPR013761 | 120 | 2 | 18521 | 50 |
ANKS1B,KAZN |
4.194e-02 | -3.17 | lipoprotein particle receptor activity | molecular function | GO:0030228 | 18 | 1 | 18094 | 43 |
LRP1B |
4.203e-02 | -3.17 | - | gene3d domains | 2.60.120.200 | 121 | 2 | 14470 | 39 |
CNTNAP5,NRXN1 |
4.211e-02 | -3.17 | cell-cell junction | cellular component | GO:0005911 | 513 | 4 | 19108 | 49 |
SLC8A1,KAZN,LRRC7,DLG2 |
4.226e-02 | -3.16 | ECM1 (extracellular matrix protein 1) | protein interactions | 1893 | 127 | 2 | 19454 | 50 |
RBFOX1,SNTG1 |
4.235e-02 | -3.16 | Guanylate_kinase_CS | interpro domains | IPR020590 | 16 | 1 | 18521 | 50 |
DLG2 |
4.235e-02 | -3.16 | Laminin_N | interpro domains | IPR008211 | 16 | 1 | 18521 | 50 |
NTNG1 |
4.237e-02 | -3.16 | regulation of developmental growth | biological process | GO:0048638 | 314 | 3 | 18204 | 45 |
TNR,DSCAM,DCC |
4.273e-02 | -3.15 | protein complex involved in cell-matrix adhesion | cellular component | GO:0098637 | 17 | 1 | 19108 | 49 |
TNR |
4.273e-02 | -3.15 | inhibitory synapse | cellular component | GO:0060077 | 17 | 1 | 19108 | 49 |
NLGN4Y |
4.282e-02 | -3.15 | GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C) | protein interactions | 2905 | 17 | 1 | 19454 | 50 |
DLGAP1 |
4.282e-02 | -3.15 | DNAAF6 (dynein axonemal assembly factor 6) | protein interactions | 139212 | 17 | 1 | 19454 | 50 |
PID1 |
4.282e-02 | -3.15 | NFASC (neurofascin) | protein interactions | 23114 | 17 | 1 | 19454 | 50 |
TNR |
4.282e-02 | -3.15 | GRID1 (glutamate ionotropic receptor delta type subunit 1) | protein interactions | 2894 | 17 | 1 | 19454 | 50 |
DLG2 |
4.282e-02 | -3.15 | RNF24 (ring finger protein 24) | protein interactions | 11237 | 17 | 1 | 19454 | 50 |
LHFPL3 |
4.282e-02 | -3.15 | CLEC1A (C-type lectin domain family 1 member A) | protein interactions | 51267 | 17 | 1 | 19454 | 50 |
LRRC4C |
4.282e-02 | -3.15 | RGPD2 (RANBP2 like and GRIP domain containing 2) | protein interactions | 729857 | 17 | 1 | 19454 | 50 |
NTNG1 |
4.282e-02 | -3.15 | DPP6 (dipeptidyl peptidase like 6) | protein interactions | 1804 | 17 | 1 | 19454 | 50 |
KCND2 |
4.282e-02 | -3.15 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 50 |
NTM |
4.286e-02 | -3.15 | EIF2B2 (eukaryotic translation initiation factor 2B subunit beta) | protein interactions | 8892 | 128 | 2 | 19454 | 50 |
DCC,FGF14 |
4.311e-02 | -3.14 | human chr2q14.3 | chromosome location | human chr2q14.3 | 23 | 1 | 26134 | 50 |
CNTNAP5 |
4.311e-02 | -3.14 | human chr18q21.2 | chromosome location | human chr18q21.2 | 23 | 1 | 26134 | 50 |
DCC |
4.318e-02 | -3.14 | Laminin_N | pfam domains | PF00055 | 16 | 1 | 17795 | 49 |
NTNG1 |
4.342e-02 | -3.14 | sole | COSMIC cancer mutations | sole | 269 | 3 | 16828 | 49 |
LUZP2,DCC,GRIK1 |
4.346e-02 | -3.14 | EIF2B4 (eukaryotic translation initiation factor 2B subunit delta) | protein interactions | 8890 | 129 | 2 | 19454 | 50 |
DCC,FGF14 |
4.359e-02 | -3.13 | ossification involved in bone maturation | biological process | GO:0043931 | 18 | 1 | 18204 | 45 |
XYLT1 |
4.359e-02 | -3.13 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 45 |
RORA |
4.422e-02 | -3.12 | ankyrin binding | molecular function | GO:0030506 | 19 | 1 | 18094 | 43 |
SLC8A1 |
4.446e-02 | -3.11 | CADHERIN_2 | prosite domains | PS50268 | 114 | 2 | 12186 | 36 |
PCDH15,PCDHGC3 |
4.487e-02 | -3.10 | - | gene3d domains | 2.60.120.1000 | 17 | 1 | 14470 | 39 |
CNTNAP5 |
4.494e-02 | -3.10 | human chr8p22 | chromosome location | human chr8p22 | 24 | 1 | 26134 | 50 |
SGCZ |
4.510e-02 | -3.10 | circadian rhythm | biological process | GO:0007623 | 137 | 2 | 18204 | 45 |
RORA,KCND2 |
4.524e-02 | -3.10 | pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 5 | 16828 | 49 |
RBFOX1,KAZN,PCDHGC3,DPP6,LRRC7 |
4.524e-02 | -3.10 | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 5 | 16828 | 49 |
LRRC7,DPP6,PCDHGC3,KAZN,RBFOX1 |
4.529e-02 | -3.09 | CXXC5 (CXXC finger protein 5) | protein interactions | 51523 | 18 | 1 | 19454 | 50 |
DSCAM |
4.529e-02 | -3.09 | MFSD3 (major facilitator superfamily domain containing 3) | protein interactions | 113655 | 18 | 1 | 19454 | 50 |
PCDHGC3 |
4.529e-02 | -3.09 | ADH1C (alcohol dehydrogenase 1C (class I), gamma polypeptide) | protein interactions | 126 | 18 | 1 | 19454 | 50 |
XYLT1 |
4.529e-02 | -3.09 | ZNF224 (zinc finger protein 224) | protein interactions | 7767 | 18 | 1 | 19454 | 50 |
LRP1B |
4.529e-02 | -3.09 | CNDP1 (carnosine dipeptidase 1) | protein interactions | 84735 | 18 | 1 | 19454 | 50 |
SCD5 |
4.529e-02 | -3.09 | GRIK5 (glutamate ionotropic receptor kainate type subunit 5) | protein interactions | 2901 | 18 | 1 | 19454 | 50 |
GRIK1 |
4.529e-02 | -3.09 | RILPL1 (Rab interacting lysosomal protein like 1) | protein interactions | 353116 | 18 | 1 | 19454 | 50 |
DSCAM |
4.529e-02 | -3.09 | LRRC4 (leucine rich repeat containing 4) | protein interactions | 64101 | 18 | 1 | 19454 | 50 |
LRRC4C |
4.529e-02 | -3.09 | ZNF365 (zinc finger protein 365) | protein interactions | 22891 | 18 | 1 | 19454 | 50 |
DSCAM |
4.529e-02 | -3.09 | OPCML (opioid binding protein/cell adhesion molecule like) | protein interactions | 4978 | 18 | 1 | 19454 | 50 |
NTM |
4.529e-02 | -3.09 | RELN (reelin) | protein interactions | 5649 | 18 | 1 | 19454 | 50 |
DAB1 |
4.529e-02 | -3.09 | CDIP1 (cell death inducing p53 target 1) | protein interactions | 29965 | 18 | 1 | 19454 | 50 |
EPN2 |
4.569e-02 | -3.09 | regulation of protein localization to cell periphery | biological process | GO:1904375 | 138 | 2 | 18204 | 45 |
GPC6,PID1 |
4.581e-02 | -3.08 | dsrm | pfam domains | PF00035 | 17 | 1 | 17795 | 49 |
ADARB2 |
4.591e-02 | -3.08 | PTPRS (protein tyrosine phosphatase receptor type S) | protein interactions | 5802 | 133 | 2 | 19454 | 50 |
LRRTM4,GPC6 |
4.596e-02 | -3.08 | excitatory synapse assembly | biological process | GO:1904861 | 19 | 1 | 18204 | 45 |
NRXN1 |
4.596e-02 | -3.08 | response to potassium ion | biological process | GO:0035864 | 19 | 1 | 18204 | 45 |
DLG2 |
4.596e-02 | -3.08 | GABAergic neuron differentiation | biological process | GO:0097154 | 19 | 1 | 18204 | 45 |
ZSWIM6 |
4.596e-02 | -3.08 | cerebellar Purkinje cell layer morphogenesis | biological process | GO:0021692 | 19 | 1 | 18204 | 45 |
RORA |
4.596e-02 | -3.08 | post-anal tail morphogenesis | biological process | GO:0036342 | 19 | 1 | 18204 | 45 |
CHST11 |
4.596e-02 | -3.08 | presynapse assembly | biological process | GO:0099054 | 19 | 1 | 18204 | 45 |
NLGN4Y |
4.596e-02 | -3.08 | base conversion or substitution editing | biological process | GO:0016553 | 19 | 1 | 18204 | 45 |
ADARB2 |
4.626e-02 | -3.07 | GUANYLATE_KINASE_1 | prosite domains | PS00856 | 16 | 1 | 12186 | 36 |
DLG2 |
4.626e-02 | -3.07 | FA58C_2 | prosite domains | PS01286 | 16 | 1 | 12186 | 36 |
CNTNAP5 |
4.626e-02 | -3.07 | LAMININ_NTER | prosite domains | PS51117 | 16 | 1 | 12186 | 36 |
NTNG1 |
4.629e-02 | -3.07 | cellular response to hypoxia | biological process | GO:0071456 | 139 | 2 | 18204 | 45 |
RORA,KCND2 |
4.653e-02 | -3.07 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 2 | 19454 | 50 |
NTM,CADM2 |
4.722e-02 | -3.05 | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | 15813 | 49 | 16828 | 49 |
CADM2,ZSWIM6,DAB1,ANKS1B,GPC6,GRIK1,LRRC4C,FGF14,KAZN,NTNG1,DLG2,CSMD3,DCC,KCNMB2,HS6ST3,KCNIP4,SCD5,NRXN1,NXPH1,KCND2,SNTG1,LRRC7,OPCML,SLC8A1,RORA,NTM,DLGAP1,ADARB2,LRRTM4,DPP6,PCDH15,CHST11,SGCZ,PDZRN4,TMEM132D,EPN2,TNR,LUZP2,PCDHGC3,CNTNAP5,LHFPL3,PID1,ZBTB20,NLGN4Y,ABHD2,LRP1B,DSCAM,XYLT1,RBFOX1 |
4.727e-02 | -3.05 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 5 | 18204 | 45 |
KCNIP4,KCNMB2,GRIK1,SLC8A1,KCND2 |
4.752e-02 | -3.05 | Iontro_rcpt_C | interpro domains | IPR001320 | 18 | 1 | 18521 | 50 |
GRIK1 |
4.752e-02 | -3.05 | Ionotropic_Glu_rcpt | interpro domains | IPR015683 | 18 | 1 | 18521 | 50 |
GRIK1 |
4.752e-02 | -3.05 | Glu/Gly-bd | interpro domains | IPR019594 | 18 | 1 | 18521 | 50 |
GRIK1 |
4.752e-02 | -3.05 | Iono_Glu_rcpt_met | interpro domains | IPR001508 | 18 | 1 | 18521 | 50 |
GRIK1 |
4.774e-02 | -3.04 | INKA1 (inka box actin regulator 1) | protein interactions | 389119 | 19 | 1 | 19454 | 50 |
ZBTB20 |
4.774e-02 | -3.04 | EGFL6 (EGF like domain multiple 6) | protein interactions | 25975 | 19 | 1 | 19454 | 50 |
LRP1B |
4.774e-02 | -3.04 | SYT7 (synaptotagmin 7) | protein interactions | 9066 | 19 | 1 | 19454 | 50 |
NRXN1 |
4.774e-02 | -3.04 | TNR (tenascin R) | protein interactions | 7143 | 19 | 1 | 19454 | 50 |
TNR |
4.774e-02 | -3.04 | HSFX1 (heat shock transcription factor family, X-linked 1) | protein interactions | 100506164 | 19 | 1 | 19454 | 50 |
RBFOX1 |
4.792e-02 | -3.04 | LY | smart domains | SM00135 | 14 | 1 | 9717 | 34 |
LRP1B |
4.792e-02 | -3.04 | cGMP effects | REACTOME pathways | R-HSA-418457 | 18 | 1 | 10285 | 28 |
KCNMB2 |
4.809e-02 | -3.03 | positive regulation of small molecule metabolic process | biological process | GO:0062013 | 142 | 2 | 18204 | 45 |
PID1,ZBTB20 |
4.809e-02 | -3.03 | neuron migration | biological process | GO:0001764 | 142 | 2 | 18204 | 45 |
DCC,DAB1 |
4.825e-02 | -3.03 | regulation of small molecule metabolic process | biological process | GO:0062012 | 331 | 3 | 18204 | 45 |
RORA,PID1,ZBTB20 |
4.832e-02 | -3.03 | regulation of synapse maturation | biological process | GO:0090128 | 20 | 1 | 18204 | 45 |
NRXN1 |
4.832e-02 | -3.03 | regulation of collateral sprouting | biological process | GO:0048670 | 20 | 1 | 18204 | 45 |
DCC |
4.832e-02 | -3.03 | retrograde axonal transport | biological process | GO:0008090 | 20 | 1 | 18204 | 45 |
DLG2 |
4.844e-02 | -3.03 | Lig_chan-Glu_bd | pfam domains | PF10613 | 18 | 1 | 17795 | 49 |
GRIK1 |
4.844e-02 | -3.03 | Lig_chan | pfam domains | PF00060 | 18 | 1 | 17795 | 49 |
GRIK1 |
4.876e-02 | -3.02 | nucleoside monophosphate kinase activity | molecular function | GO:0050145 | 21 | 1 | 18094 | 43 |
DLG2 |
4.902e-02 | -3.02 | regulation of biological quality | biological process | GO:0065008 | 2936 | 12 | 18204 | 45 |
GPC6,NRXN1,TNR,LRRC7,KCND2,PID1,DLG2,GRIK1,SLC8A1,DSCAM,KCNMB2,DCC |
4.969e-02 | -3.00 | glycoprotein metabolic process | biological process | GO:0009100 | 335 | 3 | 18204 | 45 |
XYLT1,HS6ST3,CHST11 |
4.987e-02 | -3.00 | Metapathway biotransformation | WikiPathways | WP702 | 177 | 2 | 5310 | 11 |
HS6ST3,CHST11 |